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Tuberculosis is a pulmonary disease that has ravaged the world throughout history. 
Even today, many developed and developing countries are experiencing this plight, made 
worse by the scourge of antibiotic-resistant bacteria.  
Mycobacterium tuberculosis’s class II fructose-1,6-bisphosphate aldolase presents 
an interesting target in the design of new therapies against this disease. Previous attempts 
to construct an inhibitor to this enzyme fell short due to poor selectivity or poor cellular 
uptake. However a new class of noncompetitive inhibitor based on 8-hydoxyquinoline-2-
carboxylic acid presents a fresh approach. Preliminary studies indicate various 
modifications to this scaffold could be beneficial to its inhibitory efficacy. 
Modifications made to the phenol ring of the quinoline included small hydrophobic 
moieties such as methyl groups and fluorine. Additionally various carboxylic acid 
derivatives were installed next to the nitrogen of the heteroring. These derivatives included 
esters, amides, carbamates and ureas, and heterocycles. Biochemical testing of these 
compounds is ongoing but is already showing promising results. 
Many methods exist for the construction of quinoline rings systems, which can be 
utilized based on the pattern of substitution desired. Synthesis of heteroring-unsubstituted 
quinolines, however, has historically presented more of a challenge. Herein is described a 
novel method of cyclizing anilines with acrolein diethyl acetal to form these desired 
structures. This method produces quinolines with various substitutions on the phenyl ring 
iii 
in moderate to high yields without the use of harsh oxidants, extended reaction times, or 
organic solvents. 
The Lewis base-catalyzed annulation of allenoates with alkene acceptors in [3+2] 
cycloadditions is a new but burgeoning field. Many acceptors have been used in these 
reactions, but the use of quinones is unprecedented. Due to the highly reactive nature of 
quinones, it became necessary to screen various Lewis bases that would catalyze the 
reaction without being oxidized by the quinone. This is an ongoing investigation but is 
promising in the production of novel carbocycles that have potential benefits in medicinal 
chemistry. 
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1 
1 INTRODUCTION TO TUBERCULOSIS AND ANTI-TUBERCULOSIS 
DRUG RESEARCH  
1.1 The problem of tuberculosis  Tuberculosis (TB) is a pulmonary disease that affects millions of people and is a 
leading cause of death worldwide. According to the most recent World Health Organization 
report, an estimated 9.6 million new cases of active tubercular disease were reported in 
2014, and 1.5 million deaths were attributed to this illness [1]. In fact, TB has overtaken 
HIV as the leading cause of death due to infectious disease [2]. In addition, an estimated 
two billion people harbor an asymptomatic form of tuberculosis known as latent TB 
infection which poses a risk for subsequent emergence of the disease in the infectious form 
[3]. 
The German physician Robert Koch identified the bacillus Mycobacterium 
tuberculosis as the causative agent of tuberculosis disease in 1882 [4]. However it was not 
until the 1940s that the earliest chemotherapies against the bacterium were developed. The 
first of these, the aminoglycoside streptomycin (I, Figure 1.1.1) which was isolated from 
the bacterium Streptomyces griseus in 1944 [3], was shown to cause cell death by inhibiting 
protein synthesis on the ribosome [5]. Then in 1952, the pyridine-based isoniazid (II) was 
shown to have antitubercular activity via inhibition of mycolic acid production which is 
needed for structural integrity of the cell wall [6]. 
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Figure 1.1.1 Anti-TB drugs Streptomycin and Isoniazid 
However, these therapies were shown to quickly lose efficacy due to development 
of bacterial resistance, necessitating the expansion of available treatments. This led to the 
identification of dozens of drug candidates, many of which are used regularly today. These 
therapeutics are organized into five groups, based on factors such as efficacy, potency, and 
drug class. First-line anti-TB drugs, including the two most potent drugs [7] isoniazid and 
rifampin (III, Figure 1.1.2), a semisynthetic compound that inhibits RNA synthesis [8], 
are used to treat drug-susceptible bacteria. The current TB treatment regimen, designed in 
the 1970s and termed Direct Observed Therapy (DOT), involves a six-month course of 
several of these first-line drugs. 
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Figure 1.1.2  Current TB drugs Rifampin and Ciprofloxacin 
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Adding to the problem of global tuberculosis incidence is the rapid upswing in 
prevalence of multidrug-resistant TB. MDR-TB is defined as resistance to the first-line 
drugs isoniazid and rifampin. When a case of TB is diagnosed as multidrug-resistant, the 
use of second-line drugs is indicated [3]. These second-line treatments include 
streptomycin and fluoroquinolones such as ciprofloxacin (IV, Figure 1.1.2), which inhibits 
bacterial DNA replication [9]. Even more concerning is the increasing prevalence of 
extensively drug resistant TB (XDR-TB), which is defined as resistance to any 
fluoroquinolone and an injectable second-line drug in addition to all first-line drugs [7]. 
An estimated 3.3% of all newly reported TB cases and 20% of previously treated cases are 
determined to be multidrug resistant; of those, 9.7% are considered extensively drug 
resistant [1].   
While the occurrence of drug resistance has been acknowledged since the advent 
of streptomycin therapy, the sources and mechanisms of this phenomenon have only been 
amply studied in the last decade or so [10]. A few of the underlying elements that contribute 
to resistance stem from intrinsic features of M. tuberculosis. For instance, mycobacteria 
possess thick hydrophobic cell walls that impede pharmacological molecules from entering 
the cell. Also, these bacteria are able to essentially conceal themselves from the host 
immune response by hiding out within the host’s own macrophages and phagocytes [2]. 
As opposed to intrinsic resistance, acquired resistance is due to genetic changes that result 
in deactivation of the drug or modification of the drug target [11]. As an example, 
mutations that deactivate efflux pump restrictor genes can cause overexpression of these 
pumps [12], which are used by the bacteria for general detoxification purposes, including 
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the extrusion of foreign drug molecules [13]. Interestingly, the probability of a spontaneous 
mutation that confers this type of drug resistance is abysmally small; however, this 
probability is amplified by inappropriate drug prescription and inadequate patient 
adherence to the treatment regimen [10]. 
1.2 Current research into new drugs  The expense, duration, and complexity of the current tuberculosis treatment 
regimen, as well as the global problem of drug resistance, has spurred a profusion of 
research into new possible anti-tuberculosis therapies [4]. These investigations encompass 
diverse structural designs, ranging from small heterocyclic molecules to larger 
polysaccharides and polypeptides, with a range of bacterial targets.  
Publication of the full sequence of the M. tuberculosis genome by Barrell and 
coworkers in 1998 [14] greatly expanded the opportunity for research into new anti-TB 
drugs via direct targeting of specific bacterial metabolic pathways. A comprehensive 
review by Mdluli and Spigelman in 2006 [15] summed up the known targets that were 
actively being addressed at the time. These targets included amino acid and fatty acid 
biosynthesis, DNA synthesis, regulatory proteins, the glyoxylate shunt, and the stringent 
response enzyme. More recently, Zumla, Nahid, and Cole published a review in 2013 [3] 
describing the progress made in the search for new drug candidates. One such candidate 
was the diarylquinoline referred to as bedaquiline (V, Figure 1.2.1), which had been 
introduced by Andries and coworkers in 2005 [16]. While this compound showed 
promising inhibitory activity against the Mycobacterium tuberculosis ATP synthase, it also 
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presented challenges including accumulation in tissues and potential to induce arrhythmia 
[3].  
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Figure 1.2.1 Potential Mt ATP synthase inhibitor Bedaquiline 
In addition, the M. tuberculosis flavoenzyme DprE1*, which catalyzes the 
production of the arabinose precursor that is necessary for proper cell wall assembly, was 
determined to be a vulnerable target for several classes of inhibitory compounds [3]. In 
2009, Makarov and coworkers [17] developed BTZ038† (VI, Figure 1.2.2), a 
benzothiazinone that exhibited promising antimycobacterial activity by inhibiting this 
enzyme. Also in 2009, Brodin et al. [18] reported the anti-DprE1 activity of various 
nitrobenzamides, of which N-[2-(4-methoxyphenoxy)ethyl]-3,5-dinitrobenzamide (VII) 
gave encouraging inhibitory results. In 2010, two other candidates emerged which took 
advantage of the susceptibility of DprE1. One of these, described by Reddy and coworkers 
                                                 
* Decaprenylphosphoryl‑β‑D‑ribose 2′‑epimerase 
†2-(2-methyl-1,4-dioxa-8-azaspiro[4.5]decan-8-yl)-8-nitro-6-(trifluoromethyl)-4H-benzo[e][1,3]thiazin-4-one 
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[19], is known as SQ109* (VIII). The other was identified by Cole et al. [20] and termed 
VI-9376† (IX). 
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Figure 1.2.2 Potential Mycobacterium tuberculosis DprE1 inhibitors 
Chibale and coworkers have been particularly industrious in the search for small 
molecules with anti-Mt properties. In 2012, they disclosed a series of nitroimidazooxazine 
derivatives that displayed sub-micromolar MIC99‡ values against M. tuberculosis strain 
H37Rv, the most potent being a benzaldehyde derivative§ (X, Figure 1.2.3). Then in 2014 
they introduced an assortment of 2-amino-4-(2-pyridyl)thiazole compounds, the most 
potent of which included a bromobenzamide moiety** (XI). However, despite their 
                                                 
* N-geranyl-N’-(2-adamantyl) ethane-1,2-diamine 
† 7-bromo-2-methyl-5-nitro-3-phenylquinoxaline 
‡ Minimum Inhibitory Concentration inhibiting > 99% of bacterial growth. 
§ 4-({[(6S)-2-nitro-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazin-6-yl]oxy}methyl)benzaldehyde 
** 4-bromo-N-[4-(pyridin-2-yl)-1,3-thiazol-2-yl]benzamide 
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promising activity against M. tuberculosis, these latter compounds also exhibited poor 
solubility, high cytotoxicity, and metabolic instability.  
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Figure 1.2.3 Potential anti-Mycobacterium tuberculosis compounds 
This theme of novel tuberculosis drug research has grown exponentially just in the 
last year, with several such studies published in 2015, each identifying small molecules 
that are directed at highly diverse targets. One representative example came from Carroll 
and coworkers who used high-throughput screening to find model substrates that inhibit 
sulfur metabolism in mycobacteria [21]. In addition, Yogeeswari et al. performed 
computational studies to identify potent inhibitors of N-acetylglucosamine-1-phosphate 
uridyltransferase (glmUMtb), an enzyme required for cell wall integrity [22]. Also, Sririam 
and coworkers reported on a series of aminoquinoline derivatives that showed potency 
against the M. tuberculosis DNA gyrase (GyrB), which relieves strain during DNA 
unwinding [23]. Zhang, Lu, and Ding, among others, introduced a group of pyridine-3-
carboxamides with promising anti-tubucular activity; however, the mode of action and 
specific target of these compounds remain unknown [24]. As a final example, Das and 
coworkers disclosed a series of azatidinone derivatives that exhibit dual functionality as 
both β-ketoacyl CoA reductase (FabG4) and 3(R)-hydroxyacyl CoA dehydratase (HtdX) 
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inhibitors [25]. While not exhaustive, this list shows the scope of research being conducted 
on this issue. 
1.3 Class II fructose-1,6-bisphosphate aldolase as a drug target  Energy gains and expenditures via various metabolic pathways are fundamental to 
the vitality of Mycobacterium tuberculosis. These pathways involve many steps and 
enzymes, all of which are potential targets for directed drug research. One such enzyme is 
the class II fructose-1,6-bisphosphate aldolase (FBA) that catalyzes the reversible aldol 
addition of dihydroxyacetone phosphate (DHAP) with glyceraldehyde-3-phosphate (G3P) 
to give fructose-1,6-bisphosphate (FBP, Scheme 1.3.1), a process that is present in the 
glycolysis and gluconeogenesis pathways of these bacteria [26]. 
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Scheme 1.3.1 Reversible aldol addition of dihydroxyacetone phosphate with glyceraldehyde-3-phosphate to give fructose-1,6-bisphosphate* 
FBA has been shown to be expressed to higher levels by M. tuberculosis under 
hypoxic conditions, such as within necrotic pulmonary lesions [27], and the requirement 
of this enzyme for Mt viability was demonstrated with a series of elegant experiments by 
                                                 
* Phosphate (H2PO3) moiety depicted as a P inside a blue circle. 
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Ehrt and coworkers in 2014 [26]. By engineering a strain of M. tuberculosis in which FBA 
is depleted, they observed a loss of viability in vitro when the bacteria were cultured with 
a single carbon source; they also detected the eradication of both acute and chronic 
infection in mouse models. While this phenomenon has yet to be demonstrated in humans, 
it is highly likely that depletion of FBA in human mycobacterial infection would have 
similar consequences. 
Two classes of aldolase occur in nature – class I and class II. While the two classes 
catalyze the same process, they perform the task in mechanistically divergent ways [27]. 
The class I aldolase initiates the catalysis by forming an intermediate Schiff base between 
DHAP and an active site lysine residue. Through tautomerization, an enamine is formed, 
which then attacks G3P. A water molecule then reforms the carbonyl, producing FBP and 
regenerating the lysine side chain (Scheme 1.3.2) [28]. 
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Scheme 1.3.2 Mechanism of the class I FBA 
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Conversely, class II aldolases utilize a zinc ion to achieve catalysis. Histidine-
linked Zn2+ acts as a Lewis acid and coordinates with both the carbonyl and hydroxyl 
oxygens of DHAP, stabilizing the base-assisted enolate formation. This intermediate then 
attacks G3P, and formation of FBP allows the zinc ion to dissociate and reenter the catalytic 
cycle (Scheme 1.3.3) [28]. 
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Scheme 1.3.3 Mechanism of the class II FBA 
Class I and class II aldolases exhibit almost no similarity in amino acid sequence 
and are assumed to have evolved independently. In addition to their mechanistic and 
sequence divergence, these two enzymes differ in their distribution among species. While 
class I aldolases are present in “higher” organisms such as animals (including humans), 
plants, and some prokaryotes, class II aldolases are exclusively found in bacteria, fungi, 
and protozoa [29]. This dichotomy is fundamental to the success of this enzyme as a 
potential drug target; a small molecule specific to inhibition of the bacterial class II aldolase 
would be less likely to be toxic to the human host. Furthermore, the amino acid sequence 
of the class II aldolase is 100% conserved among all strains of M. tuberculosis, including 
MDR- and XDR-TB strains [27]. 
Taken together, these characteristics make this enzyme extremely attractive as a 
potential drug target. This has not gone unnoticed; over the last few decades several 
prospective inhibitors have been introduced. Initially, these potential inhibitors were 
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targeted to be mimics of DHAP (Figure 1.3.1), designed to competitively impede substrate 
binding in the active site of FBA. The first such mimic, phosphoglycolohydroxymate 
(PGH, XII), was introduced in 1973 by Lewis and Lowe, who envisioned it as a broad 
inhibitor of both classes of aldolase as well as triosephosphate isomerase [30]. Therisod 
and coworkers [31] expanded on this theme with the introduction of amidoxime (XIII) and 
hydrazide (XIV) derivatives of PGH. These latter two were shown to be less potent 
inhibitors than PGH, but they proved to be more selective for the class II aldolase active 
site. 
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Figure 1.3.1 Hydroxamide, hydrazine, and hydrazide DHAP mimics 
Then in 2008 Therisod looked at inhibitors targeting the downstream FBP product 
(Figure 1.3.2). These included hydrazide and hydroxamide derivatives (XV, XVI, XVII). 
Compound XVI showed promising activity with high selectivity for class II over class I 
aldolases and low-nanomolar inhibitory concentrations in biological assays. However, in 
vitro tests showed significantly reduced activity. 
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Figure 1.3.2 Hydrazide and hydroxamide FBP mimics 
In 2010 [32] this group attempted to improve the in vitro inhibition of these FBP 
mimics by replacing one phosphate group with a lipophilic moiety (XVIII, Figure 1.3.3). 
However, it showed no advantage over their previous analogs for in vitro inhibitory 
efficacy. This indicates that the phosphate moiety, while essential for potent active-site 
inhibition, interferes with the compound’s ability to cross the lipophilic barrier into the 
cell’s interior. 
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Figure 1.3.3 Hydroxamide FBP mimic with alkyl ester 
All aldolases exhibit high substrate specificity for DHAP, and only a select few 
substitutions of the phosphate ester moiety are tolerated in the active site [33]. This severely 
limits the number and type of DHAP and FBP mimics that would be able to bind in the 
active site and provide competitive inhibition. However, there is significantly more 
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tolerance for compounds to bind out of the active site, thereby providing uncompetitive or 
noncompetitive inhibition. 
In 2013, through extensive enzymatic and structure-based screening, Pegan and 
coworkers [27] identified 8-hydroxyquinoline-2-carboxylic acid (HCA, XIX, Figure 1.3.4) 
as a prospective scaffold for a class II FBA inhibitor. While biochemical assays showed 
HCA to reduce MtFBA activity by 95% at a concentration of 1 mM, kinetic studies of HCA 
interaction clearly showed a decreased Vmax, as compared to substrate binding, while Km 
remained constant, indicating a noncompetitive interaction. 
NOH OH
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XIX  
Figure 1.3.4 MtFBA-inhibitor lead compound 8-hydroxyquinoline-2-carboxylic acid 
Once the binding mechanism of HCA with the class II FBA was determined, this 
group further explored the specifics of this interaction by capturing the enzyme with HCA 
in its binding site and deciphering the crystal structure of the complex. From this crystal 
structure they ascertained several interesting features of HCA binding. Not only does this 
molecule bind at a site outside of – but adjacent to – the substrate-binding pocket, it also 
alters the conformation of the active site (Figure 1.3.5, A and B). By forming a trident 
coordination with zinc and displacing the so-called “Z-loop” which contains the histidine 
residues that coordinate the Zn2+, HCA accomplishes two tasks: it blocks natural substrates 
(DHAP or FBP) from accessing the active site and also sequesters the zinc ion, disallowing 
its coordination with those substrates (C). In addition the crystal structure showed 
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supplementary stabilization of HCA by hydrogen bonding interactions with nearby 
glutamic and aspartic acid residues (D) [27]. 
  
  
Figure 1.3.5* A. Substrate binding pocket of MtFBA with linear fructose-1,6-bisphosphate bound. B. Substrate binding pocket of MtFBA with 8-hydroxyquinoline-2-carboxylic acid bound. C. Cartoon of non-competitive inhibition of HCA with MtFBA. D. HCA bound to MtFBA, showing specific interactions with Zn2+, water, and amino acid side chains 
Verification that HCA did not inhibit class I FBAs was achieved by performing 
assays with aldolases isolated from both rabbit and human muscle. As was expected due to 
the mechanistic divergence of the two classes, these assays resolutely showed no activity 
against the class I aldolase (D and E, Figure 1.3.6). Encouragingly, they saw that HCA had 
                                                 
* Images courtesy of Capodagli, et al., Biochemistry (2014) 53, 202−213. 
A B 
D C 
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the potential to be a broad-spectrum antibacterial agent; it also exhibited promising 
inhibition against the structurally similar E. coli (EcFBA, B) and MRSA (SaFBA, C) 
aldolases. 
 
Figure 1.3.6* Inhibition of aldolase activity measured in vitro using 25 μM HCA. Aldolases tested include Mycobacterium tuberculosis (A), E. coli (B), MRSA (C), Rabbit muscle (D), and Human muscle (E) 
Overall, HCA possesses many characteristics that make it interesting from a 
medicinal chemistry standpoint. Its low molecular weight (189 g/mol) and potential for 
functionalization are extremely desirable features for a lead compound. In addition, the 
lack of highly-charged phosphate groups indicates an increased likelihood for it to be 
capable of crossing the hydrophobic bacterial membrane, an essential feature for the 
successful inhibition of MtFBA. Finally, with an MIC of 600 μM, HCA shows 
extraordinary potential for optimization-induced inhibition in the low nanomolar range. 
                                                 
* Image courtesy of Capodagli, et al., Biochemistry (2014) 53, 202−213. 
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2 QUINOLINES AS POTENT NONCOMPETITIVE INHIBITORS OF MTFBA 
2.1 Introduction: Building diversity into HCA scaffold.  After Pegan and coworkers identified 8-hydroxyquinoline-2-carboxylic acid as a 
candidate small molecule to induce noncompetitive inhibition of MtFBA, the next 
objective was to introduce functionality onto the scaffold that would increase its inhibitory 
efficacy. Optimally, functionalization of the HCA skeleton would attain nanomolar affinity 
for the binding site – representing a 1-2 order of magnitude improvement – and low-
micromolar MIC values against Mt – an enhancement of 2-3 orders of magnitude. 
With this objective in mind, PyMOL molecular imaging was used to evaluate the 
most significant areas of potential functionalization and optimization of HCA. Based on 
the data obtained, several features were identified where diversity could be introduced into 
the quinoline scaffold. 
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Figure 2.1.1 Quinoline numbering system 
The aforementioned trident coordination of a Zn2+ ion with the lone pair electrons 
of the carbonyl oxygen at position 2 (see Figure 2.1.1 and A and B, Figure 2.1.2), the 
hydroxyl oxygen at position 8, and the in-ring nitrogen is central to the affinity of HCA for 
the protein. This was confirmed by substitution of one or more of these features by other 
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moieties. For instance, removal of the carboxylic acid group resulted in over 50% drop in 
inhibitory efficacy. Similarly, substitution of the hydroxyl for an amine or nitro group 
reduced the inhibition by over 70%. This also supports the vital hydrogen-bonding 
interaction of this hydroxyl with Glu161 (B, Figure 2.1.2). 
NOH OH
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Figure 2.1.2 A. Trident coordination of HCA with Zn2+. B. Interactions of HCA within the binding site of MtFBA 
Within the site where the small molecule binds, three nonpolar amino acid residues 
(Val165, Leu180, and Thr207, B, Figure 2.1.2) form a small hydrophobic pocket 
surrounding the 5-, 6-, and 7-positions on the quinoline ring. This pocket, which is 
estimated to be about 15 Å3, would be able to accommodate a small hydrophobic 
substitution. Suitable substituents for this pocket include halogens such as fluorine or alkyl 
groups such as methyl.  
In addition, the region near the carboxylic acid at position 2 could accommodate a 
variety of substitutions. These could include small aromatic rings, heterocycles, or alkyl 
chains, on condition that the metal-binding capability of the oxygen is not impeded. For 
instance, oxazoles, esters, and amides would be appropriate functionalities.  
Finally, the in-ring nitrogen of quinoline could potentially be substituted for an exo-
ring primary amine. This could hypothetically displace the zinc ion and directly interact 
with the side chains of the protein. 
A B 
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2.2 Substitutions on phenol ring of quinoline  Due to the hydrophobic pocket accommodating the 5-, 6-, and 7-positions of the 
quinoline ring system, the first analogs of 8-hydroxyquinoline-2-carboxylic acid to be 
explored contained various small hydrophobic substitutions at these positions. These 
substitutions included assorted halogens and methyl groups. 
2.2.1 Halogen-substituted quinoline target molecules  
The identification of halogens in biologically active molecules has increased 
exponentially in the last decade. Once thought a rarity, halogens are now accepted as 
commonplace in biological systems, particularly within protein-bound ligands. This is 
evidenced by the surge in hits of halogenated ligands in the Protein Data Bank in recent 
years. It was historically presumed that any specificity observed in the interaction between 
a protein and its halogenated ligand stemmed from the interaction of other moieties in the 
molecule, leaving the role of the halogen to be a general lipophilic area of electron density: 
In essence, an inactive, electron-withdrawing globule. However, recent analysis has 
determined that halogens – particularly the larger three: chlorine, bromine, and iodine – are 
actively involved in the binding of a ligand to the active site of its protein, providing unique 
and robust electrostatic interactions with Lewis acidic atoms within the protein [34]. This 
insight has led to new research into small molecule inhibitors that exploit halogen 
interactions with target proteins.  
Halogen moieties are present in several biological compounds and currently-used 
therapeutics. These include three iodo groups in the thyroid hormone triiodothyronine (XX, 
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Figure 2.2.1), brominated nicergoline (XXI), a vasodilator, and a chlorine in the widely 
used – and aptly named – antimalarial drug chloroquine (XXII).  
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Figure 2.2.1 Structures of triiodothyronine, nicergoline, and chloroquine, common halogenated therapeutics 
Fluorine has a more intriguing history in pharmaceutical compounds than its larger 
halogen cousins. Due to the highly reactive nature of elemental fluorine, it was relegated 
to military and other specialized uses through the 1940s; it was considered abiotic and its 
use in pharmaceuticals inconceivable. However in 1953 Fried and Sabo recognized the 
increased mineralocorticoid potency of 9α-fluoro-17α-hydroxycorticosterone acetate 
(XXIII, Figure 2.2.2) over other halogen substitutions, and thus began the age of 
fluorinated biological compounds. 
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Figure 2.2.2 Structure of 9α-fluoro-17α-hydroxycorticosterone acetate (fludrocortisone), a fluorine-containing therapeutic 
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Now fluorine moieties are abundant in biologically active molecules including the 
antidepressant fluoxetine, better known as Prozac (XXIV, Figure 2.2.3) and the antifungal 
fluconazole (XXV) [35]. Fluorine-substituted compounds are also essential to medical 
technology, particularly in the form of the positron emission topography tracer 2-deoxy-2-
(18F)fluoro-D-glucose (XXVI) [36].  
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Figure 2.2.3 Structures of fluorinated compounds fluoxetine, ciprofloxacin, and 2-deoxy-2-(18F)fluoro-D-glucose 
The source of increased activity of fluorinated compounds in biological systems 
diverges from the electrostatic interactions seen in the more polarizable halogens. While 
substitution of hydrogen with fluorine in a molecule does not significantly change steric 
interactions, the substantial increase in electronegativity has the potential to modulate 
acid/base properties, conformational aspects, and lipophilicity of the parent molecule. In 
addition, fluorine substitutions on pharmaceutically active molecules have the added 
benefit of reducing the metabolic deactivation of such compounds via Cytochrome P450 
monooxygenases, resulting in a longer lifetime of these molecules in the biological system 
[35]. 
2.2.1.1 Results and Discussion 
The first set of quinoline analogs targeted were designed to take advantage of the 
enzyme’s small hydrophobic pocket by having fluorine substitutions on the phenol ring of 
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the quinoline system. The selection of fluorine was not designed to exploit the previously 
mentioned electrostatic Lewis acid/base-type interactions of the larger, more polarizable 
halogens. Instead, fluorine was chosen due to its metabolic stability, small size, and 
lipophilicity.  
There are two general routes to obtain quinolines with fluorine substituents on the 
aromatic ring. The first is introduction of fluorine onto the premade quinoline ring via 
aromatic substitution. The inefficiency of fluoride as a nucleophile means a direct SNAr-
type mechanism is impractical. However, several methods of aryl fluorination involving 
transition metals have been developed recently. These include silver-mediated fluorination 
of aryl silanes (eq 1, Scheme 2.2.1) [37] and copper triflate-mediated fluorination of aryl 
borates (eq 2) [36]. 
Si(OEt)3R Ag2O, BaO
N+N+F
Cl
2 BF4- FR
BF3KR Cu(OTf)2, KF
FR
(1)
(2)
 
Scheme 2.2.1 Fluorination options via aromatic substitution. 
The second route toward fluorinated quinolines is cyclization of a pre-fluorinated 
aniline with an appropriate coupling partner to form the quinaldine, which can then be 
oxidized to the desired carboxylic acid (Scheme 2.2.2). The ready availability of fluorinated 
aniline starting materials for this approach makes it much more attractive than the former. 
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Scheme 2.2.2 Fluorinated quinoline synthesis starting from fluorinated aniline 
The latter cyclization approach to the fluorinated quinaldine precursor was first 
attempted through the route described by Perumal and coworkers [38] in which anilines 
are heated with α,β-unsaturated aldehydes or ketones in a biphasic system of toluene and 
phosphotungstic acid (Scheme 2.2.3). The use of phosphotungstic acid presents advantages 
over the more common hydrohalide and mineral acids due to its stability, relative non-
toxicity, and highly acidic nature. However, while the Perumal lab was able to obtain their 
desired quinaldines in good yield, it was decidedly less successful under the current 
conditions. No desired product was obtained using this method. 
NH2R
O
+ phosphotungstic acidtoluene
NR
 
Scheme 2.2.3 Quinoline cyclization via phosphotungstic acid 
Therefore a more traditional two-phase Doebner-Von Miller method was utilized 
to obtain the quinaldine precursors. The cyclization step was performed by heating the 
aniline with crotonaldehyde in a biphasic mixture of toluene and aqueous hydrochloric acid 
(Scheme 2.2.4) [39]. This method proved to be much more viable, resulting in isolation of 
the products (1) in very good yield. Pleasingly, purification of these compounds was not 
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necessary; a simple neutralization and extraction workup procedure was sufficient to obtain 
the crude quinaldines with less than 5% starting material contamination.* 
OH NH2F N
OH
F
O
+ 6M HCltoluene
1  
Scheme 2.2.4 Biphasic Doebner-Von Miller quinoline synthesis 
The second step was an oxidation by selenium (IV) oxide. This reaction easily 
oxidized the benzylic methyl group to a carboxylic acid (2, Scheme 2.2.5) [39]. 
Acidification of the crude carboxylate allowed precipitation of the product from the 
aqueous solution. 
OH
F
N SeO2
pyridine
OH
F
N OH
O
1 2  
Scheme 2.2.5 Oxidation of benzylic methyl to carboxylic acid 
Notably, cooling on ice during the acidification process improved isolation of the 
precipitated product drastically; in the case of the 6-fluoroquinoline product, the yield was 
increased from 18% to 74%. This could be due to two separate factors. The first is the 
decreased solubility of the product in cold solution, hence a more vigorous precipitation. 
                                                 
* As seen by NMR. 
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The second is the prevention of decarboxylation; the acidification process is highly 
exothermic, and the excess heat could spur this degradation mechanism. Using this method, 
three quinoline analogs with fluorine substitutions at the 5-, 6-, and 7-positions were 
achieved (2a, 2b, 2c, Figure 2.2.4). 
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Figure 2.2.4 Fluorinated quinoline target compounds 
The synthesis of analog 2c, with fluorine in the 7-position, included an additional 
step. Since the starting aniline (2-amino-6-fluorophenol) was not commercially available, 
the analogous nitro compound was used instead. This required reduction of the nitro group 
to an amine before cyclization could occur. While there are many reagents available to 
perform the task of reduction, it was noted that using iron powder with a catalytic amount 
of concentrated aqueous HCl [40] was the simplest, most efficient route, giving the aniline 
in excellent yield (3a, Scheme 2.2.6).  
F
OH
NO2 F
OH
NH2Fe, cat. HClH2O/THF
3a  
Scheme 2.2.6 Reduction of aryl nitro to primary aryl amine. 
In order to probe the size of the hydrophobic pocket within the binding site of the 
protein, a 5-chloroquinoline analog (2d, Figure 2.2.5) was synthesized. Starting from 2-
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amino-4-chlorophenol and using the same synthetic method, this analog was isolated in 
excellent yield. Furthermore, due to an unforeseen circumstance (details of which will be 
discussed in Section 2.3.1.1), synthesis of an analog bearing a bromine at the 8-position 
and fluorine at the 6-position (2e) was desired. The standard cyclization of 2-bromo-4-
fluoroaniline with crotonaldehyde and subsequent oxidation to the 2-carboxylic acid were 
easily accomplished. 
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Figure 2.2.5 Other halogen-substituted quinoline analogs 
Finally, a quinoline analog containing a bromine in addition to the hydroxyl group 
(1f, Figure 2.2.6) was considered interesting, even though a bromine would most likely be 
too large to fit into the hydrophobic pocket of the aldolase. Since the brominated 
aminophenol was not immediately available, a different route was sought. Imperiali and 
coworkers [41] described an electrophilic bromination of the aryl ring using the hydroxyl 
at the 8-position as a directing group in order to perform the substitution selectively in the 
5-position. Therefore 8-hydroxyquinaldine was reacted with molecular bromine, giving an 
exceedingly interesting mixture of products that were inseparable by chromatography. 
According to NMR analysis, the mixture consisted of nearly equal amounts of two doubly-
brominated quinaldines (1g and 1h), the structures of which were assigned based on the 
electrophilic aromatic substitution reactivity patterns of phenol and pyridine. Unfortunately 
not enough product was isolated to advance to the oxidation step. 
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Br NOH
Br Br
1f 1g 1h  
Figure 2.2.6 Target bromine-substituted analog and doubly-brominated compounds actually isolated 
2.2.2 Methyl-substituted quinoline target molecules 
Precisely placed alkyl substituents play an important role in pharmaceutically 
active compounds. These nonpolar groups can be of highly variable size and can be placed 
in specific locations on a molecule to optimize hydrophobic interactions with a binding site 
[42]. Aromatic alkyl groups can be found in many natural products and biologically active 
compounds  such as the metabolite Pterocellin D (XXVII, Figure 2.2.7), isolated from 
bryozoans and exhibiting strong activity against B. subtilis, and a paeciloxanthone 
(XXVIII) that is found in mangrove bark and demonstrates a broad range of activity 
against tumor cells, bacteria, and acetylcholinesterase [43]. 
N
NO
O
CH3CH3 O
CH3
CH3
XXVII
O
OH O
CH3
OH
CH3CH3
XXVIII  
Figure 2.2.7 Biologically active compounds with aromatic alkyl groups 
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2.2.2.1 Results and Discussion 
Similar to the previous halogen substitutions, the next target molecules also sought 
to take advantage of the hydrophobic pocket by employing an alkyl substitution at the 5- 
or 6-position of the quinoline ring. Since the pocket could only tolerate small substitutions, 
only methyl groups were considered at this stage.  
Alkyl-substituted quinolines can be achieved by methods similar to the previously 
discussed halide derivatives, namely through aromatic substitution or cyclization of a pre-
functionalized aniline. One of the oldest and most widely used methods of introducing 
alkyl groups onto an aromatic ring is the Friedel-Crafts alkylation. Known since 1877, this 
procedure proceeds through electrophilic substitution on the aromatic ring by an alkyl 
halide via Lewis-acid catalysis (Scheme 2.2.7). Many variations have been introduced over 
the intervening years. These include a variety of electrophiles such as alcohols and alkenes 
and an assortment of Lewis acids that display a wide range of activities. While this method 
has historically been a powerful tool for the purpose of aromatic alkylation, it also has 
several weaknesses; it is prone to alkyl-group rearrangements and polyalkylation, and it is 
unsuccessful with aromatic rings containing electron-withdrawing substituents [44]. 
+ R X Lewis acid R 
Scheme 2.2.7 Friedel-Crafts alkylation of an aromatic ring 
Due to the difficulties presented by the Friedel-Crafts alkylation and the ready 
availability of methyl-substituted aminophenols, a methylquinoline synthesis via 
cyclization of anilines – analogous to the synthesis used to obtain the halogenated 
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quinolines – was deemed to be more accessible. However, initial trials showed the 
Doebner-Von Miller quinoline cyclization to be an impractical method to synthesize these 
molecules. After coupling of the methyl aniline with crotonaldehyde to obtain the 
dimethyl-substituted quinoline, reaction with selenium (IV) oxide resulted in oxidation of 
both methyl groups, forming the dicarboxylic acid(Scheme 2.2.8). 
 
Scheme 2.2.8 Undesired formation of quinoline dicarboxylic acid from DVM synthesis 
Therefore an alternative approach was explored. Ideally, installation of the 
carboxylic acid group at position 2 would be orthogonal to oxidation of the existing methyl 
in position 5 or 6. An often-used synthetic route developed by Krasavin et al. [45] toward 
quinoline-2-carboxylic acids starts with a quinoline unsubstituted at position 2 of the ring. 
Initially a classical Skraup reaction [46] was used to obtain this compound, in which the 
appropriate methyl-substituted aminophenol was refluxed with glycerol and an oxidant* in 
concentrated sulfuric acid (Scheme 2.2.9). However, the desired product was difficult to 
OH
NH2CH3 +
OH
OH OH
[O]
H2SO4
OH
N
CH3
 
Scheme 2.2.9 Skraup quinoline synthesis 
                                                 
* Oxidants used include nitrobenzene and sodium 3-nitrobenzene sulfonate. 
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extract from the thick tarry reaction mixture, and an extremely low yield of product was 
obtained. On the other hand, when acrolein diethyl acetal was utilized as the cyclization 
partner and refluxed with the starting aniline in dilute HCl, the yield of methylquinoline 
was greatly improved (Scheme 2.2.10) [47].  
OH
NH2CH3 +
OEtEtO HCl

OH
N
CH3  
Scheme 2.2.10 Synthesis of methylquinolin-8-ols 
Subsequent oxidation of the ring nitrogen was easily accomplished with m-CPBA 
(eq 3, Scheme 2.2.11). The quinoline-N-oxide was then methylated with dimethyl sulfate 
(eq 4), and treatment with sodium cyanide afforded the quinoline-2-carbonitrile (eq 5). 
Finally, hydrolysis of the nitrile by refluxing in aqueous sodium hydroxide gave the desired 
carboxylic acid (2, eq 6) [45].  
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Scheme 2.2.11 Synthesis of methylquinolin-8-ol-2-carboxylic acids 
The aforementioned procedural change proved advantageous in the formation of 
the 5- and 6-methyl quinoline-2-carboxylic acids. Over the course of five synthetic steps, 
the overall yield of the 6-methyl analog (2f, Figure 2.2.8) increased from 0.01% (obtained 
via the Skraup method) to 12.6%, a difference of greater than 1000-fold. Similarly, the 5-
methyl analog (2g), which had not been carried through to the final step under the original 
procedure, was produced in an overall yield of 3.5% via the modified version. However, 
complete isolation of the 5-methyl analog proved difficult; several trials all resulted in a 
final product contaminated with one of the intermediates. Therefore, while it was 
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considered an interesting compound, it was not determined to be pure enough for 
biochemical testing. 
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Figure 2.2.8 Methyl-substituted quinoline products 
2.3 Carboxylic acid alternatives at position 2  Investigation of modifications to the carboxylic acid at position 2 of the quinoline 
ring system were designed to probe the unique properties of HCA’s binding site within the 
enzyme. These derivatives included amides, esters, alcohols, carbamates and ureas, 
amines, and heterocycles, each of which took individual advantage of the space and binding 
properties within that region. As will be discussed in Section 2.5, the HCA analog which 
contained a fluorine in the 6-position quinoline ring system showed the most promising 
inhibition of MtFBA, so from this point forward that scaffold was used in all derivatization 
probes. 
2.3.1 Amides 
Synthesis of amides has historically been accomplished by many methods. One 
prominent and straightforward scheme is the coupling of carboxylic acids with amines. 
However, direct coupling of the acid with amine via nucleophilic acyl substitution, and the 
necessary elimination of a water molecule (eq 7, Scheme 2.3.1), does not occur 
spontaneously at room temperature, instead forming undesirable ammonium carboxylate 
salts (eq 8) [48]. The preferred process of nucleophilic attack requires extremely high 
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temperatures, often resulting in decomposition of the starting materials. Therefore several 
alternative techniques have been developed in recent years, including the use of 
organometallic catalysis, oxidation/reduction-assisted coupling [49], and conversion of the 
acid into a derivative with enhanced electrophilicity [50].  
R OH
O NR1R2R3 HNR1R2R3R O-
O ++
R OH
O HNR1R2+ R NR1R2
O
+ OH2 (7)
(8)
 
Scheme 2.3.1 Reactions of amines with carboxylic acids: the desired substitution and the undesired acid/base 
Representing a simple, straight-forward method of coupling carboxylic acids with 
amines, derivatization is one of the foremost routes in amide synthesis. Acid halides, 
activated esters, mixed anhydrides, and carbodiimides are among the most frequently used 
activation intermediates [51]. The choice of coupling agent in a particular amidation 
reaction is highly dependent on the inherent reactivity of the substrates and the need to 
restrict the formation of undesired side reactions [50]. 
Exploiting the principle of enhanced carbonyl reactivity by introduction of a weakly 
basic leaving group, acid halides are the most reactive carboxylic acid derivatives and thus 
ideal for nucleophilic acyl substitution reactions with amines. In particular, owing to their 
practicality, simplicity, and relatively mild reaction conditions, acyl chlorides are the most 
common halide derivatives used in these coupling reactions (Scheme 2.3.2) [51].  
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Scheme 2.3.2 Reaction of amine with acyl chloride to give amide product 
Introduced by Emil Fischer who, in 1901, first applied acyl chloride intermediates 
to the coupling of amino acids [50], this method has seen numerous modifications over the 
last 115 years, particularly in the variety of chlorinating reagents used; these include, in 
their simplest forms, thionyl chloride, oxalyl chloride, and triphosgene (XXIX, XXX, 
XXXI, Figure 2.3.1).  
S
O
Cl Cl Cl
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Cl
O O
OCl
Cl Cl Cl
Cl
Cl
XXIX XXX XXXI  
Figure 2.3.1 Chlorinating reagents thionyl chloride, oxalyl chloride, triphosgene 
While there is no shortage of “designer” halogenating agents, developed for 
specific purposes such as increased reactivity with hindered substrates and functional-
group compatibility [50], the ready availability and low cost of the more common reagents, 
as well as the depth of published experiments using them, make these attractive for use in 
the formation of reactive coupling partners. 
Peptide coupling reagents such as carbodiimides are commonly used to create 
amide bonds between the free amine of one amino acid and the carboxyl group of another 
amino acid. In 1955 Sheehan [52] introduced N,N’-dicyclohexylcarbodiimide (DCC, 
XXXII, Figure 2.3.2) as a moderately reactive, reasonably inexpensive peptide coupling 
agent; since then, this has been the single most important carboxylic acid activating agent 
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in peptide synthesis. This method is particularly useful due to the easy separation of the 
main byproduct, dicyclohexylurea, which is insoluble in most reaction solvents and can be 
removed by filtration [51]. Another peptide coupling reagent is 1-(3-
dimethylaminopropyl)-3-ethylcarbodiimide (EDC, XXXIII, Figure 2.3.2). The 
amenability of this reagent to mild reaction conditions, and its convenient solubility in a 
variety of solvents including water and dichloromethane, make it highly practical. Also, 
the main urea byproduct is water-soluble, and thus can be removed by simple aqueous 
extraction [53]. 
N C N
NN C N
XXXII XXXIII  
Figure 2.3.2 Peptide coupling reagents DCC and EDC 
Despite the numerous advantages of using carbodiimides as activating agents in the 
acylation of amines, this method is also subject to several drawbacks, including 
racemization, slow reaction rates [52], and possible formation of multiple side products 
[50]. These shortcomings can be controlled or completely negated by the addition of 
additives to the reaction mixture. In 1970, Koenig and Geiger introduced 1-hydroxy-1-H-
benzotriazole (HOBt, XXXIV, Figure 2.3.3) as an epimerization-reducing agent; 
consequently they recorded a substantial drop in epimerization for their model peptide 
coupling reaction from 35% to 1.5%. It is proposed that HOBt initially reacts with the 
previously formed O-acylurea to give the activated OBt ester. This ester increases the 
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reactivity of the carbonyl by stabilizing and directing the approach of the nucleophilic 
amine via hydrogen bonding interactions [50].  
NNNOH
XXXIV  
Figure 2.3.3 HOBt: Activating agent for peptide coupling reactions 
The formation of mixed anhydride intermediates represents a third route toward 
amide synthesis (Scheme 2.3.3). Proposed independently by three separate groups in 1951, 
formation of mixed anhydrides by reaction with a chloroformate or acyl chloride provides 
a fast and simple method of activating a carboxylic acid for nucleophilic attack by an amine 
[54].  
R OH
O
+ Cl R'
O base
0 oC R O
O
R'
O
+ H Cl
 
Scheme 2.3.3 Formation of mixed anhydride by reaction of a carboxylic acid with an acyl chloride 
In contrast to peptide coupling reagents which are uneconomical, producing large 
amounts of wasted byproducts – especially when used in stoichiometric amounts and with 
additional additives – this method is more compliant with green chemistry techniques due 
to its superior atom economy. Additionally, the formation of acyl halide intermediates 
produces toxic sulfur dioxide (from thionyl chloride) or carbon monoxide (from oxalyl 
chloride), and the acyl halides themselves are relatively unstable and hydrolyze easily 
under atmospheric conditions. In comparison, the use of mixed anhydrides represents a 
relatively non-toxic alternative; the only byproducts being CO2 and an alcohol (Scheme 
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2.3.4) [55]. This is particularly attractive since the lack of byproducts gives a relatively 
clean crude product that is easily isolated in high yields [54]. It is also advantageous in that 
the formation of the mixed anhydride is easily identifiable by TLC analysis, so that the 
amine can be added as soon as all the carboxylic acid is converted. 
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Scheme 2.3.4 Formation of amide by reaction of amine with mixed anhydride 
2.3.1.1 Results and Discussion 
Amide functional groups were the first carboxylic acid derivatives to be considered 
for functionalization at the 2-position of the quinoline (8, Figure 2.3.4). The amide was 
attractive due to the retention of the zinc-coordinating carbonyl oxygen while altering the 
electronics and sterics of the attached group. Resonance of the lone pair of electrons on the 
amide nitrogen into the carbonyl group could result in interesting interactions of the 
molecule within the binding pocket. In addition, the groups attached to the nitrogen could 
possibly utilize the space inside that pocket in advantageous ways. 
N NR'R"
O
R
8  
Figure 2.3.4 Amide quinoline derivative 
Several of the aforementioned methods were applied to the installation of amide 
functional groups at the 2-position of the quinoline scaffold. Acyl chloride intermediates 
were first utilized in an attempt to produce a diethyl amide. Unfortunately, neither thionyl 
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chloride nor oxalyl chloride were effective agents in this regard, even when used in large 
excess. Under various reaction conditions, including addition of a catalytic amount of 
DMF, this method either resulted in no product formation, or extremely poor yield of 
unclean product. The results are summarized in Table 1. 
Table 1 Attempted amide formation via acyl chloride derivative.  
NOH
F
OH
O
N
OH
F
NR'R"
O
HNR'R"
2b 8
Activating agent
base, solvent
 
Entry Amine Activating agent Additive Base Solvent Yield
* (%) 
1 HNEt2 (COCl)2 None NEt3 (CH3)2CO NP 
2 HNEt2 (COCl)2 DMF NEt3 CH2Cl2 Trace 
3 HNEt2 SOCl2 None NEt3 CH3CN NP 
 
Subsequently, this reaction was attempted via peptide coupling reagents. Readily-
available EDC was used as the activating agent, and HOBt was initially utilized as additive. 
This reaction produced a trace of desired product, but it proved inseparable from the HOBt 
byproduct. Therefore HOBt was replaced with a catalytic amount of DMAP, but this 
resulted in no product formation. These results can be seen in Table 2. 
 
 
                                                 
* NP = No product obtained. 
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Table 2 Attempted amide formation via peptide coupling reagents. 
NOH
F
OH
O
NOH
F
NR'R"
O
HNR'R"
2b 8
Activating agent
base, solvent
 
Entry Amine Activating Agent Additive Base Solvent Yield (%) 4 HNEt2 EDC HOBt DIPEA DMF/DCM Trace 
5 HNEt2 EDC DMAP DIPEA DMF/DCM NP 
 
A final attempt to produce the desired amides was conducted via mixed anhydride 
derivatives. An additional consideration that required attention, however, was the 
formation of carbonate esters on the phenolic oxygen upon reaction with chloroformate 
esters (Scheme 2.3.5). This carbonate ester could then compete with the anhydride for 
nucleophilic attack by the amine, producing undesired side products and reducing yield of 
the desired amide.  
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Scheme 2.3.5 Undesired phenolic carbonate formation from reaction of phenol with ethyl chloroformate 
Therefore, it was desired to put a protecting group on the phenol to deactivate it 
from attacking the chloroformate. Numerous phenol protecting groups are available, and 
several factors must be taken into consideration when choosing one. Introduction of the 
protecting group must be selective for the functional group intended to be protected. It must 
also be stable to all subsequent reaction conditions, and it must be able to be taken off 
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without compromising any other functional groups. Some of the more common phenol 
protecting groups include ethers (XXXV, Figure 2.3.5), silyl ethers (XXXVI), acetals 
(XXXVII), carbonates (XXXVIII), and esters (XXXIX).  
O R O SiR3 O CH2OR O OR
O
O R
O
XXXV XXXVI XXXVII XXXVIII XXXIX  
Figure 2.3.5 Phenol protecting groups 
For the intended quinoline amide synthesis, it was necessary to establish the 
protecting group on the phenol before the carboxylic acid was introduced. Since the general 
mechanism of phenol protection involves nucleophilic attack by oxygen on the protecting 
group, usually via SN2 substitution, a carboxylic acid moiety would compete with the 
phenol in this attack. This would necessitate several equivalents of the protecting group 
and would also deactivate the carboxylic acid against subsequent reactions, essentially 
defeating the purpose. Therefore it was decided that the phenol should be protected directly 
after cyclization of the quinoline (Scheme 2.3.6). 
N
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Scheme 2.3.6 Preferred order of quinoline cyclization, phenol protection, and oxidation 
As previously mentioned, the choice of protecting group must take into account its 
durability through the subsequent oxidation and amidation reaction conditions. For the 
oxidation of the pyridyl methyl to a carboxylic acid via SeO2, both acidic and alkaline 
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conditions are used. Acetate and ester protecting groups would therefore be unsuitable due 
to their lability under basic conditions; similarly, silyl ethers and methoxymethyl ethers 
would be unusable due to their instability in acidic media. Furthermore, carbonates were 
ruled out since the protecting group was being installed to prevent their formation in the 
first place, and methyl ethers were not considered due to their difficulty in removal [44]. 
A benzyl ether protecting group was consequently determined to be the most 
appropriate for the situation. The tolerance of the benzyl group to acidic and basic 
conditions, its stability against nucleophilic attack, and its mode of removal orthogonal to 
amide hydrolysis made it attractive for the given reaction. Installation of the benzyl group 
was easily achieved in very high yield by reacting 6-fluoro-8-hydroxyquinaldine with 
benzyl bromide, potassium carbonate, and a catalytic amount of tetrabutylammonium 
iodide in acetone (1i, Scheme 2.3.7). Subsequent oxidation of the benzylic methyl group to 
a carboxylic acid (2h) was also a smooth process. In fact, the benzyloxy group enhanced 
the yield of this step over that of the free phenol; due to its hydrophobic nature, it 
precipitated from the acidified aqueous solution much more robustly. 
NOH
F
BnBr, K2CO3, TBAI
acetone
NOBn
F
NOBn
F
OH
O
SeO2
pyridine
1b 1i 2h  
Scheme 2.3.7 Installation of benzyl protecting group on quinoline phenol and subsequent oxidation 
With the benzyl-protected quinoline-2-carboxylic acid in hand, the mixed-
anhydride-assisted amidation reaction was performed. The carboxylic acid was first 
activated by addition of ethyl chloroformate and triethylamine in THF; upon TLC 
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confirmation of the consumption of starting material, the amine was added. This process 
proved amenable to formation of the diethyl, morpholine, and free* amides in moderate 
yields, the results of which can be seen in Table 3. 
Table 3 Attempted amide formation via mixed anhydride intermediate. 
NOBn
F
OH
O
NOBn
F
NR'R"
O
HNR'R"
2h 8
Activating agent
base, solvent
 
Entry Amine Activating agent Additive Base Solvent Yield (%) 6 HNEt2 Ethyl Chloroformate None NEt3 THF 58 7 Morpholine Ethyl Chloroformate None NEt3 THF 41 8 NH3 Ethyl Chloroformate None NEt3 THF ND
† 
 
 The final step to obtain the desired amide products was deprotection of the phenol. 
Removal of a benzyl protecting group can be accomplished through reaction with boron 
tribromide, and this method was applied to the three benzyloxyquinoline amide products. 
Deprotection of the diethyl amide gave the expected product (8a, Figure 2.3.6) in moderate 
yield.  
                                                 
* “Primary” amide with formula CONH2. 
† ND: Yield not determined. 
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8a  
Figure 2.3.6 Desired diethyl amide 
However, the morpholine and free amides gave unexpected results under these 
conditions. Following deprotection of the free amide, no desired product was obtained. In 
contrast, NMR analysis of the purified morpholine amide indicated a mixture of two similar 
but distinct compounds. Analysis by mass spectroscopy clearly showed that in addition to 
the expected morpholino quinoline amide, there was a second product, also with a 
morpholine amide in the 2-position of the quinoline ring, but with a bromine in place of 
the phenolic oxygen in the 8-position (8d). These two products proved inseparable by 
chromatography. 
NBr
F
N
O
O
8d  
Figure 2.3.7 Unexpected quinoline product from attempted amide syntheses 
Mechanistically, the most likely scenario for this substitution occurred during the 
deprotection stage. It is conceivable that upon mixture of boron tribromide with the 
quinoline amide, free bromides in solution, rather than attacking the methylene carbon of 
the benzyl group, attacked the aromatic ring and displaced the benzyloxide in an SNAr 
fashion. This process could be catalyzed by the boron coordinating with oxygen as a Lewis 
acid.  
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 Since this 8-bromo quinoline morpholine amide derivative represented an 
interesting analog in and of itself, it was prepared in pure form, starting from 2-bromo-4-
fluoroaniline. The final amide was obtained in acceptable yield through the same general 
procedure as previously described.  
 Additionally, it was desired to obtain a pure sample of the 8-hydroxyquinoline 
morpholine amide. Since the removal of the benzyl protecting group had proven to be 
problematic, a different approach was considered. The unprotected 6-fluoro-8-
hydroxyquinoline-2-carboxylic acid was subjected to the same reaction conditions. 
However in an attempt to selectively deprotonate and activate the more acidic carboxylic 
acid over the phenol, less basic imidazole was used in place of triethylamine.  Upon 
purification, NMR analysis indicated the amide had been successfully created; however, 
despite the precaution taken with the base, the phenol had also reacted with ethyl 
chloroformate to form an ethyl carbonate ester (8b, Figure 2.3.8).  
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8b  
Figure 2.3.8 Unexpected product from ethyl chloroformate addition to phenol 
This new analog was interesting with regard to its potential interaction with 
MtFBA: it could either enhance or detract from the molecule’s binding capability. The 
addition of two extra electron-rich oxygens at the 8-position of the molecule presented 
additional opportunity for coordination with the Zn2+; on the other hand it could be too 
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sterically demanding to fit into the narrow binding site of the enzyme. Regardless, a sample 
was reserved for biochemical analysis. The remaining portion was subjected to 
deprotection under basic conditions, resulting in the desired 8-hydroxyquinoline amide in 
fair yield (8c, Figure 2.3.9).  
NOH
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8c  
Figure 2.3.9 Desired morpholine amide 
With two of the three intended amide products successfully created, the focus then 
shifted to synthesis of the free amide. The first two attempts used the benzyl-protected 
quinoline-2-carboxylic acid as precursor, with ethyl chloroformate as activating agent. 
However, neither NH3 nor NH4Cl were suitable reagents in this process; only the 
intermediate ethyl anhydride was recovered. Another trial was conducted using an aqueous 
NH4Cl solution as the ammonia source with ethyl quinoline-2-carboxylate as the activated 
carbonyl component. After 48 hours of stirring at room temperature with only minimal 
conversion of starting material to product*, the temperature was increased to 50°C for an 
additional 48 hours. However, upon purification of the reaction mixture and NMR analysis 
only starting material was identifiable. 
                                                 
* As seen by TLC analysis. 
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2.3.2 Esters 
Similar to amide synthesis, an abundance of methods are available to convert 
carboxylic acids into esters. These include common and mechanistically simple approaches 
such as the eponymous Fischer esterification, nucleophilic acyl substitution via activated 
carboxylic acid intermediates, and nucleophilic substitution on an alkyl halide. Though not 
an exhaustive list, a few of the more complex routes include the Mitsunobu, Yamaguchi, 
and Steglich reactions. 
One of the most straightforward and widely-used synthetic routes to esters is the 
Fischer-Speier esterification. Announced by these two gentlemen in 1895, it is usually 
performed by refluxing a carboxylic acid in a large excess of the nucleophilic alcohol with 
an acid catalyst (Scheme 2.3.8). This method is advantageous for its simplicity and superior 
atom economy, but the unfavorable equilibrium of the reaction diminishes its utility. This 
poor equilibrium is due to the nearly identical basicity of the hydroxide and alkoxide 
leaving groups so that one is not heavily favored over the other, and similarly the ester is 
not substantially more stable than the carboxylic acid. However, this can be countered by 
passing dry HCl gas through the solution or removal of the water byproduct via addition 
of molecular sieves or Dean-Stark distillation [46].  
R OH
O
R OR'
O + O HH
acid catalyst
R' OH  
Scheme 2.3.8: Fischer-Speier esterification 
Nucleophilic acyl substitution reactions are powerful and simple methods of ester 
synthesis. As with amide synthesis, acid halides and mixed anhydrides are commonly 
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employed as electrophilic coupling partners with alcohols or alkoxides to form esters. A 
wealth of variations on this method exist that counter inherent shortcomings of the 
substrates or accord with specific reaction requirements. 
 A particular shortcoming that frequently accompanies the use of mixed anhydride 
coupling partners is the propensity for the nucleophilic alcohol to attack the carbonyl of 
the anhydride, rather than the desired substrate carbonyl. This leads to the varied 
production of carbonate side products, and a decreased yield of the desired product 
(Scheme 2.3.9). 
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Scheme 2.3.9 Dual products possible from nucleophilic attack on mixed anhydride 
As a counter to this obstacle, Yamaguchi and coworkers [56] devised a reagent for 
use with aliphatic carboxylic acids that would encourage nucleophilic attack of the alcohol 
on the appropriate carbonyl. In 1979, they disclosed 2,4,6-trichlorobenzoyl chloride 
(Scheme 2.3.10)  as a sterically-hindering carbonyl activator. The addition of triethylamine 
allows the deprotonation of the aliphatic carboxylic acid, which then couples with the 
activating agent. A catalytic amount of DMAP is added to the reaction, which then 
selectively attacks at the less-hindered carbonyl. The Yamaguchi reagent is sufficiently 
sterically encumbering to ensure that only the desired substrate carbonyl is attacked. The 
resultant dimethylaminopyridinium analog is then attacked by the alcohol, restoring the 
catalyst and forming the ester. 
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Scheme 2.3.10 Esterification using the Yamaguchi reagent 
The Yamaguchi method has been used extensively in recent years, including in the 
total synthesis of (-)-decarestrictine D by Victor and coworkers in 1998 [57] and the 
synthesis of a Lux-S aspartic acid enzyme inhibitor by SantaLucia in 2006 [58].  
In a divergent approach, Mitsunobu and Yamada introduced a procedure in 1967 
using triphenylphosphine and azodicarboxylates to form esters with a high degree of 
stereoselectivity (Scheme 2.3.11) [59]. While this approach is generally high-yielding, it 
also comes with drawbacks. For instance, in terms of green chemistry, the Mitsunobu 
reaction falls short. The byproducts in the reaction, hydrazodicarboxylate and 
triphenylphosphine oxide, are highly atom uneconomical and cannot be reused. In addition, 
the large amount of byproducts necessitates extensive workup and purification procedures. 
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Scheme 2.3.11 Mitsunobu method of stereoselective ester formation 
This latter disadvantage prompted Pelletier and Kincaid to devise a bypass [60]. In 
2000 they reported the use of resin-bound triphenylphosphine in the Mitsunobu reaction. 
This modification allowed for a simplified workup procedure in which filtration, 
evaporation, and an aqueous wash were sufficient to remove most contaminants and obtain 
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over 80% purity. This was advantageous for their high-throughput molecular screening 
process. 
Innumerable other examples of the Mitsunobu reaction have appeared in the 
literature. Three groups, including that of Barry Trost, independently used this reaction in 
the synthesis of morphine [61]. In addition, Stork and coworkers exploited this reaction in 
the first entirely stereoselective synthesis of (-)-quinine [62]. As a final example, Stephen 
Hanessian and coworkers applied the Mitsunobu reaction to the total syntheses of 
Dysinosin A [63] and Malayamycin A [64].  
Wolfgang Steglich introduced another ester synthesis method in 1978 [65]. 
Analogous to peptide coupling reactions, it utilizes DCC (see Figure 2.3.2) to combine 
carboxylic acids and alcohols. However, due to the less nucleophilic nature of alcohols 
compared to amines, this reaction tends to occur slowly which leads to the formation of 
side products such as N-acylureas. This obstacle can be overcome by addition of a catalytic 
amount of DMAP; this additive speeds up the reaction to such an extent that even sterically 
demanding esters can be formed in very high yields. As proof of this, Ghosh and coworker 
[66] applied this technique to an extraordinarily sterically challenging step in the total 
synthesis of (-)-Doliculide. 
Finally, esters can be formed by nucleophilic attack of carboxylate anions on alkyl 
halides. While this approach looks good on paper, for decades it was considered 
synthetically futile, mainly due to the solvent incompatibility of the carboxylate salt and 
alkyl halide. However, in 1968 Thompson and colleagues disclosed a valuable set of 
conditions that bypassed this obstacle. By heating the carboxylate salt and alkyl chloride 
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with catalytic amounts of triethylamine and sodium iodide in 2-butanone, they were able 
to achieve very high yields of several diverse esters [67]. 
2.3.2.1 Results and Discussion 
Similar to the amide derivatives, esters were desirable HCA analogs (9, Figure 
2.3.10) due to the retention of the zinc-coordinating carbonyl moiety and the utilization of 
the extra space in the binding pocket around the 2-position of the quinoline ring. 
OH
F
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O
9  
Figure 2.3.10 Ester quinoline derivative 
Due to its simplicity and economy – both in terms of atoms and expense – the 
Fischer-Speier esterification was the first to be tried. Refluxing the quinoline-2-carboxylic 
acid 2b in methanol with a catalytic amount of concentrated sulfuric acid resulted in the 
desired methyl carboxylate; however, after workup and purification only 11% yield of 
product was obtained (eq 9, Scheme 2.3.12). Of greater concern, the same reaction in 
ethanol did not produce any ethyl ester (eq 10).  
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Scheme 2.3.12 Fischer-Speier esterification of quinoline-2-carboxylic acid 
Therefore an alternative approach was considered. As previously mentioned, 
reaction of the carboxylic acid with alkyl halides presented a feasible course of action with 
comparable atom economy. After deprotonation of the quinoline carboxylic acid by cesium 
carbonate, the alkyl halide (either methyl iodide or ethyl iodide) was added. However, this 
method resulted in alkylation of not only the acid, but also the phenol (10a and 10b, Scheme 
2.3.13). Since removal of the alkyl group from the phenol would certainly have also 
hydrolyzed the ester, it was decided to preserve these samples as they were for biochemical 
analysis. 
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Scheme 2.3.13 Esterification of quinoline-2-carboxylic acids by nucleophilic attack on an alkyl halide, resulting in alkylation of the phenol 
Therefore, it was desired to introduce a protecting group to the phenol in order to 
prevent ether formation. However, this proved more difficult than anticipated. In order to 
selectively protect the phenol without also affecting the carboxylic acid, installation of the 
protecting group must occur before the acid is formed by SeO2 oxidation. As was the case 
with phenol protection during amide synthesis (see Section 2.3.1.1), that means the 
protecting group must be resilient to both the basic conditions of the oxidation reaction and 
the highly acidic conditions of the subsequent workup and isolation. In addition, the 
protecting group must be durable under the conditions of the ester synthesis, and the newly 
formed ester must be stable to the ensuing deprotection of the phenol. This multitude of 
requirements drastically reduced the number of viable protecting groups. 
For instance, while silyl ethers are easily introduced to phenols, they are extremely 
acid labile and would not survive the low pH required for isolation of the carboxylic acid 
after oxidation. Conversely, methyl and benzyl ethers are extremely stable to both acidic 
and basic conditions, but removal of these protecting groups requires harsh conditions such 
as BBr3 which would destroy the ester. Acetal, carbonate, and ester protecting groups all 
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pose similar difficulties. Therefore ester synthesis via nucleophilic substitution of the 
carboxylate on alkyl halides did not appear to be a viable option. 
 Rather than resort to some of the more complex ester synthesis techniques, it was 
then decided to revisit the method of Fischer esterification. The standard reaction was again 
run with a large excess of alcohol and a catalytic amount of sulfuric acid, but instead of a 
workup procedure after the reaction had finished, the crude reaction mixture was 
immediately purified via flash chromatography over silica gel. In this way the methyl, 
ethyl, and isopropyl esters (9a, 9b, 9c, Figure 2.3.11) were obtained in fair to good yields. 
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Figure 2.3.11 Desired ester quinoline derivatives 
2.3.3 Alcohols 
Primary alcohols can be obtained by several methods of carbonyl reduction. These 
range from the mild reduction of aldehydes by NaBH4 to the extremely harsh 
Superhydride* reduction of nearly any carbonyl it encounters, including relatively stable 
amides. The choice of reducing agent is highly dependent on the substrate and other 
functional groups [44].  
                                                 
* Lithium triethylborohydride 
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2.3.3.1 Results and Discussion 
A primary alcohol on the 2-position of the quinoline ring (specifically a 
hydroxymethyl group) was considered an attractive analog to explore (12, Figure 2.3.12). 
While it did not present any additional advantages over carboxylic acid derivatives in terms 
of extra zinc-coordinating lone pair electrons or space-consuming alkyl groups, the 
supplemental flexibility inherent in the sp3-hybridized methylene carbon presented 
interesting binding opportunities. 
NOH
F
OH
12  
Figure 2.3.12 Hydroxymethyl quinoline derivative 
Initially synthesis of this analog was attempted through reduction of the previously 
synthesized quinoline-2-carboxylic acid. Although sodium borohydride is generally not 
strong enough to reduce carboxylic acids, addition of a substoichiometric amount of I2 can 
catalyze the reaction to completion (Scheme 2.3.14) [68]. Disappointingly, these conditions 
did not produce any of the desired reduction product. 
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2b  
Scheme 2.3.14 Reduction of carboxylic acid to hydroxymethyl using sodium borohydride and molecular iodine 
Next a more aggressive reducing agent was used. Lithium aluminum hydride was 
combined with the quinoline methyl ester in diethyl ether, but even after several days no 
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reaction occurred; only starting material was present in the reaction mixture. After careful 
consideration, it seemed likely that the slightly acidic phenol had deactivated the 
borohydride reagent. This would occur when the basic hydride ions deprotonate the phenol, 
thereby releasing hydrogen gas and precluding these ions from performing the desired 
reduction. Therefore the next iteration of this approach involved protection of the phenol 
with a benzyl group. The benzyl-protected quinoline ethyl ester was subjected to lithium 
aluminum hydride reduction (Scheme 2.3.15) [69]; however, despite the more reactive 
reducing agent and extended reflux, the desired product was not discernable in the reaction 
mixture. 
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Scheme 2.3.15 Reduction of ethyl ester to hydroxymethyl using lithium aluminum hydride 
The final attempts to create this analog occurred through reduction of an aldehyde. 
The aldehyde itself was easily obtained through selenium (IV) oxidation. By simply 
changing the oxidation reaction solvent from pyridine to a 5:1 mixture of 1,4-dioxane in 
water, an aldehyde can be obtained rather than a carboxylic acid (11a, Scheme 2.3.16).  
NOH
F
NOH
F
O
SeO2
H2O/dioxane
1b 11a  
Scheme 2.3.16 Oxidation of benzylic methyl to aldehyde using selenium (IV) oxide in H2O/dioxane 
Since aldehydes are significantly more reactive than esters or carboxylic acids, use 
of a milder reducing agent is acceptable. Initially the quinoline-2-carbaldehyde was stirred 
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with sodium borohydride in methanol. However, the acidic phenol once again most likely 
deactivated the hydride ions, resulting in no formation of the reduction product. To prevent 
this from occurring again, in the next attempt the quinoline aldehyde was first dissolved in 
aqueous sodium hydroxide then afterwards combined with sodium borohydride. 
Promisingly NMR analysis of the crude reaction mixture showed the disappearance of the 
signature aldehyde peak, and after purification there appeared to be a new methylene peak. 
While these observations indicated the formation of the desired hydroxymethyl product 
(12, Scheme 2.3.17), it was too impure to analyze biochemically and isolated in too small 
an amount to purify again. The appearance of a successful reaction was encouraging, and 
in the future this technique could be attempted again, perhaps with a larger excess of 
reducing agent to ensure enough hydride ions are available for the reduction process. 
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Scheme 2.3.17 Reduction of quinoline-2-carbaldehyde by sodium borohydride in sodium hydroxide to give 2-hydroxymethylquinoline 
2.3.4 Carbamates and Ureas 
The latter third of the nineteenth century brought several correlated methods for the 
preparation of carbamate and urea functional groups from carboxylic acids (or derivatives 
thereof), generally by way of isocyanate intermediates. The first of these was disclosed by 
Wilhelm Lossen in 1872 [70] in which hydroxamic acid is converted to an O-acyl, sulfonyl, 
or phosphoryl intermediate, which then undergoes rearrangement to an isocyanate under 
thermal or alkaline conditions. Upon reaction with an alcohol or amine, the isocyanate is 
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then converted to a carbamate or urea (Scheme 2.3.18). However, due to the tendency of 
the hydroxamic acid to condense with the newly formed isocyanate, this reaction has not 
seen much synthetic use recently. 
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Scheme 2.3.18 Isocyanate formation by Lossen rearrangement. The isocyanate can then be combined with an alcohol or amine to form a carbamate or urea 
Then in 1881, August Wilhelm von Hofmann reported that halogenated amides also 
undergo rearrangement to the isocyanate under basic conditions, a process that has come 
to be known as the Hofmann degradation or Hofmann rearrangement (Scheme 2.3.19). This 
reaction is generally amenable to most aliphatic, aromatic, and heterocyclic amides, but the 
necessity for strong base precludes its use with compounds containing base-labile 
functional groups [71]. 
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Scheme 2.3.19 Isocyanate formation by Hofmann rearrangement. The isocyanate can then be combined with an alcohol or amine to form a carbamate or urea. 
The third installment in this series came in 1890 when Theodor Curtius reported 
the formation of acyl azides – from the reaction of acyl halides with sodium azide – which 
then decomposed under thermal conditions with loss of N2 to give the isocyanate 
intermediate [46]. As with the Lossen and Hofmann rearrangements previously mentioned, 
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carbamates and ureas can be formed from the addition of alcohol or amine to the isocyanate 
(Scheme 2.3.20).  
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Scheme 2.3.20 Isocyanate formation by Curtius rearrangement. The isocyanate can then be combined with an alcohol or amine to form a carbamate or urea 
The Curtius method is nearly universally effective with its tolerance to a wide scope 
of functionality. With N2 and NaCl as the only major byproducts, it also represents an 
improvement in green chemistry techniques over the atom-uneconomical loss of sulfonic 
or phosphoric acid with the Lossen procedure and the extrusion of toxic HBr with the 
Hofmann. Despite these advantages, this procedure also poses a significant risk due to the 
acute toxicity and explosive danger of sodium azide [72].  
Therefore the most significant modification made to this procedure was the advent 
of diphenylphosphoryl azide (DPPA, XXXIV, Figure 2.3.13) as a substitute azidation 
agent.  
 
Figure 2.3.13 Diphenylphosphoryl azide 
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Introduced by Shioiri, Ninomiya, and Yamada in 1972 [73] and reportedly first 
used in a Curtius reaction in 1974 by the same group [74], this modification increased the 
convenience and efficacy of the reaction. Treating benzoic acid with a variety of alcohols 
in the presence of DPPA and triethylamine, they obtained the corresponding carbamates in 
good yield. Moreover, they were purportedly able to expand the scope of the rearrangement 
to include previously elusive products. For instance, they found the reaction of pyridine-2-
carboxylic acid with tert-butyl alcohol, which had given poor yield of the rearrangement 
product under standard Curtius conditions, to be facile with DPPA, giving 73% yield of 
the tert-butyl carbamate (Scheme 2.3.21) [74]. 
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Scheme 2.3.21 Curtius rearrangement using Shioiri reagent modification 
The standard Curtius rearrangement and its variations have recently been widely 
utilized. For instance, Appella and coworkers [75] synthesized peptide probes containing 
benzyl carbamate side chains via this method (eq 11, Scheme 2.3.22). Lebel and coworker 
[76] used a similar technique in order to access protected anilines and ureas (eq 12 and 13). 
Utilizing chloroformates as carboxylic acid activators and heating the resulting mixed 
anhydride with sodium azide and sodium tert-butoxide in 1,2-dimethoxyethane (DME), 
they were conveniently able to exploit the inherent nucleophilicity of the extruded alkoxide 
toward the isocyanate, thus forming carbamates in a one-pot procedure. In order to achieve 
the desired urea compounds, they employed phenyl chloroformate as the acid activator, 
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which extrudes the less nucleophilic phenoxide upon reaction with sodium azide. 
Subsequent addition of amine provided the desired ureas.  
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Scheme 2.3.22 Various reactions using the Curtius rearrangement to form carbamates and ureas 
Interestingly, Richards and coworker [77] applied this method to the 
functionalization of organometallic substrates (eq 14, Scheme 2.3.22). As part of a larger 
scheme to obtain 1,2,3,4,5-pentaphenyl-1′-aminoferrocene, they were able to achieve the 
(trimethylsilyl)ethylcarbamate via Curtius rearrangement in excellent yield. 
A wealth of procedures using the DPPA modification can also be found in the 
literature. These range from simple alkyl and aryl starting carboxylic acids to highly 
intriguing heterocyclic and glycosidic substrates. Townsend et al. [78] described the 
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reaction of 1-benzyl-3-cyanopyrrole-2-carboxylic acids with DPPA, to which was added 
various alcohols to give the corresponding carbamates (eq 15, Scheme 2.3.23). These were 
then further reacted to obtain biologically interesting pyrimidine compounds. 
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Scheme 2.3.23 Various reactions to form carbamates and ureas via Curtius rearrangement using DPPA 
Also, Ikegami et al. [79] applied this modification to the synthesis of carbamate- 
and urea-linked oligosaccharides (eq 16, Scheme 2.3.23). These compounds are attractive 
targets because while they mimic natural oligosaccharides with enhanced stability due to 
the carbamate or urea linkages, they also present unique biological properties. One of the 
most important features of the Curtius rearrangement in this situation is the complete 
retention of stereochemistry at both the carboxylic acid and hydroxymethyl groups. 
2.3.4.1 Results and Discussion 
The structurally and electronically similar carbamate and urea derivatives of 6-
fluoro-8-hydroxyquinoline were the next functional groups to be explored (13 and 14, 
Figure 2.3.14). With multiple nitrogen and oxygen moieties, these analogs provide 
abundant opportunity for electronic coordination with the Zn2+ ion while utilizing the space 
within the binding pocket. 
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Figure 2.3.14 Carbamate and urea quinoline analogs 
To begin, the aforementioned Curtius rearrangement modification using the so-
called Shioiri reagent DPPA was utilized in the attempted synthesis of the tert-butyl 
carbamate derivative. The first trial involved reflux of the quinoline carboxylic acid with 
DPPA, triethylamine, and tert-butyl alcohol in DMF to form the tert-butyl carbamate (13, 
Scheme 2.3.24). Unfortunately, despite the appearance of a completed reaction on TLC, no 
product was isolated after chromatographic purification.  
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Scheme 2.3.24 Attempted synthesis of quinoline-2-tert-butyl carbamate 
However, when DMF was omitted and the alcohol was used as solvent [74], the 
desired product was produced, albeit in small yield and with inseparable impurities. 
Similarly, the reaction was run with diethylamine in place of the alcohol; in this way the 
diethyl urea derivative was produced in very small quantity (14, Scheme 2.3.25).  
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Scheme 2.3.25 Attempted synthesis of quinoline-2-diethylurea 
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Despite the attractiveness of performing this reaction with an unprotected phenol, 
the low yields were unsatisfactory. Therefore further attempts to obtain the carbamate and 
urea products were executed with the phenol of the starting quinoline-2-carboxylic acid 
protected with a benzyl group. Under these conditions, isolation of the products was much 
more productive. Removal of the benzyl ether protecting group was achieved via catalytic 
hydrogenolysis (Scheme 2.3.26) as opposed to the problematic BBr3 method. This mild 
room temperature alternative proved to be highly effective, affording the desired carbamate 
13 and urea 14 relatively cleanly and in good yield. 
O Ph
R H2, Pd/Cr.t.
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R  
Scheme 2.3.26 Catalytic hydrogenolysis of benzyl ether protecting group 
2.3.5 Amines 
Installation of aromatic amines has historically been accomplished by several 
methods, some of which are particular to aromatic nitrogen heterocycles, and others that 
are more general. These routes include, among others, the Chichibabin reaction, the 
mechanistically related Lossen, Hofmann, and Curtius rearrangements, and amination from 
the N-oxide. 
Aleksei Chichibabin reported the first direct amination of pyridine in 1914 [80]. By 
reacting the heterocycle with sodium amide in toluene, he produced mainly 2-
aminopyridine in very good yield with a small amount of 4-aminopyridine as side product 
(Scheme 2.3.27). Applicable to a wide variety of electron-deficient aromatic heterocycles 
such as quinolines, imidazoles, and pyrimidines, this methodology has proven to be 
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extremely useful over the last hundred years. However, the exceedingly aggressive and 
highly basic sodium amide reagent significantly decreases the synthetic utility of this 
procedure, particularly as it relates to functional group compatibility.  
N N NH2NaNH2
toluene
+
N
NH2
major minor  
Scheme 2.3.27 Chichibabin amination of pyridine 
 While the Chichibabin reaction exhibits a high degree of regioselectivity in the 
amination of nitrogen heterocycles, it is still subject to formation of a mixture of products. 
Alternatively, substitution of a halide by amine at the 2-position of the heterocycle would 
give only the single 2-amino product. Yet installation of the halide in the first place is itself 
beset by poor regioselectivity and low yields [81].  
A recent development in the direct amination of nitrogen heterocycles came from 
Storz and associates in 2004 [82] when they desired a scalable route to 2-amino-8-
hydroxyquinoline. After a set of unsuccessful trials with the Chichibabin reaction and an 
outright rejection of the use of toxic chloramines, they developed a new protocol in which 
the quinoline-N-oxide was initially formed by oxidation with peracetic acid. This was then 
activated by methylation with dimethyl sulfate, and the resultant salt was quenched in 
aqueous ammonia (Scheme 2.3.28). By this method they obtained the desired 2-amino-8-
hydroxyquinoline without the need for phenol protection. 
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Scheme 2.3.28 Amination of 8-hydroxyquinoline via N-oxide intermediate 
Despite the perceived ease, this and similar approaches are generally subject to poor 
yields due to various side-processes occurring simultaneously. These include attack of the 
activating agent’s counterion on the ring (eq 17 Scheme 2.3.29), amine-induced 
dimerization (eq 18), and poor regioselectivity of the amine (eq 19) [81].  
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Scheme 2.3.29 Side reactions that can occur during amination reaction via N-oxide intermediate. 
These observations induced Yin and coworkers at Merck to attempt a related 
approach to these pharmaceutically interesting pyridine derivatives. In 2007 [81], they 
reported 100% conversion of the starting pyridine-N-oxide by combining it with tert-
butylamine and triflic anhydride (trifluoromethanesulfonic anhydride, Tf2O) as activating 
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agent. After formation of the 2-tert-butylaminopyridine, the tert-butyl group was removed 
by heating in trifluoroacetic acid (TFA) to give the unprotected 2-aminopyridine (Scheme 
2.3.30).  
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Scheme 2.3.30 Primary aryl amine formation by acid hydrolysis of aryl tert-butylamine 
These conditions served to minimize the formation of unwanted 4-aminopyridine* 
while maximizing overall yield of desired product. However, this was accomplished 
mainly through saturation of the reaction mixture with superstoichiometric amounts of 
Tf2O and tert-butylamine, thereby ensuring that even if the amine was deactivated by attack 
on the triflic anhydride, there would be enough of both remaining in the mixture to react 
with the pyridine-N-oxide. Therefore, although the high yield and selectivity of this method 
are favorable, the atom economy is less so. 
 This method was also used by the team of Cheng and Judd at Amgen. In 2011 [83] 
they reported on the synthesis of a library of potent small molecule inhibitors of BACE1† 
towards a novel treatment of Alzheimer’s disease. Fragment screening identified the 2-
aminoquinoline moiety as a starting point, and one approach used to obtain these molecules 
was essentially that of Yin et al. As part of a broader synthetic strategy, they obtained 
                                                 
* 59:1 ratio of 2- to 4-aminopyridine was observed. 
† Beta-site amyloid precursor protein cleaving enzyme 1 
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several diversely substituted 2-aminoquinolines, mostly in fair to excellent yields (eqs 20, 
21, 22, Scheme 2.3.31). 
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Scheme 2.3.31 Reactions to form amines utilizing tert-butylamine and Tf2O 
As previously discussed in section 2.3.4, the Lossen, Hofmann, and Curtius 
rearrangements are mechanistically related strategies toward the formation of isocyanates. 
In addition to the ureas and carbamates that are produced upon introduction of amines or 
alcohols to the isocyanate intermediate, this reaction can also be used to form primary aryl 
amines. Addition of water to the isocyanate results in the carbamic acid, which is 
significantly less stable than the associated carbamate and spontaneously decomposes upon 
heating to carbon dioxide and the aryl amine (Scheme 2.3.32).  
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Scheme 2.3.32 Primary aryl amine formation by Curtius rearrangement 
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2.3.5.1 Results and Discussion 
Amine functional groups at the 2-position of the quinoline ring were also 
considered desirable HCA analogs (15, Figure 2.3.15). Similar to amides, resonance of the 
nitrogen lone pair electrons into the quinoline ring would present interesting interactions 
within the enzyme while imparting diverse space-exploiting alkyl groups. 
NOH
F
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Figure 2.3.15 Quinoline with amine functional group 
Building off the work of Storz and associates, it was first attempted to obtain the 
amine-substituted quinolines by activating the 2-position of the heterocycle by 
methoxylation of the ring nitrogen (Scheme 2.3.33). The N-oxide was formed through 
reaction with m-CPBA and subsequently methylated by dimethyl sulfate. Once activated, 
a solution of NH3 in dioxane was added and the reaction was stirred at room temperature. 
Unfortunately two trials of this reaction did not produce any discernible product.  
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Scheme 2.3.33 Attempted amination on 2-position of quinoline by methoxylation of ring nitrogen and addition of ammonia 
It was then noted that the previous formation of the tert-butyl carbamate could be 
an advantageous alternative to a direct amination reaction. Since a tert-butyl carbamate is 
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essentially a Boc*-protected amine, acid hydrolysis of the tert-butoxy protecting group by 
acid would result in the primary amine (Scheme 2.3.34) [84]. This was attempted through 
stirring the carbamate in a mixture of trifluoroacetic acid (TFA) and CH2Cl2 at room 
temperature. NMR analysis indicated a very small conversion of the carbamate to an 
amine; however, it was not isolable.  
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Scheme 2.3.34 Acid hydrolysis of tert-butylcarbamate to form primary amine on 2-position of quinoline 
2.3.6 Heterocycles 
Heterocycles represent one of the largest categories of compounds within organic 
chemistry and account for the majority of pharmaceutically and industrially significant 
compounds [85]. There are innumerable heterocyclic components that have countless 
combinations of nitrogens, oxygens, and sulfurs in a broad range of ring sizes and 
arrangements. Since an exhaustive accounting of these various permutations would be 
impractical, only a few will be highlighted. 
Indoles are one of the most important and widely used structural motifs in organic 
chemistry and chemical biology. Among the most plentiful heterocycles in nature, indoles 
account for over 3000 characterized biological compounds including the amino acid 
tryptophan (XXXV, Figure 2.3.16) and the neurotransmitter serotonin (XXXVI). In 
                                                 
* Boc = tert-butyloxycarbonyl 
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addition, indoles are often integral parts of powerful pharmacophores such as in the statin 
drug Fluvastatin (XXXVII) [86]. 
N
OH
O
OH OH
F
NH
NH2
OHO
NH
OH
NH2
XXXV XXXVI
XXXVII  
Figure 2.3.16 Naturally-occurring and biologically active indole-based compounds 
While there are nearly as many routes to synthesize indoles as there are indole 
compounds in nature, a few are more widely used than the others. The Fischer indole 
synthesis, introduced in 1884 by Emil Fischer – whom we have encountered a few times 
before – is one of the oldest, simplest, and most ubiquitous means to obtain this heterocycle. 
This method involves the reaction of phenylhydrazine with a ketone under acid catalysis 
(Scheme 2.3.35) [87]. The pliability of this reaction rests in its tolerance to a wide variety 
of substitution on both the aryl and ketone components.  
N NH2
H
NH
R
R'R
O R'+ acid
 
Scheme 2.3.35 Fischer indole synthesis 
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Structurally related benzoxazoles, benzimidazoles, and benzothiazoles are 
biologically and industrially important isosteres of indole. While precedent has been set 
over the last 35 years for the production and use of these structures scaffolds for compounds 
with light-emitting properties [88], there are also many examples of their use in 
biologically active compounds. These include the benzoxazole-based anti-inflammatory 
drug flunoxaprofen (XXXVIII, Figure 2.3.17), the benzimidazole-based anti-parasitic 
albendazole (XXXIX), and the benzothiazole-based ALS therapy riluzole (XL). 
N
O O
OHF N
H
N
S NH O
O
S
NNH2
O CF3
XXXVIII XXXIX
XL  
Figure 2.3.17 Structures of benzoxazole, benzimidazole, and benzothiazole compounds that show biological activity 
The most common synthetic route toward these heterocycles is a cyclization 
reaction between a functionalized aldehyde and an appropriately substituted aniline. While 
this general method is useful for all three heterocycles, the specifics of each individual 
reaction vary greatly. The benzothiazole can be synthesized by simply refluxing the 
aldehyde and 2-aminothiophenol in DMSO, but the benzimidazole needs the more acidic 
mixture of thionyl chloride and silica gel in order to cyclize. The benzoxazole requires a 
multi-step process involving functional-group protection [89], Schiff base formation, and 
DDQ oxidation [90]. 
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2.3.6.1 Results and Discussion 
An additional approach to introducing an sp2-hybridized metal coordination site at 
the 2-position of the quinoline ring came in the form of heterocyclic moieties (16, Figure 
2.3.18). In fact, there is ample precedent for the use of 8-hydroxyquinolines with 
heterocyclic substituents at the 2-position as tridentate metal chelators. While Bünzli and 
associates found 8-hydroxyquinolines with benzoxazole substituents to be excellent 
lanthanide chelators for use in near-infrared luminescent materials [90], Hwang and 
coworkers complexed benzothiazole-based compounds with iridium (III) to exploit the 
heavy metal’s phosphorescent properties [91]. Most intriguingly, Zhou et al. used 
benzimidazole-substituted 8-hydroxyquinolines as novel Zn2+ chelate ligands in order to 
take advantage of their electroluminescent properties in organic light-emitting diodes [89]. 
This directly demonstrates these compounds’ ability to tightly coordinate with a zinc ion, 
which is highly advantageous for the present study. 
NOH
F
X
N
16  
Figure 2.3.18 Heterocyclic quinoline derivatives: X can be CH, NH, O, or S 
To begin, the benzoxazole derivative was considered the most promising insofar as 
metal-chelating ability was concerned. In order to access the benzyl-protected quinoline-
8-ol-2-carbaldehyde precursor, 8-benzyloxy-6-fluoro-quinaldine was subjected to the same 
oxidation as described in Section 2.3.3.1. The intermediate Schiff base was formed by 
combination of the aldehyde with 2-aminophenol under acid catalysis, and the subsequent 
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cyclization was achieved under reflux with DDQ [90]. Upon phenol deprotection, the final 
benzoxazole compound (16a, Scheme 2.3.36) was isolated in good yield. 
NOH
F
O
NN
OBn
F
O
11b
+
OH NH2 cat. CH3COOH N
OBn
F
N OH
16a
DDQ
thendeprotection
 
Scheme 2.3.36 Formation of quinoline benzoxazole derivative 
The relatively straightforward synthesis of the benzothiazole derivative was 
attempted next. Although protection of the phenol was not strictly necessary [90], this 
precaution was taken and the benzyl-protected quinoline-2-carbaldehyde was refluxed with 
2-aminothiophenol in DMSO (Scheme 2.3.37). Upon deprotection, the desired analog was 
obtained in poor yield. In an attempt to bypass loss of product due to the extra 
protection/deprotection steps, the unprotected aldehyde was subjected to the same reaction 
conditions. However, no product was isolated from this attempt. 
NOH
F
S
NN
OBn
F
O
11b
+
SH NH2
16b
DMSO
thendeprotection
 
Scheme 2.3.37 Formation of quinoline benzothiazole derivative 
In order to obtain the benzimidazole analog, the benzyl-protected aldehyde was 
combined with o-phenylenediamine in a dichloromethane solution of oxalyl chloride and 
silica gel [89]. Under these conditions, no product was formed and only the original 
aldehyde was recovered. Simply refluxing in DMSO, though, appeared to be more 
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successful. NMR analysis indicated the consumption of aldehyde starting material and the 
apparent formation of product. Upon deprotection and purification, the product had 
appeared to be present, but was impure and in too small a quantity to pursue further. 
The final heterocyclic derivative attempted was an indole substitution on the 2-
position of the quinoline ring. The model reaction began with preparation of quinoline-2-
methylketone (17, Scheme 2.3.38) by a Grignard reaction of methyl magnesium iodide with 
the commercially available 8-hydroxyquinoline-2-carbonitrile. Protection of the phenol 
was performed in order to avoid deactivation of the Grignard reagent. 
NO OCNN
O
CH3MgI
ether
17  
Scheme 2.3.38 Grignard reaction of quinoline-2-carbonitrile to give quinoline-2-methylketone 
Under standard Fischer conditions of refluxing the quinoline-2-methylketone with 
phenyl hydrazine under acidic conditions [92], the indole cyclization did not go to 
completion. Instead, despite extended reaction times and high reflux temperatures, the 
reaction stopped at the intermediate hydrazone (18, Scheme 2.3.39). 
NO O
17
H2SO4

N NH2
H
+
NO N
NH
18  
Scheme 2.3.39 Attempted Fischer indole synthesis under acid reflux 
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 In an attempt to force the hydrazone to cyclize into an indole (19, Scheme 2.3.40), 
the intermediate was refluxed in acids of varying strengths. While trifluoroacetic acid [93], 
p-toluenesulfonic acid [94], and methanesulfonic acid [95] were ineffective in prompting 
the cyclization, acetic acid actually caused the hydrazone to revert back to the methyl 
ketone.  
18
NO N
+NHH
acid N
O
NH
19  
Scheme 2.3.40 Attempted cyclization of hydrazone to indole by acid catalysis 
2.4 Exo-ring nitrogen  Naphthalenes are important building blocks of biologically active compounds, 
especially within antidepressant therapeutics such as Agomelatine (XLIV, Figure 2.4.1) 
[96]. Naphthalenes with ortho-amino esters are less well known; therefore although there 
are innumerable means to obtain variously substituted naphthalenes, not many involve 
direct routes to this interesting derivative. 
O NH
O
XLIV  
Figure 2.4.1 Agomelatine, naphthalene-containing biologically active compound 
Amino naphthalene compounds are generally constructed one of two ways: through 
placement of the amine on a previously assembled naphthalene via substitution reaction, 
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or through cyclization of an aromatic precursor that already contains the amine 
functionality. It is generally preferred to proceed through the annulation route, since 
substitution on the naphthalene core is tedious and requires preexisting directing groups 
[97]. 
A review of the literature indicates numerous routes toward cyclization of an 
aromatic precursor into a naphthalene with an amino group in the 1-position. However, 
these methods generally suffer from highly variable yields and poor atom economy. 
Therefore Sudalai and coworkers explored a simple synthetic process toward these 
molecules. This method affords ethyl 1-aminonaphthalene-2-carboxylates by copper-
mediated substitution of a bromine for cyanide ortho to an α,β-unsaturated ester on an 
aromatic ring (XLV, Scheme 2.4.1), which then spontaneously cyclizes and rearomatizes 
to the naphthalene (XLVI) [97].  
Br
O
O
CH3
R
NH2
O
O
CH3RCuCNDMF, 
XLV XLVI  
Scheme 2.4.1 CuCN-mediated cyclization to aminonaphthalenes 
Sudalai also described the synthetic route to the o-bromo-α,β-unsaturated ester 
precursor whereby, starting with the appropriate o-bromoacetaldehyde, Wittig olefination 
affords the corresponding enol ether (XLVII, Scheme 2.4.2). Acid hydrolysis of the ether 
then gives the bromophenylacetaldehyde (XLVIII).  
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Br
O
HR
Ph3P O CH3Cl-
+
Br
R
O CH3
HCl

Br
R
H
O
KOtBuTHF, 0-25 oC
XLVII XLVIII  
Scheme 2.4.2 Synthetic scheme to phenylacetaldehyde 
The desired ethyl 4-(2-bromophenyl)-2-butenoate (XLIX) could then conceivably 
be prepared by two methods. The first approach, used by Sudalai, subjects the 
bromophenylacetaldehyde to Wittig conditions (Scheme 2.4.3).  
Br
R
H
O Ph3P O
O+ CH2Cl2, rt
Br
O
OR
XLIXXLVIII  
Scheme 2.4.3 Synthesis of ethyl 4-(2'-bromophenyl)-2-butenoate by Wittig Synthesis 
Alternatively, the aldehyde could undergo aldol condensation with ethyl acetate 
under highly basic conditions to give the same product (Scheme 2.4.4) [98].  
Br
R
H
O +
Br
O
ORO
O LDA
THF, -78oC
XLVIII XLIX  
Scheme 2.4.4: Synthesis of ethyl 4-(2'-bromophenyl)-2-butenoate by Aldol Condensation 
The aldol route would plausibly be of greater synthetic value since it uses more 
cost-effective reagents (ethyl acetate vs. pre-made or synthesized ethyl phosphorylidene) 
and has much improved atom economy with less wasteful byproducts (H2O vs. 
triphenylphosphine oxide). However, conventional mixed aldol condensations often suffer 
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from poor regioselectivity [99], meaning the yield of the desired product could be 
decreased by several undesired alternative reactions: self-condensation of the aldehyde (L, 
Figure 2.4.2) or ester (LI), or cross-condensation of the alpha carbon of the aldehyde with 
the carbonyl of ethyl acetate (LII).  
Br
R
HO
H
Br
R O
O
CH3
CH3
OCH3
Br
R
H
O
CH3 O CH3
L LI LII  
Figure 2.4.2 Undesired side reaction products of Aldol Condensation 
Formation of these undesired side products could be alleviated by directed aldol 
synthesis [99]. Preliminary deprotonation of the alpha carbon of ethyl acetate with an 
equimolar amount of lithium diisopropylamide (LDA) would ensure the ethyl acetate is 
fully deprotonated (and thus further resistant to self-aldol) before it is mixed with the 
aldehyde. This directed aldol synthesis circumvents the undesirable formation of the 
aldehyde enolate, and since it is performed at -78°C, it exerts kinetic control over the 
development of crossed-aldol products. 
This method of forming 4-(2-bromophenyl)-2-butenoate via aldol condensation is 
not without drawbacks. For one, any relatively acidic functional group would have to be 
protected before being combined with the enolate. Also lithium diisopropylamide is a 
highly reactive base [100], and use of a full equivalent would certainly create waste in the 
form of lithium chloride and diisopropylamine. However, from a green chemistry point of 
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view, aldol condensation would be far more atom-economical than Wittig synthesis for this 
reaction. 
2.4.1 Results and Discussion 
As previously mentioned, PyMol analysis of the site within MtFBA where the 
quinoline analogs bind indicated that a Zn2+ ion coordinates with several atoms on the 
structure through donated lone pair electrons. This included the nitrogen within the 
quinoline ring. It was postulated that converting that nitrogen to an exo-cyclic primary 
amine could displace the zinc at the active site, thereby allowing that nitrogen, as well as 
the two oxygens of the carboxylic acid and phenol, to directly interact with the side chains 
of the protein. Therefore, as proof of concept, it was proposed to create 1-amino-6-fluoro-
8-hydroxynaphthalene-2-carboxylic acid (24, Figure 2.4.3).  
OH
F
OH
ONH2
24  
Figure 2.4.3 Proposed analog 1-amino-6-fluoro-8-hydroxynaphthalene-2-carboxylic acid 
 To begin, it was decided that 2-bromophenol-3-carbaldehyde (Figure 2.4.4) would 
act as model substrate for this reaction since the fluorinated analogs of the desired starting 
compound were prohibitively difficult to obtain. 
 
Figure 2.4.4 Starting aldehyde 
Br
O
H
OH
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This substrate was first subjected to the conditions of the Wittig olefination, 
wherein (methoxymethylene)triphenylphosphonium chloride was deprotonated by 
potassium tert-butoxide at 0°C to give the ylide, which was then combined with the 
aldehyde to give the enol ether (20, Scheme 2.4.5). However, several trials of this reaction 
consistently gave only partial conversion of the aldehyde to the enol ether*, despite 
variations in reaction time. After some consideration, it was hypothesized that two 
variables could be at play to cause the low conversion. First, since the phosphonium 
chloride and butoxide were added together at 0°C and remained at that temperature while 
the aldehyde was added, it is possible that ylide formation was incomplete. Second, the 
relatively acidic phenol on the benzaldehyde could easily be deprotonated by the ylide, 
thus deactivating this reagent and prohibiting further reaction.  
Br
O
H
OH
Ph3P O CH3
Cl- +
Br
O CH3
OH
KOtBu
THF, 0-25 oC
20  
Scheme 2.4.5 Wittig olefination to obtain enol ether 
In order to counteract these effects, the reaction was performed again, but the 
phosphonium-butoxide mixture was allowed to warm to room temperature for an hour 
before cooling again prior to aldehyde addition. This initially appeared to facilitate the 
                                                 
* As seen by NMR. 
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reaction, as evidenced by the robust formation of white precipitate, presumably 
triphenylphosphine oxide. However, after 24 hours of stirring at room temperature, the 
precipitate had dissolved back into solution. At this point, another equivalent of butoxide 
was added to the reaction mixture and allowed to stir overnight. Vigorous formation of 
precipitate, along with positive TLC analysis, indicated the success of this tactic. 
Subsequent NMR analysis confirmed the absence of aldehyde starting material. However, 
the isolated yield of enol ether was disappointingly low. Most likely, the factor responsible 
for this phenomenon was the aforementioned deprotonation of the phenol by either KOtBu 
or the ylide. This would complicate isolation of the product since the phenoxide salt would 
not be as amenable to extraction by an organic solvent, instead remaining at least partially 
in the aqueous medium. 
Nevertheless acid hydrolysis of the enol ether was performed, and the intended (2-
bromo-3-hydroxyphenyl)acetaldehyde was obtained (21, Scheme 2.4.6).  
Br
O CH3
OH
Br
H
O
OH
20 21
HCl

 
Scheme 2.4.6 Acid hydrolysis of aryl enol ether to aryl acetaldehyde 
Next the aldehyde was converted to an α,β-unsaturated ester by Wittig reaction; 
(carbethoxymethylene)triphenylphosphorane was combined with the aldehyde to form the 
intended cyclization precursor (22, Scheme 2.4.7).  
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Scheme 2.4.7 Wittig reaction to form α,β-unsaturated ester 
Finally, reflux with CuCN gave the cyclized ethyl 1-amino-8-hydroxynaphthalene-
2-carboxylate (23, Scheme 2.4.8). However, the yield and purity of the isolated product 
were subpar. Multiple trials consistently resulted in a very small amount of product that 
was contaminated with the uncyclized α,β-unsaturated ester intermediate; unfortunately the 
amount of aminonaphthalene recovered was not enough to attempt hydrolysis of the ester 
into the carboxylic acid. While this synthetic method appeared promising, it required some 
adjustments. 
Br
O
O
OH
CuCN

NH2
OEt
OOH
22 23  
Scheme 2.4.8 CuCN-mediated cyclization to form naphthylamine 
In a subsequent attempt to obtain this product, the alternative aldol method of α,β-
unsaturated ester formation was utilized. Lithium diisopropyl amide was first combined 
with ethyl acetate at -78°C to form the enolate, which was then added to the acetaldehyde 
(Scheme 2.4.9). Despite several observed color changes and the disappearance of 
acetaldehyde starting material on TLC, no desired product was recovered.  
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Scheme 2.4.9 Aldol condensation method of obtaining α,β-unsaturated ester 
A second attempt was performed, this time at a more moderate -3°C. After workup 
and purification, NMR analysis indicated the aldol addition β-hydroxy ester product had 
likely been formed (22, Scheme 2.4.10); however, the subsequent attempt at dehydration 
by heating in acid was unsuccessful. 
OH Br
OOEt
O
OEt
O-
OH Br
OEt
OOHLDA
-3oC 22
Li+
 
Scheme 2.4.10 Aldol addition reaction that resulted in β-hydroxy ester 
Since it was possible that the commercial LDA reagent was degraded, a final trial 
was conducted in which LDA was generated in situ via deprotonation of diisopropylamine 
by butyllithium. This was then combined with ethyl acetate at -78°C, and after an hour the 
aldehyde was added. However, this procedure also resulted in no isolated product. 
As with the previous problems encountered in this series of reactions, it was 
hypothesized that the highly basic conditions of this step were incompatible with an 
unprotected phenol. The difficulty this situation posed was an unprecedented circumstance 
since Sudalai had not used any substrates with even marginally acidic functional groups. 
Therefore, as a preventive measure against this problem, it was decided that a protecting 
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group on the phenol would be beneficial. As previously mentioned, benzyl ether protecting 
groups are stable to both acidic and basic conditions, so this was decidedly the best choice 
to use on the phenol of the starting aldehyde (Scheme 2.4.11). 
OH Br
O
+
Br
K2CO3, TBAI
acetone
O Br
O
Ph
 
Scheme 2.4.11 Benzyl ether protection of starting aldehyde 
While the protection itself was a facile process, the subsequent reactions were 
disturbingly ineffective. Formation of the enol ether was partially successful, but the 
following acid hydrolysis gave only starting material and an unidentifiable product. 
Therefore this derivative was tabled for further synthetic analysis. 
2.5 Biochemical analysis, future directions, and conclusion  Pegan and coworkers utilized various assays to analyze the inhibitory capability of 
the synthesized quinoline-2-carboxylic acid analogs against MtFBA. Initially they utilized 
the Resazurin Blue Assay to analyze cell viability when exposed to the inhibitors [27]. This 
assay measures the fluorescence change seen when metabolically active cells reduce the 
non-fluorescent dye resazurin to the strongly-fluorescent dye resorufin. Since nonliving 
cells are not able to perform this reduction, it is possible to use the fluorescence output to 
detect the percentage of nonliving cells among those that have been exposed to the 
inhibitors [101]. In this way the IC50 values and percentages of inhibition of each potential 
inhibitory compound can be calculated. In addition, this assay can be used to determine 
MIC values by visually inspecting the nutrient broth for cell growth [27]. 
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Using these techniques, Pegan tested a selection of the HCA derivatives for percent 
inhibition and minimum inhibitory concentration. However, it was found that many of the 
compounds exhibit intrinsic fluorescence, which muddles the results of the assay. 
Therefore all inhibitory values are preliminary and await further analysis. The results are 
summarized in Table 4. 
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Table 4 Preliminary biochemical data for inhibition of MtFBA. 
 
Substrate 
  
% Inhibition* 
 
MIC 
NOH OH
O
HCA  
  
95 (1 mM) 
 
1.2 mM 
NOH OH
O
F
5-F-HCA
 
  
ND 
 
2.4 mM 
NOH OH
O
Cl
5-Cl-HCA
 
  
ND 
 
1.2 mM 
NOH OH
O
F6-F-HCA  
  
31.1 (25 μM) 
 
2.4 mM 
NOH O
O
F6-F-HCA-OMe  
  
24.1 (25 μM) 
 
600 μM 
  
                                                 
* ND = value not determined. 
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With these initial results, it still remains to be seen which analogs are promising 
inhibitors of MtFBA. However, the introduction of new analytical techniques such as 
isothermal calorimetry (ITC) could resolve some of the issues experienced with the 
fluorescence assays and present more solid data. At that point it would be possible to 
expand the catalog of derivatives that are specifically engineered to build on the most 
potent inhibitors and design a compound that is highly effective against MtFBA. 
On the synthetic side, it would be beneficial to continue to pursue a few of the more 
elusive compounds. This is especially true for the naphthylamine derivatives, for which an 
improved synthetic process is highly desirable. Future plans to streamline the formation of 
these derivatives include a one-pot process to both form and hydrolyze the enol ether and 
refinements to an aldol condensation alternative to the Wittig reaction step. 
In conclusion, a small library of novel compounds were prepared as potential 
inhibitors of the Mycobacterium tuberculosis fructose-1,6-bisphosphate aldolase. These 
compounds encompassed many variations on the 8-hydroxyquinoline-2-carboxylic acid 
scaffold, including alkyl and halogen substitutions on the phenol ring and many carboxylic 
acid derivatives in the 2-position. While it is as of yet unclear which, if any, of these analogs 
have the potential to become therapeutic agents against this global disease, it is clear that 
a new therapy is desperately needed and these compounds represent a promising new 
direction. 
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2.6 Experimental Details  Experimental procedure for benzyl protection of phenol [102] 
OH
R + Br
O Ph
RK2CO3, TBAIanhydrous acetone  
 Acetone (5 mL), dried over 3Å MS, was added to the phenol (1 mmol). To this was 
added K2CO3 (2 eq), TBAI (0.1 eq), and benzyl bromide (1 eq). The mixture was stirred at 
room temperature overnight. The reaction mixture was filtered through a frit, and the solids 
were washed with EtOAc. The filtrate was washed with H2O and a saturated NaCl solution. 
The organic layer was dried over Na2SO4 and evaporated under reduced pressure to give 
the desired product (1.6g, quantitative yield). 
8-(benzyloxy)-6-fluoro-2-methylquinoline (1i) 
NOBn
F  
 1.6g, quantitative yield. 
3-(benzyloxy)-2-bromobenzaldehyde 
O Br
O
Ph
 
 620.3 mg, 73%. 
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Experimental procedure for benzyl deprotection of phenol by BBr3 [103] 
OH
R
OBn
R
BBr3
CH2Cl20oC-rt  
  Anhydrous CH2Cl2 (10 mL) was added to the benzyl-protected phenol (1 mmol) 
under N2 atmosphere. The reaction flask was placed in an ice-water bath, and the mixture 
was stirred while cooling for 20 minutes. BBr3 (14.5 eq, 1M solution in CH2Cl2) was then 
added and the mixture was stirred over ice. The ice was allowed to melt, and the mixture 
was stirred at room temperature overnight. The reaction was quenched by dropwise 
addition of MeOH (15 mL), and the mixture was stirred an additional 2 hours. The solvent 
was then evaporated, and the residue was dissolved in CH2Cl2. The organic layer was 
washed with 1M NaOH then dried over anhydrous Na2SO4 and evaporated. The crude 
product was purified by flash chromatography over silica gel by elution of hexanes/ethyl 
acetate. 
Experimental procedure for benzyl deprotection by catalytic hydrogenolysis [44] 
OH
R
OBn
R
H2, Pd/C
EtOAcr.t.  
 The benzyl-protected phenol (1 mmol) and palladium on carbon (0.2 eq) were 
combined in a round bottom flask. The flask was air-purged, and ethyl acetate (5 mL, dried 
over 3Å MS) was added. A hydrogen balloon was attached to the flask, and the reaction 
was stirred at room temperature under H2 atmosphere for 2 hours. After completion the 
solids were filtered through a frit and washed with EtOAc. The filtrate was evaporated and 
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the crude residue was purified by flash chromatography with silica gel by elution of 
hexanes/ethyl acetate. 
Experimental procedure for carbonate deprotection of phenol  
NOHRN
O OEt
O
R
DMAP, K2CO3
THF  
 The carbonate-protected quinoline (1 mmol) and DMAP (2 eq) were dissolved in 
THF (5.5 mL). To this was added a 1M solution of K2CO3 in H2O (5 eq), and the mixture 
was stirred at room temperature overnight. The reaction was quenched with 1M HCl and 
the product was extracted into ethyl acetate. The organic layer was washed with a saturated 
solution of NH4Cl, dried over anhydrous Na2SO4, and evaporated to give the product. 
Experimental procedure for modified DVM quinoline synthesis [39] 
NH2R NR
O
+ 6M HCltoluene  
6M HCl (13.75 mL) was added to the aminophenol (1 mmol) under ambient 
atmosphere. To this was added toluene (2 mL), then crotonaldehyde (2 mmol). The reaction 
mixture was refluxed for 3 hours then cooled to room temperature. The organic layer was 
removed, and the aqueous layer was adjusted to pH 7-8 by addition of a saturated solution 
of Na2CO3. The aqueous mixture was extracted with CH2Cl2 (3x30 mL), and the combined 
organic layers were dried over anhydrous Na2SO4 then evaporated under reduced pressure. 
The crude product was used without purification in the next step. 
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5-fluoro-2-methylquinolin-8-ol (1a) 
NOH
F  
Brown solid. 133.4 mg, 95%. 1H NMR (500 MHz, CDCl3) δ 8.24 (d, J3-4 = 8.56 
Hz, 1H, H-4), 8.05 (s, 1H, OH), 7.33 (d, 1H, H-3), 7.05 (m, 2H, H-6, H-7), 2.73 (s, 3H, 
CH3). 13C NMR (126 MHz, CDCl3) δ 157.90, 150.73 (J = 245.32 Hz), 147.89 (J = 3.45 
Hz), 137.30 (J = 3.55 Hz), 129.76 (J = 2.67 Hz), 122.67 (J = 2.51 Hz), 116.98 (J = 19.00 
Hz), 109.63 (J =20.73 Hz), 108.48 (J =7.82 Hz), 24.96. 
6-fluoro-2-methylquinolin-8-ol (1b) 
NOH
F  
Brown solid. 268mg, 95%. 1H NMR (500 MHz, CDCl3) δ 8.00 (d, J3-4 = 8.47 Hz, 
1H, H-4), 7.35 (d, 1H, H-3), 6.94 (m, 2H, H-5, H-7), 2.73 (s, 3H, CH3). 13C NMR (126 
MHz, CDCl3) δ 160.98 (J = 244.94 Hz), 156.01 (J = 2.82 Hz), 153.31 (J = 13.80 Hz), 
135.65 (J = 5.77 Hz), 135.03, 126.59 (J = 12.22 Hz), 123.80, 100.81 (J = 4.80 Hz), 100.60 
(J = 2.27 Hz), 24.71. 
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7-fluoro-2-methylquinolin-8-ol (1c) 
NOHF
 
Brown solid. 194.0mg, 91%. 1H NMR (500 MHz, CDCl3) δ 8.03 (d, J = 8.14 Hz, 
1H), 7.29 (m, 3H), 2.73 (s, 3H, CH3). 13C NMR (126 MHz, CDCl3) δ 158.00, 147.57 (J = 
243.91 Hz), 138.92 (J = 7.30 Hz), 137.80 (J = 10.49 Hz), 136.17 (J = 1.58 Hz), 123.16, 
121.85 (J = 2.61 Hz), 117.36 (J = 7.93 Hz), 117.04 (J = 21.34 Hz), 24.91. 
5-chloro-2-methylquinolin-8-ol (1d) 
NOH
Cl  
Tan solid. 251.7mg, 93%. 1H NMR (500 MHz, CDCl3) δ 8.36 (d, J3-4 = 8.62 Hz, 
1H, H-4), 7.44 (d, J6-7 = 8.23 Hz, 1H, H-7), 7.40 (d, 1H, H-3), 7.08 (d, 1H, H-6), 2.75 (s, 
3H, CH3). 13C NMR (126 MHz, CDCl3) δ 157.64, 150.76, 138.02, 133.36, 126.35, 124.46, 
123.46, 120.29, 109.87, 24.77. 
8-bromo-6-fluoro-2-methylquinoline (1e) 
NBr
F  
 Off-white solid, 588.1mg, 94%. 1H NMR (500 MHz, CDCl3) δ 7.84 (d, J3-4 = 8.43 
Hz, 1H, H-4), 7.72 (dd, J5-7 = 2.78 Hz, 1H, H-7), 7.25 (dd, 1H, H-5), 7.22 (d, 1H, H-3), 
2.72 (s, 3H, CH3). 13C NMR (126 MHz, CDCl3) δ 159.52 (J = 2.75 Hz), 158.68 (J = 248.9 
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Hz), 141.98, 135.82 (J = 5.31 Hz), 127.21 (J =10.07 Hz), 125.36 (J = 10.45 Hz), 123.43, 
122.98 (J = 28.04 Hz), 110.49 (J =20.98 Hz), 25.45. 
Experimental procedure for the bromination of 8-hydroxyquinaldine [41] 
NOHBr
Br
NOH
Br Br
NOH Br2
CH2Cl2
+
 
 CH2Cl2 (6 mL) was added to 8-hydroxyquinaldine (1 mmol). To this was added 
bromine (Br2, 1eq, in 1 mL CH2Cl2) over the course of 40 minutes. The mixture was stirred 
at room temperature overnight, then washed with H2O. The aqueous layer was extracted 
with CH2Cl2, the combined organic layers were dried over Na2SO4, and the solvent was 
evaporated under reduced pressure. The crude residue was purified by flash 
chromatography over silica gel by elution of hexanes/ethyl acetate. 
5,7-dibromo-2-methylquinolin-8-ol (1g) and 4,5-dibromo-2-methylquinoline-8-ol (1h) 
NOHBr
Br
NOH
Br Br 
 Inseparable mixture (~0.83:1). White solid. 16.2 mg, 7%. 1H NMR (500 MHz, 
CDCl3) δ 8.35 (d, J = 8.31 Hz, 1H), 8.28 (J = 8.65 Hz, 1H), 7.97 (s, 1H), 7.80 (d, J = 1.07 
Hz, 1H), 7.55 (d, J = 8.33 Hz, 1H), 7.41 (d, J = 8.63 Hz, 1H), 2.76 (s, 3H), 2.74 (s, 3H). 
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Experimental procedure for the oxidation of benzylic methyl to carboxylic acid [39] 
NR SeO2pyridine
NR OH
O
 
The 2-methylquinoline (1 mmol) and SeO2 (1.2 eq) were dissolved in pyridine (5 
mL) and refluxed for 24 hours. The reaction mixture was then cooled to room temperature, 
and the solids were filtered through a celite frit and washed on the frit with ethyl acetate. 
The filtrate was evaporated, giving a dark brown filmy residue, which was redissolved in 
a 10% solution of KOH (20 mL). The remaining solids were filtered off and washed with 
a small amount of H2O. The filtrate was adjusted to pH 2 by addition of 6M HCl while 
cooling on ice then cooled in the refrigerator for at least two hours. The resulting precipitate 
was filtered, washed with H2O, and air-dried to give the clean product. 
5-fluoro-8-hydroxyquinoline-2-carboxylic acid (2a) 
NOH OH
O
F  
Brown solid. 77.3 mg, 95%. 1H NMR (500 MHz, DMSO-d6) δ 8.66 (dd, J = 4.27, 
8.65 Hz, 1H), 8.23 (t, J = 8.36 Hz, 1H), 7.49 (dd, J = 8.56, 10.06 Hz, 1H), 7.16 (dd, J = 
4.66, 8.58 Hz, 1H).  
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6-fluoro-8-hydroxyquinoline-2-carboxylic acid (2b) 
NOH OH
O
F  
Brown solid. 273 mg, 74%. 1H NMR (500 MHz, DMSO-d6) δ 8.51 (d, J3-4 = 8.59 
Hz, 1H, H-3), 8.15 (d, 1H, H-4), 7.32 (dd, J5-7 = 2.69 Hz, 1H, H-7), 7.11 (dd, 1H, H-5). 13C 
NMR (126 MHz, DMSO-d6) δ 165.51, 162.83 (J = 246.82 Hz), 156.64 (J = 14.89 Hz), 
144.29 (J = 2.90 Hz), 138.33 (J = 6.19 Hz), 134.75, 130.83 (J = 13.51 Hz), 121.52, 102.89 
(J = 29.12 Hz), 101.52 (J = 23.02 Hz). 
7-fluoro-8-hydroxyquinoline-2-carboxylic acid (2c) 
NOH OH
OF
 
Brown solid. 16.2 mg, 30%. 1H NMR (500 MHz, DMSO-d6) δ 10.56 (br s, 1H, 
OH), 8.62 (d, J = 8.47 Hz, 1H), 8.12 (d, J = 8.48 Hz, 1H), 7.73 (dd, J = 8.97, 11.07 Hz, 
1H), 7.61 (dd, J = 5.06, 9.04 Hz, 1H). 13C NMR (126 MHz, DMSO-d6) δ 165.46, 148.66 
(J = 243.13 Hz), 145.59, 140.41 (J = 10.56 Hz), 139.16, 138.38 (J = 7.81 Hz), 127.05, 
120.84 (J = 21.78 Hz), 119.57 (2.58 Hz), 118.21 (J = 8.18 Hz). 
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5-chloro-8-hydroxyquinoline-2-carboxylic acid (2d) 
NOH OH
O
Cl  
Tan solid. 123.2 mg, 92%. 1H NMR (500 MHz, DMSO-d6) δ 8.63 (d, J3-4 = 8.72 
Hz, 1H, H-3), 8.25 (d, 1H, H-4), 7.74 (d, J6-7 = 8.35 Hz, 1H, H-7), 7.18 (d, 1H, H-6). 13C 
NMR (126 MHz, DMSO-d6) δ 165.29, 153.93, 145.63, 137.56, 135.33, 130.66, 127.49, 
121.77, 119.05, 112.78. 
8-bromo-6-fluoroquinoline-2-carboxylic acid (2e) 
NBr OH
O
F  
Beige solid. 96.8 mg, 82%. 1H NMR (500 MHz, DMSO-d6) δ 7.84 (d, J3-4 = 8.43 
Hz, 1H, H-4), 7.72 (dd, J5-7 = 2.78 Hz, 1H, H-7), 7.25 (dd, 1H, H-5), 7.22 (d, 1H, H-3), 
2.72 (s, 3H, CH3). 13C NMR (126 MHz, DMSO-d6) δ 166.37, 161.23, 152.90 (d, J = 149.72 
Hz), 141.78, 138.61 (d, J = 5.67 Hz), 130.76 (d, J = 11.32 Hz), 127.11 (d, J = 11.07 Hz), 
124.93 (d, J = 28.94 Hz), 122.95, 111.77 (d, J = 21.65 Hz). 
8-benzyloxy-6-fluoroquinoline-2-carboxylic acid (2h) 
NO
F
Ph
OH
O
 
 Brown solid. 1.2g, 95%. 
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Experimental procedure for the reduction of nitro to amine [40] 
NO2R Fe, HClH2O/THF
NH2R
 
The nitrobenzene (1 mmol) and iron powder (10 eq) were added to a round bottom 
flask. H2O (5 mL) and THF (15 mL) were added to the flask, then 6 drops of 6M HCl. The 
reaction mixture was refluxed for 3 hours then cooled to room temperature. The mixture 
was diluted with saturated NaCl (25 mL), and the solids were filtered off. The solids were 
rinsed on the filter with ethyl acetate. The organic layer of the filtrate was extracted off, 
and the aqueous was extracted with EtOAc. The combined organic layers were dried over 
anhydrous Na2SO4 and evaporated under reduced pressure to give the product.  
2-amino-6-fluorophenol (3a) 
NH2
OHF
 
 159.8 mg, 94%. 1H NMR (500 MHz, CDCl3) δ 6.69 (m, 1H), 6.54 (m, 2H), 3.90 
(br s, 2H, NH2). 13C NMR (126 MHz, CDCl3) δ 151.56 (d, J = 233.93 Hz), 136.42 (d, J = 
4.03 Hz), 131.34 (d, J = 16.64 Hz), 120.29 (d, J = 9.00 Hz), 111.49 (d, J = 2.40), 105.27 
(d, J = 18.68 Hz). 
Experimental procedure for heteroring-unsubstituted quinoline synthesis [47] 
N
R
NH2
R
OEtEtO
+ 1M HCl  
 1M HCl (82.5 mL) was added to the methyl aminophenol in a round bottom flask. 
To this was added acrolein diethyl acetal (2.5 eq). The reaction was refluxed for 24 hours, 
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then cooled to room temperature. The solution was neutralized to pH 7-8 by addition of 
solid Na2CO3 then extracted into CH2Cl2. The organic layers were combined and dried over 
Na2SO4 then concentrated by rotary evaporation. The crude residue was purified by column 
chromatography by elution of EtOAc/hexanes to give the pure product. 
5-methylquinolin-8-ol (39) 
NOH
 
 1.5 g, 58%. Characterization in Section 3.3. 
6-methylquinolin-8-ol (38) 
NOH
 
 66.3 mg, 50%. Characterization in Section 3.3. 
6-fluoroquinolin-8-ol (41) 
NOH
F  
 40.0 mg, 42%. Characterization in Section 3.3. 
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Experimental procedure for preparation of quinoline-N-oxides [104] 
N
R
N+
R
O-
m-CPBA
ether  
The quinoline (1 mmol) was dissolved in Et2O (15 mL) and stirred at room 
temperature. Then m-CPBA (1.5 eq) was added slowly to the mixture. The reaction mixture 
was stirred at room temperature for 24 hours. After TLC analysis indicated full conversion 
of starting material, the solvent was evaporated, and the resultant solid residue was 
dissolved in ethyl acetate. This mixture was extracted with saturated NaHCO3 (3x30 mL). 
The aqueous layers were washed with ethyl acetate, then the combined organic layers were 
dried over anhydrous Na2SO4 then evaporated to give the quinoline-N-oxide which was 
used in the next step without purification. 
5-methylquinolin-8-ol-N-oxide (5a) 
N+OH O
-
 
 355.1 mg, 77%. 
6-methylquinolin-8-ol-N-oxide (5b) 
N+OH O
-
 
 256.1 mg, 94%. 
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6-fluoroquinolin-8-ol-N-oxide (5c) 
N+O
-OH
F  
 24 mg, 45%. 
Experimental procedure for methylation of quinoline-N-oxide [45] 
N+
R
O- (CH3)2SO4
CCl4N2, 
N+
R
O CH3SO4-
 
In a round bottom flask, the quinoline-N-oxide (0.25 mmol) was degassed and 
flushed with N2. To this was added dimethyl sulfate (1 eq) in CCl4 (2 mL). The reaction 
was refluxed for 24 hours under N2 atmosphere. Upon full conversion of starting material 
to product, as seen by TLC analysis, the mixture was cooled to room temperature, then the 
solvent was removed by rotary evaporation. The crude residue was washed with diethyl 
ether and evaporated under reduced pressure to give the N-methoxyquinolinium 
methylsulfate salt, which was used in the next step without purification. 
8-hydroxy-1-methoxy-5-methylquinolin-1-ium methylsulfate (6a) 
N+OH O CH3SO4-
 
Crude product used in subsequent reaction. 
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8-hydroxy-1-methoxy-6-methylquinolin-1-ium methylsulfate (6b) 
N+OH O CH3SO4-
 
 Crude product used in subsequent reaction. 
6-fluoro-8-hydroxy-1-methoxyquinolin-1-ium methylsulfate (6c) 
N+OH
F
O CH3SO4-
 
 Crude product used in subsequent reaction. 
Experimental procedure for cyanation of N-methoxyquinoline [45] 
N+
R
O CH3SO4- aq NaCN
0oC
N
R
CN
 
The N-methoxyquinoline (0.13 mmol) was combined with sodium cyanide (3 eq) 
and dissolved in H2O (0.2 mL). The reaction was stirred on ice for 4 hours, until the starting 
material was no longer visible by TLC. The pH of the mixture was reduced to 4-5 by 
addition of AcOH, then the solids were filtered off and washed with H2O. The crude solid 
was used without purification in the following step. 
8-hydroxy-5-methylquinoline-2-carbonitrile (7a) 
NOH CN
 
 Crude product used in subsequent reaction. 
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8-hydroxy-6-methylquinoline-2-carbonitrile (7b) 
NOH CN
 
 Crude product used in subsequent reaction. 
Experimental procedure for hydrolysis of cyano to carboxylic acid [45] 
N
R
CN NaOH

N
R
OH
O
 
A solution of 6M NaOH (6 mL) was added to the quinoline-2-carbonitrile (0.13 
mmol) and refluxed for 5 hours. The reaction mixture was cooled to room temperature then 
washed with ethyl acetate. The pH of the aqueous layer was reduced to 2 by addition of 
6M HCl then extracted with EtOAc. The combined organic layers were dried over 
anhydrous Na2SO4 then evaporated under reduced pressure. The crude product was 
purified by flash chromatography on silica gel by elution of ethyl acetate-hexanes to give 
the final product. 
8-hydroxy-5-methylquinoline-2-carboxylic acid (2f) 
NOH OH
O
 
 Tan solid. 17.8 mg, 8% (over three steps). 1H NMR (500 MHz, DMSO-d6) δ 10.06 
(br s, 1H), 8.64 (d, J = 8.70 Hz, 1H), 8.18 (d, J = 8.66 Hz, 1H), 7.47 (d, J = 7.78 Hz, 1H), 
7.11 (d, J = 7.78 Hz, 1H), 2.59 (s, 3H).  
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8-hydroxy-6-methylquinoline-2-carboxylic acid (2g) 
NOH OH
O
 
 Yellow solid. 428.8 mg, 27% (over three steps). 1H NMR (500 MHz, DMSO-d6) δ 
8.45 (d, J = 8.51 Hz, 1H), 8.10 (d, J = 8.50 Hz, 1H), 7.33 (m, 1H), 7.08 (d, J = 1.66 Hz), 
1.92 (s, 3H). 
Experimental procedure for amide formation [55] 
NR OH
O
+ Cl O
O NEt3
THF, 0oC
NR NR2
O
HNR2
 
 The quinoline-2-carboxylic acid (1 mmol) was dissolved in THF (5.5 mL) and 
stirred in an ice bath. NEt3 (2 eq) was added to the mixture, then ethyl chloroformate (1.1 
eq). The reaction was stirred at 0°C for one hour, then the amine was added dropwise. The 
mixture was stirred at 0°C until the ice melted naturally, then was allowed to stir at room 
temperature overnight. The solvent was evaporated, and the crude residue was dissolved 
in EtOAc and washed with saturated NaHCO3 and H2O. The organic layer was dried over 
Na2SO4, the solvent was evaporated under reduced pressure, and the crude residue was 
purified by flash chromatography on silica gel by elution of hexanes/ethyl acetate. 
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N,N-diethyl-6-fluoro-8-hydroxyquinoline-2-carboxamide (8a) 
NOH
F
N
O
 
 Brown solid. 24.5 mg, 53% (after amide formation and benzyl deprotection). 1H 
NMR (500 MHz, CDCl3) δ 8.70 (d, J = 8.49 Hz, 1H), 7.85 (d, J = 8.49 Hz, 1H), 7.31 (dd, 
J = 2.59, 8.91 Hz, 1H), 7.13 (dd, J = 2.55, 10.22 Hz, 1H), 3.67 (q, J = 7.20 Hz, 2H), 3.38 
(q, J = 7.15 Hz, 2H), 1.34 (t, J = 7.23 Hz, 3H), 1.21 (t, J = 7.12 Hz, 3H). 
Ethyl 6-fluoro-2-(morpholine-4-carbonyl)quinolin-8-yl carbonate (8b) 
NO
F
N
OOEt
O
O 
 Tan solid. 22.7 mg, 27%. 1H NMR (500 MHz, CDCl3) δ 8.28 (d, J = 8.57 Hz, 
1H), 7.95 (m, 1H), 7.44 (m, 2H), 4.39 (q, J = 7.16 Hz, 2H), 3.88 (m, 6H), 3.76 (m, 2H), 
1.46 (t, J = 7.12 Hz, 3H).  
(6-fluoro-8-hydroxyquinolin-2-yl)(morpholin-4-yl)methanone (8c) 
NOH
F
N
O
O 
 11.8 mg, 25% (after amide formation and carbonate deprotection). 1H NMR (500 
MHz, CDCl3) δ 8.25 (d, J = 8.52 Hz, 1H), 8.05 (s, 1H, OH), 7.79 (d, J = 8.54 Hz, 1H), 7.05 
(m, 2H), 3.90 (m, 4H), 3.70 (m, 4H). 13C NMR (126 MHz, CDCl3) δ 166.93, 162.40 (J = 
248.94 Hz), 154.04 (J = 14.54 Hz), 150.16 (J = 3.04 Hz), 137.07 (J = 6.04 Hz), 133.77, 
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128.81 (J = 12.42 Hz), 122.68, 102.25, 102.02, 101.49, 101.31, 99.99, 66.90 (J = 16.80 
Hz), 47.85, 42.73. 
(8-bromo-6-fluoroquinolin-2-yl)(morpholin-4-yl)methanone (8d) 
NBr
F
N
O
O 
 Beige solid. 34.1 mg, 36%. 1H NMR (500 MHz, CDCl3) δ 8.26 (d, J = 8.51 Hz, 
1H), 8.02 (d, J = 8.47 Hz, 1H), 7.93 (dd, J = 2.69, 8.03 Hz, 1H), 7.50 (dd, J = 2.69, 8.20 
Hz, 1H), 4.13 (m, 2H), 3.91 (m, 6H). 13C NMR (126 MHz, CDCl3) δ 165.85, 160.25 (J = 
253.78 Hz), 152.72 (J = 3.03 Hz), 140.48, 137.16 (J = 5.60 Hz), 129.38 (J = 10.61 Hz), 
127.00 (J = 10.54 Hz), 124.22 (J = 28.41 Hz), 123.44, 110.60 (J = 21.49 Hz), 67.47, 67.01, 
48.36, 43.55. 
Experimental procedure for Fischer ester synthesis [46] 
N OH
O
R
cat. H2SO4
ROH
N OR
O
R
 
6-fluoro-8-hydroxyquinoline-2-carboxylic acid (0.72 mmol) was dissolved in the 
appropriate alcohol (5 mL) in a round bottom flask. Five drops of concentrated sulfuric 
acid was added, and the reaction was refluxed 16 hours. After cooling to room temperature, 
the alcohol was evaporated off under reduced pressure, and the crude product was purified 
by flash chromatography over silica gel by elution of 10% ethyl acetate-hexanes to give 
the quinoline-2-carboxylate ester. 
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Methyl 6-fluoro-8-hydroxyquinoline-2-carboxylate (9a) 
NOH
F
O
O
 
 Peach-colored solid 113.7mg, 70%. 1H NMR (500 MHz, CDCl3) δ 8.86 (br s, 1H, 
OH), 8.20 (m, 2H), 7.02 (m, 2H), 4.07 (s, 3H, CH3). 13C NMR (126 MHz, CDCl3) δ 165.28, 
163.24 (J = 250.37 Hz), 155.35 (J = 14.81 Hz), 144.49 (J = 3.02 Hz), 136.64 (J = 6.27 Hz), 
135.30, 130.22 (J = 12.77 Hz), 122.56, 101.06 (J = 22.98 Hz), 102.24 (J = 29.69 Hz), 
52.95. 
Ethyl 6-fluoro-8-hydroxyquinoline-2-carboxylate (9b) 
NOH
F
O
O
 
 Off-white solid 56.0mg, 33%. 1H NMR (500 MHz, CDCl3) δ 8.93 (br s, 1H, OH), 
8.21 (m, 2H), 7.03 (m, 2H), 4.54 (q, J = 7.14 Hz, 2H), 1.50 (t, J = 7.15 Hz, 3H). 13C NMR 
(126 MHz, CDCl3) δ 164.83, 163.20 (J = 250.26 Hz), 155.31 (J = 14.90 Hz), 144.84 (J = 
3.04 Hz), 136.60 (J = 6.30 Hz), 135.30, 130.17 (J = 12.80 Hz), 122.60, 102.15 (J =  29.85 
Hz), 101.05 (J = 22.98 Hz), 62.18, 14.31. 
Isopropyl 6-fluoro-8-hydroxyquinoline-2-carboxylate (9c) 
NOH
F
O
O
 
 Off-white solid 58.7mg, 33%. 1H NMR (500 MHz, CDCl3) δ 8.94 (br s, 1H, OH), 
8.21 (m, 2H), 7.03 (m, 2H), 5.40 (hept, J = 6.29 Hz, 1H), 1.48 (d, J = 6.27 Hz, 6H). 13C 
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NMR (126 MHz, CDCl3) δ 164.32, 163.16 (J = 250.10 Hz), 155.30 (J = 14.96 Hz), 145.20 
(J = 3.05 Hz), 136.54 (J = 6.28 Hz), 135.31, 130.12 (J = 12.68 Hz), 122.61, 102.09 (J = 
29.74 Hz), 101.02 (J = 22.89 Hz), 70.00, 21.91.  
Experimental procedure for dual ester/phenol ether synthesis [67] 
NOHR OH
O
alkyl iodide, Cs2CO3
DMF
NO-alkyl O-alkyl
O
R  
 The 8-hydroxyquinoline-2-carboxylic acid (1 mmol) was dissolved in DMF. 
Cesium carbonate (2 eq) and the appropriate alkyl iodide (2 eq) were added, and the 
mixture was stirred at room temperature overnight. The reaction mixture was diluted with 
H2O and extracted into EtOAc. The organic layer was washed with saturated NaHCO3, 
H2O, and 1M HCl. The organic layer was then dried over Na2SO4, the solvent was 
evaporated, and the crude product was purified by flash chromatography over silica gel by 
elution with hexanes/ethyl acetate. 
Methyl 6-fluoro-8-methoxyquinoline-2-carboxylate (10a) 
NO
F
O
O
 
 Dark brown viscous oil. 11.5 mg, 28%. 1H NMR (500 MHz, CDCl3) δ 8.26 (q, J = 
8.56 Hz, 2H), 7.10 (dd, J = 2.55, 8.65 Hz, 1H), 6.92 (dd, J = 2.54, 10.61 Hz, 1H), 4.13 (s, 
3H), 4.08 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 165.79, 162.44 (J = 250.54 Hz), 136.96, 
136.67, 136.62, 130.92 (J = 12.60 Hz), 122.55, 102.12 (J = 22.21 Hz), 99.83 (J = 30.27 
Hz), 56.57, 53.11. 
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Ethyl 6-fluoro-8-ethoxyquinoline-2-carboxylate (10b) 
NO
F
O
O
 
 Dark brown viscous oil. 18.8 mg, 25%. 1H NMR (500 MHz, CDCl3) δ 8.23 (m, 
2H), 7.07 (dd, J = 2.56, 8.65 Hz, 1H), 6.89 (dd, J = 2.58, 10.84 Hz, 1H), 4.54 (q, J = 7.15 
Hz, 2H), 4.32 (q, J = 7.03 Hz, 2H), 1.70 (t, J = 6.99, 3H), 1.52 (t, J = 7.14, 3H). 13C NMR 
(126 MHz, CDCl3) δ 165.35, 162.37 (J = 250.36 Hz), 146.27, 137.08, 136.58 (J = 6.10 
Hz), 130.88 (J = 12.54 Hz), 122.42, 101.90 (J = 22.05 Hz), 100.46 (J = 29.96 Hz), 65.19, 
62.20, 14.34, 14.25. 
Experimental procedure for benzylic oxidation to aldehyde [88] 
R R
O
SeO2
H2O/dioxane  
SeO2 (1.5 eq) was dissolved in H2O (0.2 mL) and 1,4-dioxane (2 mL) and placed 
in a 105°C oil bath. Once reflux had begun, the 2-methylquinoline (1 mmol) in 1,4-dioxane 
(1.5 mL) was added to it. The reaction was refluxed for 5 hours then removed from heat 
and cooled to room temperature. The reaction mixture was diluted with H2O, extracted into 
CH2Cl2, and dried over Na2SO4. The crude residue was purified by flash chromatography 
on silica gel by elution of hexanes/ethyl acetate. 
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6-fluoro-8-hydroxyquinoline-2-carbaldehyde (11a) 
N OOH
F  
 302.0 mg, 72%. 
8-(benzyloxy)-6-fluoroquinoline-2-carbaldehyde (11b) 
N OO
F
Ph
 
 803.0 mg, 95%. 
Experimental procedure for synthesis of carbamates and ureas [74] 
N O OHR N NR
H
O
R'DPPA, NEt3
R' = alcohol or amine  
 The quinoline-2-carboxylic acid (1 mmol) and NEt3 (1 eq) were placed in a round 
bottom flask. To this was added DPPA (1 eq) and the alcohol or amine (10 mL). The 
mixture was refluxed for 8 hours then cooled to room temperature. The crude reaction 
mixture was purified over silica gel by elution of hexanes/ethyl acetate. 
tert-butyl (6-fluoro-8-hydroxyquinolin-2-yl)carbamate (13) 
NOH
F
NH
O
O
 
 Yellow solid. 29.2 mg, 22% (after carbamate formation and benzyl deprotection). 
1H NMR (500 MHz, CDCl3) δ 8.25 (d, J = 8.99 Hz, 1H), 8.08 (d, J = 9.06 Hz, 1H), 7.76 
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(br s, 1H), 7.42 (br s, 1H), 6.94 (m, 2H), 1.59 (s, 9H). 13C NMR (126 MHz, CDCl3) δ 
160.19 (J = 244.05 Hz), 152.13, 149.19 (J = 2.31 Hz), 137.98 (J = 5.53 Hz), 133.48, 125.52 
(J = 11.93 Hz), 114.47, 101.56, 101.27 (J = 12.90 Hz), 101.04, 81.68, 28.25. 
N,N-diethyl-N'-(6-fluoro-8-hydroxyquinolin-2-yl)urea (14) 
NOH
F
NH
O
N
 
 9.8 mg, 7%. 1H NMR (500 MHz, CDCl3) δ 8.22 (d, J = 8.48 Hz, 1H), 8.11 (br s, 
1H), 7.74 (d, J = 8.48 Hz, 1H), 7.04 (m, 2H), 3.66 (q, J = 7.14 Hz, 2H), 3.42 (q, J = 7.08 
Hz, 2H), 1.35 (t, J = 7.15 Hz, 3H), 1.27 (t, J = 7.09 Hz, 3H). 
Experimental procedure for synthesis of benzoxazole derivative [90] 
N OR cat. CH3COOHEtOH
+ NH2
OH N NR OH
N NR OH
DDQ
toluene
NR
N
O
(1)
(2)
 
(1) Under N2 atmosphere, the aldehyde (1 mmol) was added to a round bottom 
flask. 2-aminophenol (1.1 eq) was dissolved in absolute ethanol (10 mL) and added to the 
flask along with glacial acetic acid (5 drops). The mixture was refluxed under N2 overnight. 
The solvent was evaporated, and the crude residue was used directly in the subsequent 
reaction. 
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(2) The crude product from the first reaction was dissolved in anhydrous toluene 
(33 mL). DDQ (2 eq) was added in portions, and the mixture was refluxed for 3 hours. The 
solvent was evaporated, the crude residue was dissolved in CH2Cl2, and the residual solids 
were filtered off. The filtrate was evaporated onto silica gel and the product purified with 
flash chromatography by elution of hexanes/ethyl acetate. 
2-(1,3-benzoxazol-2-yl)-6-fluoroquinolin-8-ol (16a) 
N N O
OH
F  
 90.5 mg, 70% (after (1), (2), and benzyl deprotection). 1H NMR (500 MHz, CDCl3) 
δ 8.45 (d, J = 8.60 Hz, 1H), 8.34 (d, J = 8.59 Hz, 1H), 7.84 (d, J = 7.67 Hz, 1H), 7.78 (d, J 
= 8.00 Hz, 1H), 7.51 (dt, J = 7.35, 19.55 Hz, 2H), 7.13 (dd, J = 2.61, 9.20 Hz, 1H), 6.98 
(dd, J = 2.55, 10.54 Hz, 1H).  
Experimental procedure for synthesis of benzothiazole derivative [90] 
N OR +
SH NH2
DMSO
N S NR  
 The quinoline-2-carbaldehyde (1 mmol) and 2-aminothiophenol (1 eq) were added 
to a round bottom flask with DMSO (2 mL). The mixture was refluxed for 4.5 hours then 
cooled to room temperature. The crude mixture was diluted with H2O and extracted into 
CH2Cl2. The organic layer was washed with saturated NaCl and dried over Na2SO4. The 
crude product was purified by flash chromatography over silica gel by elution with 
hexanes/ethyl acetate. 
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2-(1,3-benzothiazol-2-yl)-6-fluoroquinolin-8-ol (16b) 
N S N
OH
F  
 5.8 mg, 3.2% (after benzothiazole formation and benzyl deprotection). 1H NMR 
(500 MHz, CDCl3) δ 8.57 (dd, J = 0.75, 8.71 Hz, 1H), 8.28 (d, J = 8.61 Hz, 1H), 8.17 (dt, 
J = 0.85, 8.29 Hz, 1H), 8.01 (ddd, J = 0.61, 1.23, 8.02 Hz, 1H), 7.57 (ddd, J = 1.28, 7.19, 
8.32 Hz, 1H), 7.50 (ddd, J = 1.20, 7.21, 8.18 Hz, 1H), 7.07 (d, J = 9.47 Hz, 2H).  
Experimental procedure for Wittig olefination [97] 
OR
O
R + Ph3P+ O
Cl- KOt-Bu
THF
 
 THF (5 mL) was added to (methoxymethyl)triphenylphosphonium chloride (2.5 
mmol) and placed in an ice-water bath. KOt-Bu (2.5 mmol) was added, and the mixture 
was stirred on ice. After one hour, the mixture was removed from the ice, allowed to stir at 
room temperature for 30 minutes, then placed back on ice. The aldehyde (1 mmol) was 
added to the reaction mixture, which was stirred on ice until the ice melted naturally, and 
it was then stirred at room temperature overnight. The reaction was quenched with H2O 
and extracted into EtOAc. The organic layer was washed with saturated NaCl then dried 
over Na2SO4. The solvent was evaporated to give the crude product, as seen by NMR 
analysis. 
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2-bromo-3-(2-methoxyethenyl)phenol (20) 
O
OH Br
 
 Crude product used in subsequent reaction. 
Experimental procedure for acid hydrolysis of enol ether to aldehyde [97] 
OR
1M HCl

OR
 
 THF (2 mL) was added to the enol ether (1 mmol), then 1M HCl (2 mL) was added. 
The mixture was refluxed for 2.5 hours, then cooled to room temperature. The product was 
extracted into EtOAc, then the organic layer was dried over Na2SO4 and evaporated to give 
the crude product, as seen by NMR analysis. 
(2-bromo-3-hydroxyphenyl)acetaldehyde (21) 
OH Br O
 
 Crude product used in subsequent reaction. 
Experimental procedure for Wittig synthesis of aryl butenoate [97] 
OR + Ph3P O
OEt
CH2Cl2
R OEt
O
 
CH2Cl2 (1 mL) was added to the phenyl acetaldehyde (1 mmol), and the 
phosphorylidene (1.1 eq) was then added. The mixture was stirred at room temperature for 
2 hours, then the solvent was evaporated and the crude residue was purified by flash 
chromatography over silica gel by elution of hexanes/ethyl acetate. 
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Ethyl 4-(2-bromo-3-hydroxyphenyl)but-2-enoate (22) 
OH Br
OEt
O
 
Gray/white solid. 204.8 mg, 72.8%. 
Experimental procedure for CuCN-mediated cyclization to aminonaphthalene [97] 
R OEt
O CuCN
DMF
R
NH2
OEt
O
 
The reaction flask containing the α,β-unsaturated ester (1 mmol) was air-purged 
and saturated with N2. Anhydrous DMF (10 mL) was added, then CuCN (3 eq) was added. 
The mixture was refluxed 24 hours, cooled to room temperature, and diluted with H2O. 
The product was extracted into EtOAc, then the organic layer was washed with saturated 
NaCl and dried over Na2SO4. The crude product was purified by flash chromatography 
over silica gel by elution of hexanes/ethyl acetate. 
Ethyl 1-amino-8-hydroxynaphthalene-2-carboxylate (23) 
NH2
OEt
OOH
 
Yellow solid. 27.8 mg, 27%. 1H NMR (500 MHz, DMSO-d6) δ 11.34 (s, 1H), 7.74 
(d, J = 15.91 Hz, 1H), 7.51 (m, 2H), 7.08 (dd, J = 1.22, 7.95 Hz, 1H), 6.82 (d, J = 15.90 
Hz, 1H), 4.23 (q, J = 7.10 Hz, 2H), 1.27 (t, J = 7.11 Hz, 3H). 
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3 IMPROVED SKRAUP-DOEBNER-VON MILLER QUINOLINE SYNTHESIS 
3.1 Introduction to quinoline synthesis  The quinoline ring system is ubiquitous in the areas of medicinal and industrial 
chemistry [105]. Several promising anti-inflammatory (LIV, Figure 3.1.1) [106] and 
antitumor (LV) [107] agents that have been recently developed contain the quinoline 
scaffold. Prominently, the first and most widely used antimalarial agent [108], quinine 
(LVI), is also based on the quinoline framework [109].  
NMeO
MeO
OMe
OMe
O
OEt
S
N
N N
N
N
O
N
MeO
OH N
LIV LV LVI  
Figure 3.1.1 Quinoline-based therapeutics 
In addition, quinoline-based dyes such as ethyl red iodide (LVII, Figure 3.1.2) and 
pinacyanol (LVIII) have been used since the beginning of the nineteenth century in 
photographic plates, and quinolines provide frameworks for other industrial uses including 
organic light-emitting diodes (OLEDs), photovoltaic cells [110], and as solvent for 
terpenes and resins [111].  
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N+
N
I- N
+ NCl-
LVII LVIII  
Figure 3.1.2 Quinoline-based dyes 
The synthesis of quinolines has been practiced since Koenigs published the first in 
1879, in which he passed allylaniline over heated lead (II) oxide [112]. Soon afterwards, 
in 1880, Czech chemist Zdenko Hans Skraup developed one of the most well-known 
syntheses of quinolines: heating anilines and glycerol with an oxidant in concentrated 
sulfuric acid (Scheme 3.1.1) [105].  
NH2R +
OH
OH OH
conc. H2SO4oxidant

N
R
 
Scheme 3.1.1 Classical Skraup quinoline synthesis 
For nearly a century and a half, numerous modifications of the Skraup quinoline 
synthesis have been developed in an attempt to improve product yield, introduce various 
functional groups, and minimize harsh reaction conditions. The beginning of the last 
century saw various attempts at improving the efficiency of this method. In the late 1920s 
and early 1930s, Essie White Cohn of the University of Denver introduced acetic and boric 
acid modifications in order to reduce the violence of the reaction [113]. Around the same 
time, Clarke and Davis introduced the addition of ferrous sulfate; and Darzens, Delaby, 
and Hiron implemented a thorium-vanadium oxide modification. Employing the generally 
held belief that acrolein is the active intermediate in the cyclization mechanism, in 1947 
Yale reacted this component with 3-nitro-4-aminoanisole in a mixture of concentrated 
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sulfuric acid and arsenic pentoxide [114]. This group also found success with 85% 
phosphoric acid and arsenic acid in place of the previously used acid catalyst and oxidant 
[115]. However, none of these modifications completely addressed or alleviated the 
problems inherent in the method, namely low yield, violent reactions, toxic reagents, and 
inconvenient isolation processes [113]. More recently, microwave-assisted Skraup 
reactions have provided a means of decreasing reaction time and slightly increasing yield, 
but these methods still required large amounts of sulfuric acid [111] or toxic arsenic oxide 
as an oxidant [116].  
In 1881, Doebner and Von Miller conducted similar quinoline synthesis 
experiments; they replaced the glycerol component of the reaction with ethylene glycol and 
produced 2-methylquinoline. They also heated aniline with paraldehyde (the cyclic trimer 
of acetaldehyde) in sulfuric acid and again obtained 2-methylquinoline. Through these 
experiments they determined that crotonaldehyde was the key reactive intermediate, 
signifying that the use of any α,β-unsaturated aldehyde or ketone as the annulation partner 
to aniline would similarly result in quinoline (Scheme 3.1.2) [117].  
NH2R +
R2
R1
O N
R
R2
R1
acid catalyst/I2
 
Scheme 3.1.2 Doebner-Von Miller quinoline synthesis 
With omission of the oxidant and replacement of the concentrated acid with an acid 
catalyst or iodine (I2) [105], this modification represents an important step forward in the 
practicality of quinoline synthesis, particularly for quinolines bearing a substituent on C-2 
or C-4 of the nitrogen ring. However, there are several serious drawbacks to this method 
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in its classical form. Tedious isolation and purification procedures and acid-catalyzed 
polymerization of the α,β-unsaturated aldehyde or ketone are detrimental to the yield and 
purity of quinoline product [118]. In addition, this method is not compatible with the 
synthesis of heteroring-unsubstituted quinolines, as acrolein would be the obligatory 
annulation partner; the propensity of acrolein to quickly polymerize in acidic environments 
makes this an unsuitable procedure [47]. 
An important modification to this technique was the introduction by Matsugi and 
coworkers in 2000 of a two-phase solvent system in the cyclization of various substituted 
anilines with crotonaldehyde [118]. Introducing toluene to the reaction mixture in addition 
to the aqueous hydrochloric acid ensured crotonaldehyde would remain in the organic 
layer, thereby avoiding acid-catalyzed self-condensation. The actual cyclization, then, 
would necessarily occur on the interface of the two layers. This modification resulted in a 
significant increase in yield (80% in the two-phase reaction versus 47% in HCl alone) and 
also simplified the isolation of product. 
Of the other quinoline syntheses regularly performed, the Friedländer reaction is 
one of the simplest and most well-established [119]. Traditionally, a Friedländer annulation 
combines a 2-amino aryl carbonyl with another carbonyl compound containing an active 
α-carbon; these two components are either refluxed in acid or base or subjected to 
microwave heating to perform the cyclization (Scheme 3.1.3) [119].  
R
O
NH2
R' R'''
O
R''+
acid/base
 N R
R'''
R''
R'
 
Scheme 3.1.3 Friedlander quinoline synthesis 
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The synthetic utility of this reaction lies in its remarkable compatibility with a wide 
variety of functional groups, as long as those groups are stable to the acidic or basic reaction 
conditions or intense heating. However, this method is not without its limitations. 
Unsymmetrical ketone annulation partners exhibit poor regioselectivity, thereby 
significantly reducing yield of the desired product.  
Advances in quinoline syntheses continue to be highly desirable. Recently, several 
groups have published alternative routes to these structures that utilize various methods to 
obtain diversely-substituted quinolines. These methods range from microwave irradiation 
to one-pot cascade reactions, oxidative annulations, and numerous metal-catalyzed 
syntheses. 
In 2007 Silberg et al. [120] described a procedure in which they obtained 7-amino-
8-methylquinoline from 2,6-diaminotoluene and glycerol (Scheme 3.1.4). Using 132°C 
microwave irradiation, they were able to achieve the desired product in 33 minutes reaction 
time. While this showed a marked improvement in reaction time (conventional heating at 
140°C took 270 minutes), product yield was significantly decreased. The use of super-
stoichiometric amounts of arsenic (V) oxide and sulfuric acid also reduced the scalability 
of this procedure. 
NH2 NH2 +
OH
OH OH
As2O5, H2SO4
MW 132oC
NNH2
 
Scheme 3.1.4 Synthesis of 7-amino-8-methylquinoline using 2,6-diaminotoluene and glycerol in arsenic (V) oxide and sulfuric acid via microwave irradiation 
Then, in 2014 Len and coworkers [121] published a novel Skraup-like cyclization 
of anilines with glycerol to give various quinolines (Scheme 3.1.5). They accomplished this 
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in sulfuric acid (three equivalents) by 200°C microwave irradiation. While on the surface 
their method appeared promising, including the use of “green” solvent-free conditions and 
the elimination of toxic oxidizing agents such as arsenic oxide and nitrobenzene that had 
been used by other groups, it presented several challenges. The high concentration and 
volume of sulfuric acid made the workup procedure difficult (presumably because of the 
thick tar that surrounds the crude product), and although this method was amenable to both 
electron-donating and electron-withdrawing substitutions on the 2-, 3-, and 4-positions of 
the aniline, their yields only ranged from fair to moderate. 
NH2R +
OH
OH OH
NR
H2SO4
MW 200oC  
Scheme 3.1.5 Quinoline synthesis from anilines and glycerol using sulfuric acid and microwave irradiation 
Skraup-like procedures are convenient for the synthesis of heteroring-unsubstituted 
quinolines, but since the glycerol annulation partner cannot contain functional groups, this 
procedure is not amenable to divergent functionality on the nitrogen ring. Other methods 
resolve this issue. The Shi group [122] introduced a one-pot cascade route in 2013 in which 
various carbonyl compounds were cyclized and aromatized with ortho-azido-β-nitro-
styrenes to give functionalized quinolines (Scheme 3.1.6). Using a catalytic amount of L-
proline and an equimolar amount of triethylamine in dichloromethane, they were able to 
obtain various heteroring-substituted quinolines in good to excellent yield. The mild, short, 
room temperature reaction conditions make this an interesting route toward quinolines. 
However, it is unclear whether this method is amenable to diverse substitutions on the 
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phenyl ring; only two trials were conducted with chlorine para to the azide group on the 
starting styrene. 
NO2
N3
R + R'
O R" L-proline, NEt3 NR R'R" 
Scheme 3.1.6 One-pot cascade synthesis of substituted quinolines 
Another interesting and novel approach came from the group of Lei and coworkers 
[123] who, in 2014, disclosed an aerobic C-N bond activation in the formation of 
quinolines. Reacting 2-(aminomethyl)aniline with various ketones and an equimolar 
addition of lithium chloride under one atmosphere of molecular oxygen afforded 2-
substituted quinolines in very good yields (Scheme 3.1.7). Their reaction appeared 
adaptable, tolerating both electron-donating and electron-withdrawing aryl rings on the 
ketone annulation partner, but they did not conduct any trials with aliphatic ketones or 
substitutions on the aniline. In addition, the reaction required very high temperatures and 
extended reaction times. 
NH2
NH2 + R'
O R" N R'
R"
O2 balloon
LiCl  
Scheme 3.1.7 Aerobic C-N activation synthesis of substituted quinolines 
Metal catalysis has become a highly desirable method recently due to the reduction 
in waste achieved by using sub-stoichiometric reagents [124]. Several recent publications 
have utilized this strategy toward the synthesis of quinolines. One such paper from Singh 
and coworkers in 2012 described indium (III) chloride as an efficient Lewis acid catalyst 
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in the solvent-free cyclization of ortho-amino aryl ketones with alkynes (Scheme 3.1.8) 
[110]. 
X R
O
NH2
N
X R R"
R'R"
R'
+
InCl3(20 mol %)
solvent-free80oC  
Scheme 3.1.8 InCl3-catalyzed cyclization of ortho-carbonyl anilines with alkynes 
3.2 Heteroring-unsubstituted quinoline synthesis   As mentioned in Section 2.3.5.1, an analog of 8-hydroxyquinoline-2-carboxylic 
acid bearing an amine group in the 2-position was desired as a potential inhibitor against 
the class II Mycobacterium tuberculosis fructose-1,6-bisphosphate aldolase. The proposed 
synthetic scheme toward this 2-amino quinoline commenced with the heteroring-
unsubstituted quinoline, which would subsequently be converted to the quinoline-N-
methoxide then reacted with ammonia to form the desired product (Scheme 3.2.1). 
N
OH
F
m-CPBA N+
OH
F
O-
N
OH
F
NH2
1) (CH3)2SO42) aq. NH3
 
Scheme 3.2.1 Synthetic scheme toward amination of 2-position of quinoline, necessitating the use of heteroring-unsubstituted quinoline 
As the go-to reaction for the assembly of a heteroring-unsubstituted quinoline, the 
Skraup reaction was first attempted to obtain this precursor. 2-amino-5-fluorophenol was 
refluxed with glycerol in concentrated sulfuric acid, using sodium 3-nitrobenzene sulfonate 
as the oxidizing agent; this resulted in a thick tarry crude product. Extraction and 
purification of the quinoline from this tar proved to be prohibitively difficult; only 4% yield 
of the quinoline was attained. Since this method was not feasible as the first step of a multi-
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step synthetic scheme, it was necessary to investigate an alternative route to synthesize this 
heterocycle. 
Mechanistically related to the Skraup quinoline synthesis, the Doebner-Von Miller 
protocol is attractive due to the relatively simple workup procedure and the omission of 
harsh oxidizing agents. However, since the desired quinoline product required the 2-, 3-, 
and 4-positions of the heterocyclic ring to be unsubstituted, the α,β-unsaturated carbonyl 
annulation partner would have to be acrolein. As previously mentioned, under the standard 
DVM reaction conditions of refluxing in acid, acrolein has a high propensity to 
oligomerize, complicating the purification procedure and requiring a large excess of this 
relatively costly reagent. Tellingly, Yale’s investigation into the use of acrolein as the enal 
partner in the cyclization with aniline produced only a trace of unsubstituted quinoline 
[114].  
Previous success with the biphasic DVM method of Matsugi et al. in the cyclization 
of anilines with crotonaldehyde (Section 2.2.1) recommended the application of this 
procedure to the analogous cyclization with acrolein. Therefore, 2-amino-5-fluorophenol 
was refluxed with acrolein in a mixture of toluene and 6M HCl, giving 26% yield of the 
desired product, an increase of more than six-fold over the same reaction run under Skraup 
conditions. Encouraged by these results, it was decided to explore the optimization of this 
reaction [47]. 
3.2.1 Optimization Studies 
Investigations into the validity of this method began with the reaction of 
unsubstituted aniline with acrolein in a biphasic mixture of equal volumes of 6M HCl and 
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toluene. This reaction mixture was refluxed for 24 hours, but aniline concentrations of both 
0.50M and 0.25M yielded less than 10% of the desired quinoline.  
While substitution of HCl with either a Lewis acid (aluminum trichloride, AlCl3), 
or ten mole percent of a phase-transfer catalyst (tetrabutylammonium chloride, NBu4Cl), 
resulted in only a trace amount of product formation, dilution of the reaction mixture and 
reduction of the ratio of organic cosolvent proved advantageous. A 28% yield of quinoline 
was obtained from a 3.4:1 mixture of HCl/toluene at 0.06M aniline concentration, and the 
yield was increased to 35% with a 6.9:1 ratio of solvents at the same concentration. Both 
were allowed to react for 24 hours. Even though lower ratios of organic cosolvent were 
beneficial to the success of the reaction, complete elimination of the organic layer was 
decidedly detrimental; as had been expected, only a trace of quinoline was observed. The 
results are summarized in Table 5. 
 
 
 
 
 
 
 
 
 
 
 124 
Table 5 Optimization of quinoline synthesis using acrolein. 
NH2 + O Nacidorganic solvent  
Entry Acid Organic Solvent 
Ratio Acid: Organic 
Concentration* (M) Yield
† (%) 
1 6M HCl Toluene 1:1 0.50 2 
2 6M HCl Toluene 1:1 0.25 9 
3 6M HCl Xylenes 3.4:1 0.06 20 
4 6M HCl Xylenes 6.9:1 0.06 23 
5 6M HCl Toluene 3.4:1 0.06 28 
6 6M HCl Toluene 6.9:1 0.06 35 
7 AlCl3 CH2Cl2 - 0.20 Trace 
8 NBu4Cl (0.1 eq) Toluene - 0.25 Trace 
9 6M HCl - - 0.06 Trace 
 
Modification of other variables did not improve the reaction outcome. Under the 
most efficient reaction conditions of a 6.9:1 ratio of 6M HCl to toluene with an aniline 
concentration of 0.06M, a decreased reaction time from 24 hours to either three or six hours 
caused the yield to drop into the single digits. 
                                                 
* Aniline concentration. 
† Isolated yields. 
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The moderate product yields seen under these conditions indicated that, even with 
super-stoichiometric amounts of acrolein and an organic cosolvent to reduce acid-catalyzed 
self-condensation of this reagent, oligomerization was still a problem.  
Therefore an alternative annulation partner was sought that would be resistant to 
this process. Acrolein diethyl acetal (ADA, Figure 3.2.1) was used in lieu of acrolein due 
to its increased stability in acidic media, and a comparable yield of quinoline was obtained 
from reaction conditions identical to those that had produced 35% yield with acrolein. 
Although this did not initially represent much of an advantage, it was encouraging enough 
to continue with optimization. 
OEt
OEt
 
Figure 3.2.1 Acrolein diethyl acetal 
While conducting optimization of this reaction, it was hypothesized that the organic 
cosolvent would not be necessary. In fact, it may even hinder the efficiency of the reaction. 
Since hydrolysis of one ethoxy group of the diethyl acetal would initially need to occur for 
the reaction to proceed, sequestration of this reagent in the organic layer would only allow 
the acid-mediated hydrolysis and the subsequent annulation to take place on the interface 
of the two layers. However, omission of the organic layer would likely allow the desired 
hydrolysis to occur without incurring undesired oligomerization. 
This hypothesis was substantiated when the reaction was performed without an 
organic cosolvent. Initial conditions of refluxing aniline with acrolein diethyl acetal in 6M 
HCl at a concentration of 0.07M for 24 hours gave a very encouraging 54% yield of 
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quinoline. Even on a larger scale the reaction was relatively efficient, producing 45% of 
the expected product. However, attempts to decrease the reflux time to three or six hours 
reduced the yield by more than half. Increasing the aniline concentration to 0.1M and 0.2M 
proved even more detrimental, producing only traces of product. 
On the other hand when the reaction mixture was diluted to 0.01M, nearly the same 
efficiency was achieved after 24 hours of reflux. Increasing the reaction time to 67 hours 
marginally improved the outcome, but not enough to outweigh the inconvenience and extra 
energy usage resulting from the extended reaction time. Pleasingly, it was noted that under 
the more dilute conditions isolation of quinoline was significantly simplified, giving a 
much cleaner crude product. The results can be seen in Table 6. 
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Table 6 Optimization of quinoline synthesis using acrolein diethyl acetal. 
NH2 + NOEt
OEt HCl
  
Entry Acid Time (h) Concentration* (M) Yield† (%) 1‡ 6M HCl 24 0.06 25 
2 6M HCl 24 0.07 54 
3§ 6M HCl 24 0.07 45 
4 6M HCl 3 0.07 22 
5 6M HCl 6 0.07 25 
6 6M HCl 24 0.10 Trace 
7 6M HCl 24 0.20 Trace 
8 1M HCl 67 0.01 63 
9 1M HCl 24 0.01 56 
 
This procedure represents a marked improvement in terms of yield and purity and 
is equally efficient with both 6M and 1M HCl, meaning the amount of acid can be adjusted 
based on the scale of the reaction. It is also an advancement over previous methods – such 
as that of Yale – in terms of green chemistry practices. The omission of organic cosolvent, 
highly concentrated acids, harsh oxidizing agents, and extremely high reflux temperatures 
                                                 
* Aniline concentration. 
† Isolated yields. 
‡ Reaction run with 3.4:1 ratio of 6M HCl to toluene. 
§ Reaction run on 500 mg scale. 
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greatly increases the synthetic utility of this reaction. Also, exchanging acrolein for the 
more stable acrolein diethyl acetal drastically improved the reaction outcome. It is 
interesting to note that Yale and coworker also investigated the use of ADA in place of 
acrolein in a modified version of their quinoline synthesis [115]. However, they actually 
observed a decrease in efficiency with this reagent and decided it was not a necessary 
substitution. 
3.2.2 Scope of the Reaction 
Once the optimal reaction conditions were determined, the scope of the reaction 
was then probed with regard to various starting anilines. Initially, a variety of moderately 
electron-donating methyl substitutions on this substrate were investigated. While reaction 
of p-toluidine under these conditions gave a modest yield of 6-methylquinoline, o-toluidine 
was much more efficient, giving 83% of 8-methylquinoline. When m-toluidine was used, 
both 5- and 7-methylquinoline were produced in nearly equal amounts, showing no 
preference for cyclization one way or the other; these were produced as an inseparable 
mixture. Along the same lines, more vigorously electron-donating substituents gave similar 
results. While p-aminophenol and p-anisidine were only modestly successful, o-
aminophenol gave a more robust yield of 8-hydroxyquinoline. These series clearly show 
that electron-donating substituents ortho to nitrogen in the starting aniline assist the 
cyclization process more than other positions. The results are shown in Table 7. 
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Table 7 Singly-substituted quinoline products. 
Entry Starting Aniline Quinoline Product(s) Yield (%)* 
1 NH2 
N
26  
36 
2 NH2
 
N
27  
83 
3 NH2 
N N
28a 28b  
26 
4 NH2OH  
N
OH 29  
23 
5 NH2O  
N
O 30  
27 
6 NH2
OH
 
NOH
31  
41 
 
However, electron-withdrawing substituents in the ortho position of the starting 
aniline were slightly detrimental to the reaction efficiency. Under the same reaction 
conditions, 2-bromoaniline gave a relatively poor yield of 8-bromoquinoline. In addition, 
                                                 
* Purified yields. 
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other halogenated starting anilines were similarly ineffective. 3,4-difluoroaniline only gave 
16% yield of the single 6,7-difluoroquinoline product. Similarly, 4-iodoaniline produced 
only 9% of the desired 6-iodoquinoline. The low yield in this reaction, though, was partially 
due to extrusion of the iodine from the final product; initial purification gave a mixture of 
6-iodoquinoline and unsubstituted quinoline. Careful separation by chromatography 
allowed for isolation of the desired product. An outlier in this series was 2-bromo-4-
fluoroaniline, which produced the desired 8-bromo-6-fluoroquinoline in 55% yield. 
Aromatic and heterocyclic substituents on the aniline were also moderately 
successful but surprisingly regioselective. 6-aminobenzothiazole cyclized with ADA 
exclusively at the 5-position to give the corresponding tricyclic product in modest yield. 
The reaction with 2-aminonaphthalene was more fruitful under these conditions. The single 
product from this reaction, isolated in 46% yield, was benzo[f]quinoline, implicating the 
preference for cyclization closer to the aromatic ring rather than at the symmetric 3 
position. These results are summarized in Table 8. 
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Table 8 Variously-substituted quinoline products. 
Entry Starting Aniline Quinoline Product Yield* (%) 
1 NH2
Br
 
NBr
32  
32 
2 NH2FF  
NF
F 33  
16 
3 NH2I  
N
I 34  
9 
4 NH2
F
Br
 
N
F
Br
35  
55 
5 NH2SN  
NS
N
36  
21 
6 NH2 
N
37  
46 
                                                 
* Purified yields. 
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In a final sequence of investigations into the scope of this reaction, a series of 
substituted ortho-aminophenols were tested. These aminophenols, featuring a variety of 
both electron-donating and electron-withdrawing substituents at the 4-, 5-, or 6- positions 
on the aromatic ring, underwent the reaction with widely varying success. 
To begin, the reaction was performed on aminophenols with an electron-donating 
substituent. 2-amino-5-methylphenol and 2-amino-4-methylphenol were similarly 
amenable to this reaction, giving the appropriate quinoline products in 50% and 58% 
yields, respectively. With a combination of electron-donating and electron-withdrawing 
substituents, 2-amino-4-chlorophenol gave equally robust results with 49% yield of the 
quinoline product. While some of the fluorine-substituted 8-hydroxyquinoline products 
were easily obtained – 6-fluoro-8-hydroxyquinoline and 7-fluoro-8-hydroxyquinoline 
were isolated in 42% and 43% yields, respectively – others were less so. 5-fluoro-8-
hydroxyquinoline was substantially less successful, representing the least productive 
cyclization of the aminophenol series. These results are shown in Table 9. 
 
 
 
 
 
 133 
Table 9 Doubly-substituted hydroxyquinoline products. 
Entry Starting Aniline Quinoline Product Yield (%)* 
1 NH2
OH
 
NOH
38  
50 
2 NH2
OH
 
NOH
39  
58 
3 NH2
OH
Cl  
NOH
Cl 40  
49 
4 NH2
F
OH
 
N
F
OH
41  
42 
5 NH2
OHF
 
NOHF
42  
43 
6 NH2
OH
F  
NOH
F 43  
18 
In addition to these successful results, there were a few unexpected outcomes. 
Subjecting 4-ethynylaniline to the previous reaction conditions in 6M HCl resulted in the 
                                                 
* Purified yields. 
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cyclization product, but it also caused oxidation of the aryl alkyne to a methyl ketone 
(Scheme 3.2.2). It was determined that the kinetics of the acid-mediated oxidation of an 
alkyne is first-order in acid concentration; therefore, lowering the acid concentration could 
potentially allow the cyclization to occur more rapidly than the oxidation. However, it was 
also necessary to maintain a minimum molar ratio of acid to aniline, since it had been 
determined that lowering this molar ratio was detrimental to the cyclization. With this in 
mind, the concentration of HCl was reduced to 1M while the volume was increased 
accordingly to maintain the molar ratio. While this tactic did not result in the desired 6-
ethynylquinoline, it did proceed smoothly with a much more straightforward workup, 
providing the basis for the eventually adopted procedure. 
OEt
OEtNH2 + H3O+
N
OH
N
O  
Scheme 3.2.2 Acid-catalyzed oxidation of ethyne group to methyl ketone during quinoline cyclization 
In addition, attempts to subject 2-aminothiophenol to these reaction conditions gave 
similarly surprising results. Initial investigation into the product structure by NMR seemed 
to support product formation. However, mass spectral analysis indicated the sole product 
to be a disulfide dimer of two quinolines. These results can be seen in Table 10. 
 
 135 
Table 10 Unexpected quinoline products. 
Entry Starting Aniline Quinoline Product Yield (%)* 
1 
NH2
 
N
O 44  
32 
2 NH2
SH
 
NS
NS
45  
3 
 
3.2.3 Mechanism 
Ever since Skraup published his synthesis of quinoline via the acid-catalyzed 
annulation of aniline with glycerol over a century ago, various groups have endeavored to 
evaluate and establish a reasonable mechanism for this reaction. While it is generally 
accepted that the initial step involves acid-mediated dehydration of glycerol to acrolein 
(Scheme 3.2.3), the subsequent annulation with aniline has been a source of contention 
[105]. 
                                                 
* Purified yields. 
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OH
OH OH H
+
O
 
Scheme 3.2.3 In situ acid-catalyzed dehydration of glycerol to acrolein 
Skraup himself postulated a direct carbonyl addition and subsequent condensation 
of the aniline with acrolein, forming an intermediate Schiff base. Attack of π electrons from 
the aromatic ring on the terminal end of the alkene would result in cyclization, and the 
dihydroquinoline intermediate would rearomatize upon oxidation (Scheme 3.2.4).  
ONH2 N NH+
-H2O
H+ NH [O]
 
Scheme 3.2.4 Mechanism of quinoline cyclization postulated by Skraup 
However, this was quickly disproven by the observation that anilines react with β-
substituted α,β-unsaturated aldehydes to give exclusively 2-substituted quinolines* rather 
than the 4-substituted products expected from the Schiff base mechanism Skraup proposed 
(Scheme 3.2.5) [125]. 
N R N
R
O
R
NH2+
observed not observed  
Scheme 3.2.5 Observed 2-substituted quinoline and not observed 4-substituted quinoline products of cyclization of aniline with β-substituted α,β-unsaturated aldehydes 
                                                 
* As seen experimentally in section 2.2.1.1. 
 137 
In order to justify this observation, Bischler soon after proposed an alternative 
pathway. Taking into account Skraup’s contention that the intermediate Schiff base is 
central to the mechanism, he conceived a dual pathway, whereby the reaction could 
proceed through a direct 1,4-addition of the aniline with either the aldehyde (blue route, 
Scheme 3.2.6) or the preformed Schiff base (green route). Elimination of water or aniline 
would then provide the observed 2-substituted quinoline [125]. Koenig expanded on 
Bischler’s proposal by suggesting the product of 1,4-addition undergoes condensation with 
a second molecule of aniline (red route), thereby forming the highly electrophilic imine, 
which then undergoes ring closure and expulsion of aniline to give the 2-substituted 
quinoline [105]. 
NH2 O
R
N
OH
H R N
O
H R N R
N
R
+
+
NH2 N
R
NH
cyclization,aromatization
-PhNH2
N R
[O]
-H2O
PhNH2
N
N
H R
Ph
cyclization,aromatization
-PhNH2
N R
-H2O
 
Scheme 3.2.6 Three possible mechanistic routes for the formation of 2-substituted quinolines from the cyclization of aniline with β-substituted α,β-unsaturated aldehydes 
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In a series of ingenious experiments, several groups have independently attempted 
to determine which (if any) of these mechanistic proposals is at play in the synthesis of 
quinolines. Prominently, Denmark and coworker published a review of these studies and 
also conducted their own research on the matter. Through extensive carbon-13 labeling 
experiments, they determined that β-disubstituted carbonyls underwent a conjugate 
addition-fragmentation mechanism when combined with anilines under Skraup conditions 
(Scheme 3.2.7). This mechanism then proceeds through enamine formation, condensation 
with the carbonyl fragment, conjugate addition of a second molecule of aniline, and finally 
cyclization and aromatization. 
NH2 O+ conjugateaddition
NH O fragmentation N+H
O
enamine
NH
+H
OcondensationNconjugateaddition
PhNH2
N
NH
cyclizationaromatization N
H
 
Scheme 3.2.7 Conjugate addition-fragmentation mechanism of quinoline synthesis proposed by Denmark 
Under the novel conditions of employing acrolein diethyl acetal as the annulation 
partner, the proposed Denmark mechanism would be unproductive since the intermediate 
enamine fragment could not form. Therefore, a more traditional pathway was proposed, 
initiated by the acid-catalyzed hydrolysis of the diethyl acetal, giving the reactive 
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protonated acrolein or oxocarbenium species (Scheme 3.2.8). Subsequently, any of the 
three mechanistic routes proposed by Bischler and Koenig (blue, green, and red routes, 
Scheme 3.2.6) could conceivably occur. 
EtO OEt H+ O+ Et+O
+ H
 
Scheme 3.2.8 Protonated acrolein or oxocarbenium reactive species 
3.3 Conclusion  The synthesis of quinolines has been studied for well over a century, and there are 
a wealth of procedural options for nearly any substitution pattern desired. However, an 
efficient and “green” synthesis of heteroring-unsubstituted quinolines has been elusive, 
forcing chemists to resort to procedures that use toxic reagents or result in extremely poor 
yields. 
Therefore, the new procedure reported herein, which uses aqueous media and 
results in decent to very good yields, represents a significant step in this direction. This 
method is amenable to a broad range of substitutions on the aniline, including many 
different electron-withdrawing and electron-donating groups.  
As a highly desirable framework for building biologically active molecules, 
including a potent inhibitor of Mycobacterium tuberculosis fructose-1,6-bisphosphate 
aldolase, the quinoline moiety is an important scaffold in the field of synthetic medicinal 
chemistry. This new procedure adds to the arsenal of processes that can be used to obtain 
functionally diverse quinolines and will prove to be highly valuable in this regard. 
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3.4 Experimental Details  Experimental procedure for synthesis of heteroring-unsubstituted quinolines  
NH2R + EtO OEt 1M HCl
NR
 
1M HCl (82.5 mL) was added to the aniline in a round bottom flask. To this was added 
acrolein diethyl acetal (2.5 eq). The reaction was refluxed for 24 hours, then cooled to room 
temperature. The solution was neutralized to pH 7-8 by addition of solid Na2CO3 then 
extracted into CH2Cl2. The organic layers were combined and dried over Na2SO4 then 
concentrated by rotary evaporation. The crude residue was purified by column 
chromatography by elution of EtOAc/hexanes to give the pure product. 
Quinoline (25) Compound known in literature. 
N
 
 82.2 mg, 56% (isolated yield). 1H NMR (500 MHz, CDCl3) δ 9.24 (dd, J = 1.41, 
5.40 Hz, 1H), 9.05 (d, J = 8.23 Hz, 1H), 8.84 (d, J = 8.62 Hz, 1H), 8.24 (m, 1H), 8.10 (m, 
2H), 7.93 (ddd, J = 1.07, 6.98, 8.23 Hz, 1H). 
6-methylquinoline (26) Compound known in literature. 
N
 
 55.4 mg, 36%. 1H NMR (500 MHz, CDCl3) δ 8.87 (dd, J = 1.75, 4.24 Hz, 1H), 
8.09 (m, 1H), 8.03 (d, J = 8.56 Hz, 1H), 7.60 (dt, J = 1.02, 2.03 Hz, 1H), 7.57 (dd, J = 2.01, 
8.59 Hz, 1H), 7.38 (dd, J = 4.20, 8.27 Hz, 1H), 2.56 (s, 3H).  
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8-methylquinoline (27) Compound known in literature. 
N
 
 115.9 mg, 83%. 1H NMR (500 MHz, CDCl3) δ 8.97 (dd, J = 1.81, 4.19 Hz, 1H), 
8.90 (s, 1H), 8.16 (dd, J = 1.83, 8.22 Hz, 1H), 7.69 (m, 1H), 7.59 (m, 1H), 7.47 (m, 1H), 
7.42 (dd, J = 4.20, 8.22 Hz, 1H), 2.85 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 149.26, 
137.06, 136.38, 129.67, 128.34, 126.32, 125.89, 120.85, 18.18. 
5-methylquinoline (28a) and 7-methylquinoline (28b) Compounds known in literature. 
N N
 
 34.7 mg, 26% (mixture inseparable by chromatography). 1H NMR (500 MHz, 
CDCl3) δ 8.96 (dd, J = 1.70, 4.23 Hz, 1H), 8.91 (dd, J = 1.76, 4.30 Hz, 1H), 8.37 (ddd, J = 
0.91, 1.71, 8.50 Hz, 1H), 8.15 (m, 1H), 8.00 (m, 1H), 7.92 (m, 1H), 7.74 (d, J = 8.29 Hz, 
1H), 7.63 (dd, J = 7.02, 8.56 Hz, 1H), 7.47 (dd, J = 4.21, 8.50 Hz, 1H), 7.41 (m, 1H), 7.37 
(dd, J = 4.29, 8.23 Hz, 1H), 2.72 (m, 3H), 2.60 (d, J = 0.95 Hz, 3H). 
Quinoline-6-ol (29) Compound known in literature. 
N
OH  
35.5 mg, 23%. 1H NMR (500 MHz, MeOD) δ 8.62 (dd, J = 1.67, 4.30 Hz, 1H), 
8.15 (m, 1H), 7.89 (d, J = 9.11 Hz, 1H), 7.42 (dd, J = 4.29, 8.35 Hz, 1H), 7.37 (dd, J = 
2.69, 9.11 Hz, 1H), 7.16 (d, J = 2.72 Hz, 1H). 13C NMR (126 MHz, MeOD) δ 155.95, 
146.48, 142.62, 135.19, 130.00, 128.97, 122.13, 121.12, 108.19. 
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6-methoxyquinoline (30) Compound known in literature. 
N
O  
 44.1 mg, 27%. 1H NMR (500 MHz, CDCl3) δ 8.80 (dd, J = 1.70, 4.25 Hz, 1H), 
8.08 (m, 1H), 8.03 (d, J = 9.21 Hz, 1H), 7.39 (ddd, J = 3.54, 8.77, 10.54 Hz, 2H), 7.10 (d, 
J = 2.82 Hz, 1H), 3.96 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 157.73, 147.95, 144.46, 
134.76, 130.88, 129.30, 122.26, 121.36, 105.12, 55.54. 
Quinoline-8-ol (31) Compound known in literature. 
NOH
 
58.9 mg, 41%. 1H NMR (500 MHz, CDCl3) δ 8.82 (dd, J2-3 = 4.21 Hz, J2-4 = 1.62 
Hz, 1H, H-2), 8.42 (br s, 1H, OH), 8.18 (dd, J3-4 = 8.39 Hz, 1H, H-4), 7.47 (m, 2H, H-3, 
H-6), 7.36 (dd, J5-6 = 8.39 Hz, J5-7 = 1.19 Hz, 1H, H-5), 7.23 (dd, J6-7 = 7.69 Hz, 1H, H-7). 
13C NMR (126 MHz, CDCl3) δ 152.3, 147.9, 138.4, 136.1, 128.6, 127.7, 121.8, 117.9, 
110.1. 
8-bromoquinoline (32) Compound known in literature. 
NBr
 
 41.0 mg, 32%. 1H NMR (500 MHz, CDCl3) δ 9.08 (dd, J = 1.72, 4.23 Hz, 1H), 
8.19 (dd, J = 1.72, 8.26 Hz, 1H), 8.08 (dd, J = 1.34, 7.51 Hz, 1H), 7.82 (dd, J = 1.33, 8.21 
Hz, 1H), 7.49 (dd, J = 4.22, 8.25 Hz, 1H), 7.43 (t, J = 7.78 Hz, 1H). 13C NMR (126 MHz, 
CDCl3) δ 151.28, 145.32, 136.63, 133.21, 129.60, 127.80, 124.82, 121.93. 
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6,7-difluoroquinoline (33) 
NF
F  
Light brown powder, 23.1 mg, 16%. 1H NMR (500 MHz, CDCl3) δ 8.92 (dd, J2-3 
= 4.34 Hz, J2-4 = 1.67 Hz, 1H, H-2), 8.12 (dd, J3-4 = 8.35 Hz, 1H, H-4), 7.88 (dd, 1H, H-8), 
7.57 (dd, 1H, H-5), 7.44 (dd, 1H, H-3). 13C NMR (126 MHz, CDCl3) δ 153.3 (J = 16.2 
Hz), 151.2 (J = 11.9 Hz, 16.1 Hz), 150.6 (J = 2.9 Hz), 149.2 (J = 16.0 Hz), 145.5 (J = 10.6 
Hz), 135.2 (J = 2.0 Hz, 5.3 Hz), 125.2 (J = 8.1 Hz), 121.2 (J = 2.5 Hz), 115.8 (J = 16.4 
Hz), 112.9 (J = 1.7 Hz, 17.4 Hz). 
6-iodoquinoline (34) 
N
I  
Light tan powder, 11.2 mg, 9%. 1H NMR (500 MHz, CDCl3) δ 8.95 (dd, J2-3 = 4.09 
Hz, J2-4 = 1.61 Hz, 1H, H-2), 8.24 (d, J5-7 = 1.95, 1H, H-5), 8.07 (dd, J3-4 = 8.28 Hz, 1H, 
H-4), 7.97 (dd, J7-8 = 8.91, 1H, H-7), 7.86 (d, 1H, H-8), 7.44 (dd, 1H, H-3). 13C NMR (126 
MHz, CDCl3) δ 150.9, 147.2, 138.2, 136.5, 134.8, 131.2, 129.9, 121.7, 92.1. 
8-bromo-6-fluoroquinoline (35) 
N
F
Br
 
Off-white powder, 68.0 mg, 55%. 1H NMR (500 MHz, CDCl3) δ 9.00 (dd, J2-3 = 
4.26 Hz, J2-4 = 1.65 Hz, 1H, H-2), 8.12 (dd, J3-4 = 8.30 Hz, 1H, H-4), 7.87 (dd, J5-7 = 2.75 
Hz, 1H, H-7), 7.48 (dd, 1H, H-3), 7.43 (dd, 1H, H-5). 13C NMR (126 MHz, CDCl3) δ 159.4 
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(J = 251.6 Hz), 150.5 (J = 2.8 Hz), 142.6, 136.0 (J = 5.6 Hz), 129.3 (J = 10.3 Hz), 126.6 
(J = 10.7 Hz), 123.6 (J = 28.3 Hz), 122.5, 110.7 (J = 21.1 Hz). 
[1,3]thiazolo[4,5-g]quinoline (36) 
NS
N  
Light orange-brown powder, 40.6 mg, 21%. 1H NMR (500 MHz, CDCl3) δ 9.16 
(s, 1H, H-9), 9.03 (dd, J2-3 = 4.30 Hz, J2-4 = 1.69 Hz, 1H, H-2), 8.42 (m, 2H, H-4, H-8), 
8.20 (d, J5-8 = 9.04, 1H, H-5). 13C NMR (126 MHz, CDCl3) δ 153.5, 151.7, 150.1, 146.8, 
133.2, 130.9, 129.0, 125.3, 123.4, 121.6. 
Benzo[f]quinoline (37) Compound known in literature. 
N
 
 63.3 mg, 46%. 1H NMR (500 MHz, CDCl3) δ 8.99 (dd, J = 1.62, 4.36 Hz, 1H), 
8.96 (dd, J = 1.64, 8.33 Hz, 1H), 8.64 (dd, J = 1.30, 8.16 Hz, 1H), 8.01 (m, 2H), 7.96 (dd, 
J = 1.51, 7.92 Hz, 1H), 7.70 (dddd, J = 1.39, 7.06, 8.15, 21.48 Hz, 2H), 7.58 (dd, J = 4.37, 
8.38 Hz, 1H). 13C NMR (126 MHz, CDCl3) δ 149.74, 148.25, 131.70, 130.86, 130.68, 
129.66, 128.72, 128.23, 127.10, 127.33, 125.44, 122.59, 121.31. 
 
 
 
 
 
 145 
6-methylquinolin-8-ol (38) 
NOH
 
Light brown powder, 59.0 mg, 50%. 1H NMR (500 MHz, CDCl3) δ 8.74 (dd, J2-3 
= 4.25 Hz, J2-4 = 1.59 Hz, 1H, H-2), 8.50 (br s, 1H, OH), 8.06 (dd, J3-4 = 8.32 Hz, 1H, H-
4), 7.40 (dd, 1H, H-3), 7.11 (m, 2H, H-5, H-7), 2.52 (s, 3H, CH3). 13C NMR (126 MHz, 
CDCl3) δ 151.9, 147.0, 138.0, 137.1, 135.4, 128.6, 121.8, 116.9, 112.2, 22.2. 
5-methylquinolin-8-ol (39) 
NOH
 
Off-white powder, 1.5g, 58%. 1H NMR (500 MHz, CDCl3) δ 8.81 (dd, J2-3 = 4.20 
Hz, J2-4 = 1.57 Hz, 1H, H-2), 8.30 (dd, J3-4 = 8.51 Hz, 1H, H-4), 7.48 (dd, 1H, H-3), 7.29 
(dd, J6-7 = 7.67 Hz, 1H, H-7), 7.11 (d, 1H, H-6), 2.61 (s, 3H, CH3). 13C NMR (126 MHz, 
CDCl3) δ 150.6, 147.3, 138.6, 133.0, 127.64, 127.61, 124.3, 121.3, 109.3, 17.8.  
5-chloroquinolin-8-ol (40) Compound known in literature. 
NOH
Cl  
 61.2 mg, 49%. 1H NMR (500 MHz, CDCl3) δ 8.86 (dd, J = 1.56, 4.22 Hz, 1H), 
8.55 (dd, J = 1.56, 8.61 Hz, 1H), 8.30 (br s, 1H, OH), 7.58 (dd, J = 4.22, 8.53 Hz, 1H), 7.55 
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(d, J = 8.24 Hz, 1H), 7.14 (d, J = 8.23 Hz, 1H). 13C NMR (126 MHz, CDCl3) δ 151.39, 
148.36, 138.69, 133.38, 127.48, 126.32, 122.55, 120.38, 109.95.  
6-fluoroquinolin-8-ol (41) 
N
F
OH
 
Off-white powder, 40.0 mg, 42%. 1H NMR (500 MHz, CDCl3) δ 8.75 (dd, J2-3 = 
4.28 Hz, J2-4 = 1.53 Hz, 1H, H-2), 8.55 (br s, 1H, OH), 8.12 (dd, J3-4 = 8.34 Hz, 1H, H-4), 
7.48 (dd, 1H, H-3), 6.99 (m, 2H, H-5, H-7). 13C NMR (126 MHz, CDCl3) δ 161.6 (J = 
246.6 Hz), 154.0 (J = 14.6 Hz), 147.0 (J = 2.8 Hz), 135.8, 135.6 (J = 5.9 Hz), 128.7 (J = 
12.2 Hz), 122.8, 101.1 (J = 12.8 Hz), 100.9 (J = 5.7 Hz). 
7-fluoroquinolin-8-ol (42) 
NOHF
 
Beige powder, 25.4 mg, 42%. 1H NMR (500 MHz, CDCl3) δ 8.86 (dd, J2-3 = 4.30 
Hz, J2-4 = 1.59 Hz, 1H, H-2), 8.19 (dd, J3-4 = 8.33 Hz, 1H, H-4), 7.43 (m, 2H, H-5, H-6), 
7.34 (dd, 1H, H-3). 13C NMR (126 MHz, CDCl3) δ 148.8, 147.6 (J = 244.9 Hz), 139.5 (J 
= 7.2 Hz), 138.4 (J = 10.6 Hz), 136.2 (J = 1.8 Hz), 125.1, 120.9 (J = 2.7 Hz), 118.3 (J = 
21.5 Hz), 117.7 (J = 7.8 Hz). 
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5-fluoroquinolin-8-ol (43) 
NOH
F  
Off-white powder, 23.0 mg, 18%. 1H NMR (500 MHz, CDCl3) δ 8.86 (dd, J2-3 = 
4.33 Hz, J2-4 = 1.61 Hz, 1H, H-2), 8.43 (dd, J3-4 = 8.53 Hz, 1H, H-4), 8.03 (br s, 1H, OH), 
7.53 (dd, 1H, H-3), 7.13 (m, 2H, H-6, H-7). 13C NMR (126 MHz, CDCl3) δ 150.5 (J = 
245.9 Hz), 148.7, 148.5 (J = 3.6 Hz), 137.8 (J = 3.6 Hz), 129.8 (J = 3.0 Hz), 121.8 (J = 2.7 
Hz), 119.0 (J = 18.9 Hz), 110.7 (J = 20.8 Hz), 108.6 (J = 7.7 Hz). 
1-(quinolin-6-yl)ethan-1-one (44) 
N
O  
 110.1 mg, 37%. 1H NMR (500 MHz, DMSO-d6) δ 9.04 (m, 1H), 8.75 (s, 1H), 8.58 
(d, J = 8.29 Hz, 1H), 8.17 (m, 2H), 7.65 (dd, J = 4.20, 8.20 Hz, 1H), 2.74 (s, 3H). 13C NMR 
(126 MHz, DMSO-d6) δ 197.98, 153.33, 149.92, 138.19, 134.85, 131.14, 129.82, 127.69, 
122.81, 27.29. 
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8,8'-disulfanediyldiquinoline (45) 
NS
NS
 
 10 mg, 3%. 1H NMR (500 MHz, CDCl3) δ 9.04 (dd, J = 1.74, 4.29 Hz, 1H), 8.23 
(dd, J = 1.74, 8.35 Hz, 1H), 7.94 (dd, J = 1.25, 7.48 Hz, 1H), 7.66 (dd, J = 1.25, 8.15 Hz, 
1H), 7.53 (dd, J = 4.25, 8.31 Hz, 1H), 7.44 (dd, J = 7.48, 8.11 Hz, 1H). 13C NMR (126 
MHz, CDCl3) δ 149.46, 145.95, 136.31, 135.51, 128.36, 126.94, 125.24, 124.71, 121.78. 
Experimental procedure for reduction of nitrobenzenes to anilines. 
NO2R Fe, HClH2O/THF
NH2R
 
Procedure detailed in Section 2.6. 
2-amino-6-fluorophenol (3a) 
NH2
OHF
 
 159.8 mg, 94%. Characterization in Section 2.6. 
3,4-difluoroaniline (3b) 
NH2F
F  
 163.1 mg, 98%. 1H NMR (500 MHz, CDCl3) δ 7.78 (m, 2H), 7.36 (m, 1H).  
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1,3-benzothiazol-6-amine (3c) 
NH2S
N  
 147.4 mg, 94%. 1H NMR (500 MHz, CDCl3) δ 8.68 (s, 1H), 7.88 (d, J = 8.70 Hz, 
1H), 7.11 (d, J = 2.35 Hz, 1H), 6.84 (dd, J = 2.31, 8.69 Hz, 1H), 3.96 (s, 2H).  
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4 PHOSPHINE-CATALYZED [3+2]-CYCLOADDITION OF ALLENOATES 
WITH NAPHTHOQUINONE 
4.1 Introduction to Lewis-base catalysis and allenoate chemistry  Heterocyclic compounds such as quinolines play an important role in medicinal 
chemistry, and as has been discussed, there are a multitude of methods through which they 
are synthesized. Equally important are aromatic carbocycles, in which the main polycyclic 
skeleton is made up of only carbon atoms. This chapter will focus on the synthesis of a 
series of carbocycles via Lewis-base catalyzed [3+2] cycloadditions. 
4.1.1 Lewis-base catalysis 
The Lewis theory of acids and bases was advanced by G.N. Lewis at the beginning 
of the twentieth century. He proposed that all acids are simply electron acceptors, and bases 
are electron donors; therefore all reactions between atoms and molecules can be described 
as acid-base interactions [126]. Take for example the nucleophilic addition of a phosphorus 
ylide to a carbonyl compound (Figure 4.1.1); here the carbanion nucleophile of the Wittig 
reagent acts as the Lewis base (electron pair donator) while the carbonyl carbon 
electrophile acts as the Lewis acid (electron pair acceptor). 
PPh3 +
O
CH3
 
Figure 4.1.1 Lewis base/acid interaction 
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 In addition to acting as reagents in their own right, Lewis acids and bases can also 
act as catalysts in reactions by either drawing electron density away from (acids) or pushing 
electron density toward (bases) the substrate. Historically, Lewis acids have been the more 
popular of the two for catalytic usage. Until recently, Lewis base catalysis was 
underrepresented in the literature; generally these reagents were used instead as ligands in 
transition metal catalysts [126]. However, the last two decades have seen an influx of 
tertiary amines and phosphines as activating agents in organic syntheses [127].  
 Lewis base catalysis can very succinctly be defined, in the words of Denmark and 
Beutner, as “the process by which an electron-pair donor increases the rate of a given 
chemical reaction by interacting with an acceptor atom” with the ever-important caveat 
that the catalyst “should not be consumed or altered during the course of the reaction”. 
Lewis base catalysis takes two general forms: catalysis by nucleophilic addition and 
catalysis by polarization. Catalysis by nucleophilic addition is defined as the interaction of 
a nonbonding pair of electrons – termed “n” in molecular orbital theory – and a pi 
antibonding orbital – termed “π*”. This type of interaction is exemplified by the addition 
of an oxygen, nitrogen, or phosphorus to an alkyne, alkene, or carbonyl. Conversely, the 
interaction of a lone pair of electrons (“n”) with a sigma antibonding orbital (“σ*”) or n-
antibonding orbital (“n*”) is termed catalysis by polarization. The σ* orbital is generally 
found in organometallic species containing main-group elements, while the n* orbital is 
present in Group 13 elements such as boron and aluminum which are able to expand their 
valence shells. Of these two forms of catalysis, nucleophilic addition is by far the more 
prominent [126]. 
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 This type of catalysis represents a powerful mode of enhancing reactions and 
building complex structures from simple components [128], and it presents several key 
advantages over other forms. For instance, substrate activation by Lewis bases can be 
achieved by a wide range of modes, including enhancement of either the nucleophilicity or 
electrophilicity – or both – of the substrate [126]. In addition, Lewis base catalysts are 
highly versatile, allowing a high degree of tunability to specific requirements of reactions, 
including enantio- and regioselectivity [129]. Similarly, altering substituents on a Lewis 
base catalyst will promote varying degrees of nucleophilicity, which can be finely tuned 
depending on the needs of the reaction [130]. Finally, this method does not rely on 
transition metals to provide catalysis. This offers several advantages: metal impurities, 
which are difficult and costly to remove from compounds such as polymers, are not present 
to hinder their application in biomaterials and electronics [131]; it also eliminates heavy 
metal waste that can be toxic and expensive [130]. Indeed, Lewis base catalysts can often 
be recovered and reused. 
 During the latter half of the twentieth century, Lewis base catalysis emerged as a 
new and exciting method to achieve various reactions that previously were either 
prohibitively slow or unattainable. Tertiary and aromatic amines dominated the field in the 
beginning, catalyzing reactions such as the acylation of anilines (eq. 23, Scheme 4.1.1) and 
[2+2] cycloadditions of ketenes with aldehydes (eq 24). Phosphine catalysis emerged as 
viable method of carbon-carbon bond formation in 1962 when Price used 
triphenylphosphine as a catalyst in the hexamerization of acrylonitrile [128]. However, a 
patent from Rauhut and Currier one year later describing the phosphine-catalyzed 
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dimerization of alkenes solidified the widespread dissemination of this method (eq 25) 
[127].  
(25)
C O + Cl3C H
O N
OH
N
OMe
O
O
Cl3C
(24)
NH2Cl + Cl
O NR NH
O
Cl (23)
EWG2 P(alkyl)3 or P(Ar)3EWG=CN, CO2R
EWG
EWG
NEt3
 
Scheme 4.1.1 Examples of Lewis-base catalysis 
Less than a decade later, the eponymous Morita-Baylis-Hillman coupling of an 
activated alkene with an aldehyde built on this theme. In 1968 Morita used a phosphine 
catalyst, while four years later Baylis and Hillman used tertiary amines, but subsequent 
studies have generally shown phosphines to be the superior reagent [127]. Since then, 
phosphine catalysts have been used in Michael additions of alkenes (eq 26, Scheme 4.1.2) 
[127], cycloadditions of alkynes (eq 27) [132], and even isomerizations of alkynes to dienes 
(eq 28) [133]. 
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Scheme 4.1.2 Examples of phosphine-catalyzed reactions 
Notably, tertiary amines and phosphines often exhibit disparate catalytic 
reactivities and efficiencies; therefore the outcome of a reaction can be modified by 
switching between these two classes of catalyst (Scheme 4.1.3) [129]. The reasoning behind 
these differences encompasses various characteristics such as polarizability, geometry, and 
orbital availability.  
C OEt
O O
+
O
OEtO
O
C OEt
O
PR3 quinuclidine
phosphine-catalyzed pathway amine-catalyzed pathway  
Scheme 4.1.3 Divergent products from phosphine and amine-catalyzed reactions 
For instance, amines and phosphines display disparate reactivity in terms of basicity 
versus nucleophilicity. In the 1960s, several studies were conducted that support the 
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general tendency of amines to act predominantly as bases and phosphines to be more 
nucleophilic. The overarching theme in these trends is related to the hard/soft acid-base 
theory (HSAB). Since phosphorus, as a more polarizable atom, is a softer base than 
nitrogen, it will be less reactive toward a Brønsted acid, as protons are considered hard 
[134]. Alternatively, phosphines are more nucleophilic toward soft Lewis acids than 
otherwise comparable amines.  
These assertions are evidenced by several notable studies conducted over the last 
half-century. The aforementioned Rauhut-Currier dimerization (See eq 25, Scheme 4.1.1) 
involved conjugate addition of the phosphine catalyst to an α,β-unsaturated carbonyl, 
taking advantage of the soft phosphine nucleophile preferring addition at the similarly soft 
β carbon, rather than the harder carbonyl carbon. In fact, subsequent studies using amine 
catalysts were unable to match the catalytic power of the phosphines, and the 
intramolecular version was similarly indisposed to amine catalysis. Perhaps unsurprisingly, 
the related Morita-Baylis-Hillman reaction, in which catalysis occurs by conjugate 
addition, was also more successful using phosphines. This includes the intramolecular, 
asymmetric, and sulfinimine variants [127].  
In addition, although tertiary amines and phosphines both have pyramidal 
geometry, the inversion barriers at room temperature are quite different [127]. With an 
inversion barrier of six kcal/mol [135], amines rapidly invert (the “umbrella flip”). 
However, at 35 kcal/mol [136], the activation energy for phosphine inversion is high 
enough to consider these compounds configurationally stable at room temperature. For this 
reason, tertiary phosphines are more useful than amines in controlling stereochemistry.  
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4.1.2 Allene Chemistry and Reactivity 
Cumulated dienes, commonly known as allenes, are an interesting class of 
molecules in which both double bonds are connected to the same carbon atom (Figure 
4.1.2). They exhibit characteristics similar to both alkenes and alkynes while displaying 
reactivity greater than either [137].  
C C C
R1
R2 R4
R3
 
Figure 4.1.2 Cumulated diene, also known as allene 
Allenes have been known and synthesized since before the 1880s – clearly a highly 
productive era in the history of organic chemistry – but only in the last several decades 
have they been recognized for their versatility and synthetic utility. The peculiar reactivity 
patterns of these molecules can be at least partially attributed to their unconventional 
geometry. Since a single sp-hybridized carbon atom unites both double bonds, the three 
carbons of the allene are laid out in a straight line, but the two pi bonds are necessarily 
orthogonal [138]. This means that the molecule is not planar and the substituents on either 
end of the allene moiety are perpendicular to each other. This confers potential chirality on 
the molecule – even if there are no stereocenters – when the substituents at each end are 
distinct (Figure 4.1.3) [139].  
C C C C C C
R1
R2 R4
R3 R
1
R2
R3 R4
 
Figure 4.1.3 Perpendicular π orbital arrangement of allenes and stereochemical consequences 
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 Variations in substituents on the ends of the allene moiety drastically affect the 
reactivity of the molecule. For instance, electron-donating groups push electron density 
toward the central carbon, making it nucleophilic. On the other hand, electron-withdrawing 
groups confer electrophilicity on the central carbon, favoring addition reactions [138]. In 
particular, allenoates – a unique class of allenes in which an ester is connected to the α-
carbon – display a distinctive electrophilicity due to the strongly electron-withdrawing 
group. 
 With that being said, the diverse reactivity of allenoates render them apt for Lewis 
base-catalyzed reactions. Upon contact, a Lewis base will add to the β-carbon of the allene, 
resulting in a zwitterionic intermediate which can be depicted as an enolate, α-centered 
anion, γ-centered anion, or 1,3-dipole (Figure 4.1.4). The predominant form the 
zwitterionic intermediate takes is highly dependent on the type of Lewis base used [129]. 
In this way, switching the class of catalyst can vastly alter the resultant reactive species, 
thus altering its interaction with other substrates [140].  



OR
O
L.B.
L.B.
OR
O-
+ - L.B.
OR
O
+
-
L.B.
OR
O
+ L.B.
OR
O
- +
enolate gamma-centered alpha-centered 1,3-dipole  
Figure 4.1.4 Zwitterion intermediates from Lewis base addition: enolate, gamma-centered anion, alpha-centered anion, and 1,3-dipole 
Allenoates undergo several intriguing processes in the presence of Lewis bases, 
including coupling reactions with a variety of annulation partners. These include formal 
[3+2], [4+2], [4+3], [3+3], and [3+2+3] cycloadditions. The ability of allenoates to form 
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cyclization products is directly related to the zwitterionic intermediate. In the α-centered 
anion resonance form, the intermediate possesses both nucleophilic (at the α-carbon) and 
electrophilic (at the γ-carbon) character (see Figure 4.1.4) [141]. Therefore the single 
molecule has the ability to both donate and accept electron density, facilitating a cyclization 
reaction. Many products of these annulations have seen use as building blocks in the 
synthesis of natural products such as Lu’s total synthesis of (-)-hinesol in 2005 (Scheme 
4.1.5) [142].  
Ot-Bu
O
+
O P(Bu)3 O CO2t-Bu
OH
 
Scheme 4.1.4 Synthesis of (-)-hinesol via [3+2] cycloaddition 
One decade earlier, the same Lu had reported the first phosphine-catalyzed [3+2] 
annulation of allenoates with electron-deficient olefins to obtain cyclopentene derivatives. 
While the reaction was generally facile, furnishing the cyclization product in good yield 
under substoichiometric amounts of phosphine, the regioselectivity was minimal (Scheme 
4.1.6) [143].  
OEt
O
+ R'
ER PR3
COOEt
R
R'E
COOEt
R'E
R
+
 
Scheme 4.1.5 Lu’s intermolecular [3+2] cycloaddition between allenoates and olefins to give two regioisomeric products 
Since then many modifications have emerged, including intramolecular variants. 
Kwon et al. disclosed a simple procedure to obtain highly complex coumarins in good yield 
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with high regio- and stereoselectivity by the annulation of intramolecular allenoates and 
nitro olefins (Scheme 4.1.7) [130]. 
NO2
O O
P(p-FC6H4)3
O
N+O
O-
O  
Scheme 4.1.6 Intramolecular phosphine-catalyzed [3+2] cycloaddition 
4.2 Lewis Base Catalyzed [3+2]-Cycloaddition Reactions of Allenoates with Naphthoquinone  As previously mentioned, α-allenic esters activated by Lewis base catalysis can 
display both nucleophilic and electrophilic activity. If the anion formed from Lewis base 
attack on the central carbon is captured by an α,β-unsaturated carbonyl compound, a 
cycloaddition reaction can occur. While many reactions of this type have been reported, 
examples in the literature of quinones as the electrophilic partner are unknown. Rather, the 
only report citing the use of this reagent, by Maruyama in 1988, described the production 
of spiro compounds via photochemical [2+4] cyclizations of allene with the carbonyl of a 
quinone (Scheme 4.2.1) [144]. 
O
O
Cl
Cl
+
PhPh
h
O
Cl
Cl
O
 
Scheme 4.2.1 Photochemical [2+4] cyclization of quinone and allene 
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Exploration of this reaction began during the investigation into new quinoline 
derivatives as frameworks for biologically active molecules. Quinoline-5,8-dione, formed 
by the oxidation of 8-hydroxyquinoline (Scheme 4.2.2), was originally produced for use in 
a subsequent cyclopropanation reaction. It was noted, however, that this compound’s α,β-
unsaturated carbonyl moiety could be a suitable electrophile for attack by an allenoate 
anion. 
NO
O
NOH PIFA
 
Scheme 4.2.2 Oxidation of 8-hydroxyquinoline to quinoline-5,8-dione 
Initial attempts to perform the cyclization reaction with the quinoline derivative 
gave complex but promising results. It was decided that a simpler symmetrical analog 
would be ideal for investigating and optimizing the reaction before more complex 
substrates were employed. Therefore 1,4-naphthoquinone was identified as a possible 
replacement. 
Naphthoquinones are an intriguing class of molecules with dichotomous biological 
reactivities. On one hand, they are prevalent components of fuel combustion and tobacco 
smoke; conversely, they are important moieties in anti-inflammatory and anti-cancer 
therapeutics [145]. It is this second set of properties that make these molecules interesting 
from a medicinal chemistry perspective.  
Since quinones are responsive acceptors for conjugate addition reactions, it was 
hypothesized that a Lewis base-catalyzed reaction between allenoates and 1,4-
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naphthoquinone would result in polycyclic [3+2]-cycloaddition products (Scheme 4.2.3), 
which could potentially have interesting biological or therapeutic applications. 
O
O
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+
O
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Scheme 4.2.3 Hypothesized [3+2] cycloaddition of 1,4-naphthoquinone with allenoates 
4.2.1 Optimization Studies 
Due to the aforementioned simplicity and commercial availability of the reagents, 
1,4-naphthoquinone and ethyl-2,3-butadienoate were used as model substrates to 
determine the optimal conditions of the reaction. Using a full molar equivalent of 
triphenylphosphine as the Lewis base activator, the first variable studied was the solvent.  
To begin, in a few of the solvents that are more commonly used in this class of 
cycloaddition reaction were tested with the model substrates on a 50 mg scale. Stirring at 
room temperature under ambient atmosphere, all the trials with solvent variations gave 
encouraging results. Among the most successful trials were the reactions run under highly 
polar acetonitrile and the nearly nonpolar dichloromethane. The full results can be seen in 
Table 11. Since the reaction in dichloromethane was so efficient, giving a quantitative yield 
of product in as little as 30 minutes, it was decided to continue with the rest of the 
optimization using this solvent. 
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Table 11 Solvent variation in optimization reaction.   
O
O
+ OEt
O O
OO OEt
PPh3 (1 eq)
solventr.t., 24 hours  
Entry Solvent Yield* (%) 
1 Toluene 58 
2 Dichloromethane >99 
3 Chlorobenzene 54 
4 1,2-Dichloroethane 65 
5 Tetrahydrofuran 53 
6 Acetonitrile 91 
  
 Next the catalyst loading was explored. While the reaction proceeded robustly with 
a full equivalent of triphenylphosphine, lower ratios of the Lewis base were detrimental. 
Although a slightly reduced amount of phosphine did not seriously hinder the reaction – 
lowering the yield from 99% to 76% – further reductions were more significant. Because 
of this, further reactions were run with a full equivalent of Lewis base. The results can be 
seen in Table 12. 
                                                 
* Purified yield. 
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Table 12 Phosphine catalyst loading trials.   
O
O
+ OEt
O O
OO OEt
PPh3 (X eq)
CH2Cl2r.t., 24 hours  
Entry Phosphine equivalent Yield* (%) 
1 1 >99 
2 0.75 76 
3 0.5 31 
4 0.2 NP† 
 
 Though the outcome of the reaction using a full equivalent of triphenylphosphine 
was no doubt outstanding, it was troubling that substoichiometric amounts of the catalyst 
gave such poor results. After all, the reagent was expected to act as a “catalyst”, meaning 
it should be regenerated after each cycle and available to perform its duty again. Most 
literature examples of similar cyclization reactions use no more than ten mole percent of 
the phosphine catalyst [146, 147], therefore it was perplexing that the current reaction could 
not tolerate low phosphine loading. 
 One clue as to the source of this phenomenon was the appearance of 
triphenylphosphine oxide as a byproduct of the reaction. Unlike the Wittig or Mitsunobu 
reactions in which triphenylphosphine oxide is an expected byproduct of the normal 
                                                 
* Purified yield. † NP = No product obtained. 
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progress of the reaction, when used as a catalyst the phosphine should never oxidize but 
instead remain in its original form to participate in several catalytic cycles.  
 Since ethyl-2,3-butadienoate is an extremely common coupling reagent in Lewis 
base-catalyzed reactions, it was assumed that this compound was not the cause of the 
unwelcome oxidation. Instead the highly reactive quinone was considered the more likely 
source. To probe the validity of this insight, a trial was run in which just the 
naphthoquinone and triphenylphosphine were stirred together in DCM. As expected, TLC 
analysis of the mixture showed that in as few as ten minutes triphenylphosphine oxide had 
begun to appear. NMR analysis after chromatography of the reaction mixture showed 
definitive triphenylphosphine oxide formation as well as an unidentifiable quinone 
byproduct (Scheme 4.2.4). 
O
O
PPh3 (1 eq)
CH2Cl2
? + P Ph
O
Ph Ph  
Scheme 4.2.4 Oxidation of triphenylphosphine by 1,4-naphthoquinone 
With the deactivation of triphenylphosphine under these conditions confirmed, the 
next priority was to screen various Lewis base catalysts for resistance to oxidation by the 
quinone. As it was alluded to previously, alteration of the substituents on a phosphine or 
amine greatly affects its nucleophilicity. For instance, in the scale devised by Pearson et 
al. triethylphosphine and tributylphosphine – in which the phosphorus is attached to three 
electron-donating alkyl groups – are several orders of magnitude more nucleophilic than 
triphenylphosphine [148]. Similar trends are seen with amines.  
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Although it was assumed that alkyl substituents would make the phosphine catalyst 
too reactive, in the interest of thoroughness triethylphosphine was the first alternative 
Lewis base catalyst to be tested. It was no surprise that this resulted in almost instantaneous 
oxidation of the phosphine and no product formation. Tri(para-tolyl)phosphine gave 
similar results, as did methyldiphenylphosphine and the amine DABCO. 
In a divergent approach, it was hypothesized that an adjustment to either the steric 
or electronic properties of the catalyst would be advantageous. In response to the former, 
it was noted that Buchwald and Barder [149] had extensively studied the oxidation of 
various phosphines with molecular oxygen. During the course of their study, they 
determined the phosphine X-Phos* (Figure 4.2.1) to be extraordinarily resistant to 
oxidation.  
PiPr
iPriPr  
Figure 4.2.1 X-Phos 
Intrigued by the possible application to the current reaction, this reagent was 
utilized as the Lewis base catalyst in the cyclization of naphthoquinone with allenoate. The 
phosphine proved to be as resistant to oxidation as hoped; however, after 24 hours of 
reaction no product had formed. The excess steric hindrance of the catalyst had not only 
                                                 
* 2-Dicyclohexylphosphino-2′,4′,6′-triisopropylbiphenyl 
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prevented the unwanted interaction with the quinone, it had also prevented the desired 
interaction with the allenoate. 
After the inefficacy of the sterically hindered phosphine, it was conjectured that a 
modification to the electronic properties of the catalyst would be more efficient. Therefore, 
a phosphine containing three of the more electron-withdrawing furyl groups was utilized. 
Again, oxidation of the phosphine was minimal, but after seven days of stirring only a trace 
amount of product was formed. 
Under the assumption that a catalyst with electronic properties midway between 
triphenylphosphine and tri(2-furyl)phosphine would be ideal, a hybrid of these two 
compounds was sought. Di(2-furyl)phenylphosphine was synthesized easily from 
dichlorophenylphosphine and 2-lithiated furan (58, Scheme 4.2.5) [150].  
O n-BuLi
THF-78oC-0oC
P
O
O
58
2 PPhCl20oC-r.t.
 
Scheme 4.2.5 Synthesis of di(2-furyl)phenylphosphine 
This novel reagent was applied in equimolar amount to the model reaction. 
However, it showed much the same reactivity as the tri(2-furyl)phosphine catalyst; it gave 
very little product, with mostly naphthoquinone recovered. The full results of these trials 
can be seen in Table 13. 
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Table 13 Lewis-base catalyst optimization. 
O
O
+ OEt
O O
OO OEt
Lewis base catalyst (1 eq)
CH2Cl2  
Entry Lewis base (1 eq) Reaction time Yield* (%) 
1 Triphenylphosphine 30 min >99 
2 Methyldiphenylphosphine 1.5 hr NP 
3 Triethylphosphine 1.5 hr NP 
4 Tri(p-tolyl)phosphine 24 hr NP 
5 X-Phos 24 hr NP 
6 Tri(2-furyl)phosphine 7 days Trace 
7 Di(2-furyl)phenylphosphine 2 days Trace 
8 DABCO 1.5 hr NP 
 
Interestingly, throughout the trials it was noted that two products were formed from 
the cyclization. Upon careful scrutiny of the NMR spectra from these reactions, it appeared 
that neither of the two products were actually identical to the expected product, in which 
both carbonyls of the quinone remained intact. The proposed structures of the actual 
products can be seen in Figure 4.2.2 (59a and 59b). 
                                                 
* NP = No product formed. 
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Figure 4.2.2 Observed products of [3+2] cyclization 
These proposals initially came from the detection of a singlet at 5.49 ppm, 
indicating a phenolic OH. This led to the identification of A on compound 59a. A second 
singlet at 7.56 ppm was indicative of another phenolic OH, particularly one that is 
hydrogen-bonded, due to the downfield shift. This implied the presence of B on 59a, which 
could be hydrogen bonding with the carbonyl oxygen of the nearby ester. 
In contrast to the observed doublet and triplet resulting from the coupling of the 
protons on carbons 1 and 2 on 59a, the appearance of two sets of doublets at 7.15 and 7.2 
ppm suggested the existence of a second molecule. These doublets indicated the presence 
both carbon 1 and carbon 2 each had a single proton, which were necessarily on a double 
bond and coupling with each other, as in compound 59b.  
All reactions executed during the optimization stage resulted in a nearly equivalent 
mixture of these two products. It has not been determined what causes the additional 
oxidative step from 59a to 59b, although it is clear that the oxidation is not caused by 
atmospheric oxygen – since a sample that was left exposed to air for several weeks 
appeared unchanged in the NMR spectrum. Attempts to force the conversion to 59b by 
stirring the crude reaction mixture on silica gel were also unsuccessful. 
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Despite the uncertainty of the product mixture and the unproductive oxidation of 
the phosphine catalyst, this is undoubtedly an interesting reaction that has the potential to 
produce very high yields of polycyclic products that are appealing in a medicinal chemistry 
perspective. 
4.2.2 Scope of the Reaction 
With the most favorable reaction conditions in hand, the focus then shifted to the 
substrate scope of the reaction. Since there are two possible ways to introduce diversity 
into the reaction – by modifying the quinone or the allenoate annulation partner – both 
were addressed in this stage. 
O
O
R + R"
O
R'
O
OO R"
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Lewis base catalyst
solventr.t.
 
Scheme 4.2.6 Exploring the scope of quinone substrate 
To begin, several diversely-substituted quinones with varying electronic and steric 
characteristics were investigated (Scheme 4.2.6). These included chloro (LIX and LX, 
Figure 4.2.4), tert-butyl (LXI), and phenyl (LXII) substituents, as well as another trial 
with quinoline-5,8-dione (LXIII). Surprisingly, none of these attempted reactions resulted 
in identifiable cyclization products. 
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Figure 4.2.3 Variously substituted quinones tested in [3+2] cyclization reaction 
Therefore it was decided to concentrate on variations in the allenoate partner of the 
cycloaddition. Several simple modifications can result in interestingly diverse products, so 
a few of these were explored, including an assortment of ester and γ-carbon substitutions. 
Many non-commercially available allenoates can be synthesized through a series 
of reactions starting with the production of bromoacetyl bromide by refluxing acetic acid 
and molecular bromine with phosphorus tribromide (Scheme 4.2.7). However, due to the 
harsh conditions and the difficulty in removing excess bromine from the product, it was 
found to be much more productive to use commercial bromoacetyl bromide. 
CH3 OH
O
+ Br2 PBr3 Br
OBr
 
Scheme 4.2.7 Production of bromoacetyl bromide by reaction of acetic acid with bromine 
The formation of α-bromo esters [147] from bromoacetyl bromide was a 
straightforward process by which the bromide and the desired alcohol were combined 
under anhydrous conditions and stirred at room temperature (Scheme 4.2.8). The esters 
were generally formed in very high yield, although a few – such as the isopropyl and tert-
butyl esters – were less facile due to steric complications. 
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Scheme 4.2.8 Formation of alpha-bromo esters by reaction of bromoacetyl bromide with alcohols 
Next the α-bromo esters were easily converted to their corresponding 
triphenylphosphonium salts by addition of triphenylphosphine in universally high yields 
(Scheme 4.2.9) [147]. This procedure was aided by the use of toluene as solvent, which 
ensured that the salts would precipitate out of solution, enabling a smooth isolation. 
Br OR
O
+ toluene Ph3P OR
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P Ph
Ph
Ph  
Scheme 4.2.9 Formation of triphenylphosphonium bromide esters 
In order to form the ylide esters that would subsequently be converted into the 
allenoates by Wittig reaction, the triphenylphosphonium bromide esters were vigorously 
stirred in sodium hydroxide (Scheme 4.2.10) [147]. It was noted that the deprotonation at 
the α-carbon was nearly instantaneous – the insoluble ylide clumped around the stirbar 
within seconds. Therefore a small volume of DCM was added to the reaction mixture, 
allowing the ylide esters to dissolve and facilitating their isolation.  
Ph3P OR
O+
Br-
NaOH
H2O
Ph3P OR
O
 
Scheme 4.2.10 Formation of ylide ester by NaOH deprotonation at the alpha-carbon 
Finally the allenoates were prepared by a method similar to that of MacMillan 
[151], whereby the ylide was combined with an acyl chloride under basic conditions 
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(Scheme 4.2.11). It was noted that the use of triethylamine and DCM that had been dried 
over molecular sieves increased the yield of allenoate product.  
Ph3P OR
O
+ Cl R'
O NEt3
CH2Cl20 oC-rt
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O
R'  
Scheme 4.2.11 Formation of allenoates by reaction of ylide esters with acyl chlorides 
However, isolation of some allenoates proved extraordinarily difficult. Smaller 
allene esters – especially those unsubstituted at the γ-carbon – are predicted to have boiling 
points in the vicinity of many common solvents such as hexane and ethyl acetate, meaning 
the same conditions used to isolate the allenoates from these solvents would also cause at 
least partial evaporation of the products. This effect was not as pronounced with the larger 
alkyl and aromatic esters – and those with substitutions on the γ-carbon – so the range of 
yields was broad. Even with modifications to the procedure such as cooling during 
filtration, liquid injection of the crude product into the chromatography column, and 
heatless evaporation of solvent from the product fractions, several attempted allenoates 
proved too difficult to obtain. 
 The allenoates that were isolated in acceptable quantity were then subjected to the 
previously described conditions of [3+2]-cycloaddition with 1,4-naphthoquinone. Much 
like the model reagent ethyl-2,3-butadienoate, the γ-unsubstituted allenoates proved 
amenable to the phosphine-assisted cyclization process. However, despite the 
disappearance of the starting quinone on TLC, the isolated yields of these products were 
not as impressive as the initial trial during the optimization phase.  
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In addition, the ratio of products (analogous to 59a and 59b, see Figure 4.2.2) were 
inconsistent for these trials. While the butyl and isopentyl derivatives produced only the 
diphenol product (60 and 62, respectively, Figure 4.2.5), the n-pentyl allenoate cyclized to 
give only the monophenol product (61). 
OH
OHO O
OH
OO O
60 61
OH
OHO O
62  
Figure 4.2.4 [3+2] cycloaddition products of butyl, pentyl, and isopentyl allene esters with 1,4-naphthoquinone 
 Even more perplexing were the products of γ-substituted allenoate cyclization. 
While NMR analysis indicated a successful cyclization, the form the products took is yet 
to be determined. There may be other as-of-yet unidentified mechanistic factors at play in 
these cases. Also, because of the inherent chirality of γ-substituted allenoates, the increased 
complexity of the reaction due to enantiomeric product formation is a matter that should 
be taken into account.  
4.2.3 Mechanism 
Lu was the first to report the phosphine-catalyzed [3+2] cycloaddition reaction of 
allenoates with olefins and was also the first to propose a mechanism for the process, which 
is applicable to the current conditions of using quinones as the olefin acceptor. Very 
simply, the mechanism begins with nucleophilic attack of the phosphine on the 
electrophilic β-carbon of the allene (Scheme 4.2.12). This leads to a zwitterionic 
intermediate. The anion then attacks the double bond of the olefin via either the α- or γ-
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carbon, displacing the π electrons, which then attack the nearby electrophilic center on the 
allene, generating an ylide intermediate. Proton transfer and elimination of the phosphine 
to form the double bond complete the process and result in product formation [143].  
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Scheme 4.2.12 Mechanism of [3+2] cycloaddition of allenoate with quinone 
Several groups have undertaken mechanistic studies to more thoroughly elucidate 
this elegant process. Specifically, through a joint effort of experiment and computation, Yu 
and coworkers [152] concluded the reaction proceeded as indicated through the [3+2] 
cycloaddition process. However, at the proton transfer stage, they determined that the 
activation energy of an intramolecular [1,2] proton shift was prohibitively high (39.6 
kcal/mol) and could not be accomplished. However if a trace amount of water is available 
to act as a catalyst (Scheme 4.2.13), the activation energy of this transfer is substantially 
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decreased (7.7 kcal/mol). Deuterium-labeling experiments confirmed the exchange of 
deuterium for a proton (from H2O) in the final product (blue H in red molecule, Scheme 
4.2.13). This insight could have interesting implications in the experimental procedure of 
this type of reaction. 
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Scheme 4.2.13 [1,2] proton transfer assisted by a molecule of water 
4.3 Future directions and conclusion  The [3+2] cycloaddition of allenoates with quinones is appealing on both a 
mechanistic and functional level. While the mechanism of the reaction is elegantly 
straightforward, the carbocycles achieved by these annulations are inherently interesting 
on a medicinal basis. These details enhance the synthetic practicality of this reaction.  
However, there are still many challenges to overcome. The inconsistency of 
annulation products is one area that needs to be addressed. Since the reaction mixture most 
often produces an equal amount of the oxidized and unoxidized products, this decreases 
the yield of each. Finding a method to force the product into one or the other form is a top 
priority of future research in this area. 
Also, the current loading of a full equivalent of phosphine is problematic. The 
increased reactivity of quinones over other α,β-unsaturated carbonyls means the phosphine 
catalyst needs to be specifically tuned to prevent its interaction with the quinone. Further 
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investigation into hybrid phosphines that present an intermediate reactivity pattern would 
be beneficial to the efficiency of the process. 
Stereochemical tuning is also an interesting direction for research in this area. The 
enantiomeric resolution of allenoates and their cyclization products would be intriguing. In 
addition, the successful use of asymmetric quinones would lend additional insight into the 
mechanistic tendencies and regioselectivity of the reaction. 
In all, while a lot has been accomplished on this front, including the synthesis of 
interesting new allenoates and their novel cyclizations with 1,4-naphthoquinone, there 
remains a multitude of areas to explore. This process, while new and not fully developed, 
possesses a great amount of potential, and it will be interesting to see where it leads. 
4.4 Experimental Details  Experimental procedure for the synthesis of alpha-bromo acetates [147] 
Br
OBr + ROH OR
OBrDIPEA
CHCl3  
Anhydrous CHCl3 (5 mL) was added to bromoacetyl bromide (25 mmol). The 
appropriate alcohol (2 eq, dried over 3Å MS), and anhydrous diisopropylethylamine (1 eq) 
were combined, and this mixture was added to the flask dropwise at room temperature, via 
addition funnel, over the course of 30 minutes. This mixture was stirred at room 
temperature overnight, then purified by flash chromatography over silica gel by elution of 
5% ethyl acetate/hexanes. 
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Propyl bromoacetate (46a) 
Br O
O
 
 2.67g, 60%. 
Isopropyl bromoacetate (46b) 
Br O
O
 
 2.02g, 45%. 
Butyl bromoacetate (46c) 
Br O
O
 
 15.79g, 82%. 
Butan-2-yl bromoacetate (46d) 
Br O
O
 
 4.32g, 89%.  
 
 
tert-Butyl bromoacetate (46e) 
Br O
O
 
 1.57g, 33%. 
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Pentyl bromoacetate (46f) 
Br O
O
 
 5.09g, 99%. 
Isopentyl bromoacetate (46g) 
Br O
O
 
 4.12g, 80%. 
Octyl bromoacetate (46h) 
Br O
O
 
 5.76g, 92%. 
Experimental procedure for triphenylphosphonium bromide esters [147] 
Br OR
O
+ P toluene Ph3P OR
O+
Br-  
Toluene (3 mL) was added to the alpha-bromo ester from the previous reaction (1 
mmol). To this was added triphenylphosphine (1 eq). The reaction was stirred at room 
temperature overnight. The solid precipitate was then filtered off, washed on the filter with 
toluene, and air-dried to give the triphenylphosphonium bromide ester. 
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(Propoxycarbonylmethyl)triphenylphosphonium bromide (47a) 
Ph3P O
O+
Br-  
 4.58g, 70%. 
(Isopropoxycarbonylmethyl)triphenylphosphonium bromide (47b) 
Ph3P O
O+
Br-  
 3.8g, 88%. 
(Butoxycarbonylmethyl)triphenylphosphonium bromide (47c) 
Ph3P O
O+
Br-  
 31.64g, 85%. 
(sec-Butoxycarbonylmethyl)triphenylphosphonium bromide (47d) 
Ph3P O
O+
Br-  
 2.85g, 74%. 
(tert-Butoxycarbonylmethyl)triphenylphosphonium bromide (47e) 
Ph3P O
O+
Br-  
 521.9mg, 74%. 
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(Pentoxycarbonylmethyl)triphenylphosphonium bromide (47f) 
Ph3P O
O+
Br-  
 9.02g, 79%. 
(Isopentoxycarbonylmethyl)triphenylphosphonium bromide (47g) 
Ph3P O
O+
Br-  
 8.59g, 93%. 
(Octoxycarbonylmethyl)triphenylphosphonium bromide (47h) 
Ph3P O
O+
Br-  
 10.53g, 89%. 
Experimental procedure to produce ylide esters [147] 
Ph3P OR
O+
Br-
NaOH
H2O
Ph3P OR
O
 
 H2O (16 mL) was added to the triphenylphosphonium bromide ester from the 
previous reaction (6 mmol). This mixture was stirred at room temperature for 10 minutes, 
then 6M NaOH was added (10 mL). This was stirred at room temperature for an additional 
10 minutes. Dichloromethane (30 mL) was added and stirred an another 30 minutes. The 
aqueous layer was separated and extracted with dichloromethane (3x30mL). The combined 
organic layers were dried over Na2SO4 then evaporated to give the ylide ester. 
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  Propyl (triphenylphosphoranylidene)acetate (48a) 
 Ph3P O
O
 
2.41g, 99%. 
Isopropyl (triphenylphosphoranylidene)acetate (48b) 
Ph3P O
O
 
2.26g, 93%. 
Butyl (triphenylphosphoranylidene)acetate (48c) 
Ph3P O
O
 
26.39g, quantitative yield. 
sec-Butyl (triphenylphosphoranylidene)acetate (48d) 
Ph3P O
O
 
2.04g, quantitative yield. 
tert-Butyl (triphenylphosphoranylidene)acetate (48e) 
Ph3P O
O
 
656.0mg, 78%. 
Pentyl (triphenylphosphoranylidene)acetate (48f) 
Ph3P O
O
 
3.98g, 96%. 
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Isopentyl (triphenylphosphoranylidene)acetate (48g) 
Ph3P O
O
 
3.5g, 85%. 
Octyl (triphenylphosphoranylidene)acetate (48h) 
Ph3P O
O
 
4.0g, 95%. 
Experimental procedure for the synthesis of allenoates [151] 
Ph3P OR
O
+ Cl R'
O NEt3
CH2Cl20 oC-rt
OR
O
R'  
Anhydrous dichloromethane (3 mL) was added to the phosphorus ylide (1 mmol). 
To this was added triethylamine (2 eq, dried over 3Å MS), and the mixture was stirred on 
ice. After 20 minutes, the acyl chloride (2 eq) was added dropwise. After addition, the 
mixture was stirred on ice for 1.5 hours, then taken off ice and stirred at room temp for an 
additional 1-2 hours. The solvent was evaporated from the reaction mixture under reduced 
pressure. Diethyl ether was added to the crude oil, and the solids were filtered off. The 
ether was partially evaporated from the filtrate, and the crude product was purified by flash 
chromatography over silica gel by elution with hexanes-ethyl acetate. 
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Propyl buta-2,3-dienoate (49a) 
O
O
 
 Colorless oil 8.6 mg, 10%.  
Propyl penta-2,3-dienoate (49b) 
O
O
 
Colorless oil 30.5 mg, 27%.  
Propyl hexa-2,3-dienoate (49c) 
O
O
 
Colorless oil 12.5 mg, 10%. 
Isopropyl buta-2,3-dienoate (50a) 
O
O
 
Colorless oil 3.4 mg, 8%.  
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Isopropyl penta-2,3-dienoate (50b) 
O
O
 
Colorless oil 12.9 mg, 19%.  
Isopropyl hexa-2,3-dienoate (50c) 
O
O
 
Colorless oil 41.6 mg, 58%.  
Butyl buta-2,3-dienoate (51a) 
O
O
 
Colorless oil, 560.1 mg, 36%. 1H NMR (500 MHz, CDCl3) δ 5.65 (t, J = 6.55 Hz, 
1H), 5.23 (d, J = 6.56 Hz, 2H), 4.16 (t, J = 6.73 Hz, 2H), 1.65 (m, 2H), 1.40 (m, 2H), 0.95 
(t, J = 7.41 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 215.72, 165.79, 88.03, 79.16, 64.85, 
30.65, 19.08, 13.68. 
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Butyl penta-2,3-dienoate (51b) 
O
O
 
Colorless oil, 1.35g, 86%.  1H NMR (500 MHz, CDCl3) δ 5.58 (m, 2H), 4.15 (t, J 
= 6.70 Hz, 2H), 1.80 (dd, J = 3.32, 7.23 Hz, 3H), 1.65 (m, 2H), 1.41 (m, 2H), 0.95 (t, J = 
7.41 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 212.94, 166.31, 90.14, 87.67, 64.67, 30.68, 
19.11, 13.70, 12.77. 
Butyl hexa-2,3-dienoate (51c) 
O
O
 
Colorless oil, 4.07g, 83%. 1H NMR (500 MHz, CDCl3) δ 5.68 (q, J = 6.33 Hz, 1H), 
5.61 (dt, J = 3.29, 3.29, 6.32 Hz, 1H), 4.14 (qt, J = 6.67, 10.83 Hz, 2H), 2.15 (m, 2H), 1.64 
(ddt, J = 6.50, 7.91, 8.87 Hz), 1.40 (m, 2H), 1.08 (t, J = 7.41 Hz, 3H), 0.94 (t, J = 7.40 Hz, 
3H). 13C NMR (126 MHz, CDCl3) δ 212.12, 166.37, 96.99, 88.81, 64.59, 30.67, 20.32, 
19.10, 18.03, 13.67. 
sec-Butyl buta-2,3-dienoate (52a) 
O
O
 
Colorless oil 56.4 mg, 19%.  
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sec-Butyl penta-2,3-dienoate (52b) 
O
O
 
Colorless oil 203.7 mg, 63%.  
sec-Butyl hexa-2,3-dienoate (52c) 
O
O
 
Colorless oil 222.1 mg, 63%. 1H NMR (500 MHz, CDCl3) δ 5.69 (qd, J = 2.07, 
6.36 Hz, 1H), 5.61 (dt, J = 3.27, 6.35 Hz, 1H), 4.91 (hd, J = 1.13, 6.27 Hz, 1H), 2.17 (m, 
2H), 1.61 (m, 2H), 1.25 (dd, J = 4.59, 6.28 Hz, 3H), 1.09 (t, J = 7.42 Hz, 3H), 0.93 (td, J = 
3.13, 7.45 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 212.04 (J = 4.02 Hz), 166.04, 96.96, 
89.22 (J = 3.80 Hz), 72.55, 28.84, 20.85, 19.46 (J = 13.35 Hz), 13.10 (J = 6.50 Hz), 9.62 
(J = 2.14 Hz). 
tert-Butyl buta-2,3-dienoate (53a) 
O
O
 
Colorless oil 2.4 mg, 4%.  
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tert-Butyl penta-2,3-dienoate (53b) 
O
O
 
Colorless oil 7 mg, 15%.  
tert-Butyl hexa-2,3-dienoate (53c) 
O
O
 
Colorless oil 55.5 mg, 90%.  
Pentyl buta-2,3-dienoate (54a) 
O
O
 
Colorless oil 195.4 mg, 50%. 1H NMR (500 MHz, CDCl3) δ 5.64 (t, J = 6.54 Hz, 
1H), 5.22 (d, J = 6.55 Hz, 2H), 4.14 (t, J = 6.80 Hz, 2H), 1.66 (m, 2H), 1.34 (m, 4H), 0.91 
(m, 3H). 13C NMR (126 MHz, CDCl3) δ 215.72, 165.78, 88.03, 79.16, 65.13, 28.29, 27.99, 
22.29, 13.92. 
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Pentyl penta-2,3-dienoate (54b) 
O
O
 
Colorless oil 310.8mg, 51%. 1H NMR (500 MHz, CDCl3) δ 5.49 (m, 2H), 4.05 (m, 
2H), 1.71 (dd, J = 3.31, 7.28 Hz, 3H), 1.58 (m, 2H), 1.27 (m, 4H), 0.83 (t, J = 1.76 Hz, 
3H). 13C NMR (126 MHz, CDCl3) δ 212.94, 166.32, 90.15, 87.68, 64.96, 28.31, 28.04, 
22.30, 13.95, 12.78. 
Pentyl hexa-2,3-dienoate (54c) 
O
O
 
Colorless oil 462.0mg, 69%. 1H NMR (500 MHz, CDCl3) δ 5.65 (dq, J = 1.10, 
6.29 Hz, 1H), 5.58 (dtd, J = 1.13, 3.29, 6.34 Hz, 1H), 4.10 (m, 2H), 2.13 (m, 2H), 1.63 (p, 
J = 6.45 Hz, 3H), 1.32 (m, 3H), 1.05 (td, J = 1.05, 7.39 Hz, 3H), 0.88 (m, 3H). 13C NMR 
(126 MHz, CDCl3) δ 212.14, 166.42, 97.02, 88.84, 64.91, 28.31, 28.05, 22.30, 20.84, 
13.95, 13.05. 
Isopentyl buta-2,3-dienoate (55a) 
O
O
 
Colorless oil 80.8mg, 17%. 1H NMR (500 MHz, CDCl3) δ 5.63 (t, J = 6.56 Hz, 
1H), 5.21 (d, J = 6.62 Hz, 2H), 4.18 (t, J = 6.92 Hz, 2H), 1.69 (m, 1H), 1.55 (q, J = 6.90, 
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6.85 Hz, 2H), 0.92 (d, J = 8.07 Hz, 6H). 13C NMR (126 MHz, CDCl3) δ 215.72, 165.75, 
88.01, 79.13, 63.65, 37.29, 25.07, 22.43. 
Isopentyl penta-2,3-dienoate (55b) 
O
O
 
Colorless oil 156.4mg, 58%. 1H NMR (500 MHz, CDCl3) δ 5.57 (m, 2H), 4.17 (t, 
J = 6.87 Hz, 2H), 1.79 (dd, J = 3.29, 7.27 Hz, 3H), 1.70 (m, 1H), 1.55 (q, J = 6.87, 6.88 
Hz, 2H), 0.93 (d, J = 6.68 Hz, 6H). 13C NMR (126 MHz, CDCl3) δ 212.94, 166.29, 90.13, 
87.68, 63.50, 37.32, 25.15, 22.47. 
Isopentyl hexa-2,3-dienoate (55c) 
O
O
 
Colorless oil 285.4 mg, 65%. 1H NMR (500 MHz, CDCl3) δ 5.67 (q, J = 6.34 Hz, 
1H), 5.60 (dt, J = 3.29, 6.36 Hz, 1H), 4.16 (m, 2H), 2.15 (m, 2H), 1.70 (dp, J = 6.72, 13.44 
Hz, 1H), 1.55 (m, 2H), 1.07 (t, J = 7.41 Hz, 3H), 0.93 (dd, J = 1.18, 6.67 Hz, 6H). 13C 
NMR (126 MHz, CDCl3) δ 212.12, 166.33, 96.98, 88.82, 63.42, 37.32, 25.13, 22.47, 22.43, 
20.82, 13.03. 
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Octyl buta-2,3-dienoate (56a) 
O
O
 
Colorless oil 276 mg, 44%. 1H NMR (500 MHz, CDCl3) δ 5.62 (t, J = 6.56 Hz, 
1H), 5.20 (d, J = 6.54 Hz, 2H), 4.12 (t, J = 6.80 Hz, 2H), 1.64 (dq, J = 6.75, 6.75, 6.73, 
8.14 Hz, 2H), 1.29 (m, 10H), 0.87 (t, J = 6.87 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 
215.70, 165.67, 87.99, 79.06, 65.09, 31.74, 29.14 (J = 3.43 Hz), 28.58, 25.82, 22.59, 14.00. 
Octyl penta-2,3-dienoate (56b) 
O
O
 
Colorless oil 299 mg, 69%. 1H NMR (500 MHz, CDCl3) δ 5.52 (m, 2H), 4.08 (t, J 
= 6.78 Hz, 2H), 1.73 (dd, J = 3.35, 7.26 Hz, 2H), 1.60 (m, 2H), 1.26 (m, 11H), 0.84 (t, J = 
6.86 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 212.86, 166.09, 89.99, 87.59, 64.81, 31.71, 
29.13 (J = 1.68 Hz), 28.57, 25.82, 22.57, 13.97, 12.67. 
Octyl hexa-2,3-dienoate (56c) 
O
O
 
Colorless oil 527 mg, 80%. 1H NMR (500 MHz, CDCl3) δ 5.68 (q, J= 6.33 Hz, 
1H), 5.62 (dt, J = 3.29, 3.29, 6.30 Hz, 1H), 4.13 (m, 2H), 2.17 (m, 2H), 1.66 (dq, J = 6.70, 
8.34 Hz, 2H), 1.32 (m, 10H), 1.09 (t, J = 7.40 Hz, 3H), 0.89 (t, J = 6.88 Hz, 3H). 13C NMR 
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(126 MHz, CDCl3) δ 212.12, 166.34, 96.98, 88.84, 64.89, 31.75, 29.17 (J = 1.71 Hz), 
28.63, 25.88, 22.62, 20.83, 14.04, 13.05. 
Benzyl buta-2,3-dienoate (57a) 
O
O
 
Colorless oil. 90.2mg, 42%. 1H NMR (500 MHz, CDCl3) δ 7.32 (m, 5H), 5.69, (t, 
J = 6.53 Hz, 1H), 5.24 (d, J = 6.55 Hz, 2H), 5.20 (s, 2H). 13C NMR (126 MHz, CDCl3) δ 
216.02, 165.54, 135.90, 87.88, 79.44, 77.36, 77.10, 76.85, 66.64. 
Benzyl penta-2,3-dienoate (57b) 
O
O
 
Colorless oil. 12.0 mg, 2%. 
Benzyl hexa-2,3-dienoate (57c) 
O
O
 
Colorless oil. 156.5 mg, 63%. 
 
 
 
 
 192 
Experimental procedure for the synthesis of di(2-furyl)phenylphosphine [150] 
O n-BuLi
THF-78oC-0oC
PCl2Ph
0oC-r.t. PO
O2
 
 THF (5 mL) was added to furan (2.2 mmol) at -78°C. n-Butyl lithium (2.2 mmol) 
was cooled to -78°C and added to the mixture. This was stirred at -78°C for 30 minutes, 
then placed in an ice bath. After 30 minutes in the ice bath, dichlorophenylphosphine (1 
mmol) was added slowly. The reaction was allowed to slowly warm to room temperature, 
and was stirred at that temperature overnight. It was then diluted with NH4Cl and extracted 
into EtOAc. The organic layers were washed with saturated NaCl, dried over Na2SO4, and 
purified by flash chromatography over silica gel by elution of hexanes/ethyl acetate. 
Di(2-furyl)phenylphosphine (58) 
P
O
O
 
 Yellow oil, 313.4 mg, 22%. 
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Experimental procedure for the [3+2] cyclization of allenoates with quinones  
O
O
R + R"
O
R'
O
OO R"
R
R'
Lewis base catalyst
solventr.t.
 
 The quinone (1 mmol) was dissolved in CH2Cl2 (3 mL). To this was added the 
allenoate (2 eq) then the Lewis base (0.2, 0.5, 0.75. or 1.0 eq, depending on the reaction). 
The reaction was stirred at room temperature for the specified amount of time, then the 
solvent was evaporated and the crude product was purified by flash chromatography over 
silica gel via elution of hexanes/ethyl acetate. 
Ethyl 4,9-dihydroxy-1H-cyclopenta[b]naphthalene-3-carboxylate (59a) 
OH
OHO OEt  
 29.3 mg, 32%. 1H NMR (500 MHz, CDCl3) δ 8.14 (ttd, J = 2.05, 3.29, 3.90, 5.64 
Hz, 2H), 7.58 (s, 1H, OH), 7.50 (m, 2H), 6.92 (t, J = 4.31 Hz, 1H), 5.49 (s, 1H, OH), 4.96 
(d, J = 4.31 Hz, 2H), 4.37 (q, J =7.13 Hz, 2H), 1.41 (t, J = 7.13 Hz, 3H). 
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Ethyl 9-hydroxy-4-oxo-4H-cyclopenta[b]naphthalene-3-carboxylate (59b) 
OH
OO OEt  
 62.7 mg, 68%. 1H NMR (500 MHz, CDCl3) δ 8.15 (m, 1H), 8.07 (m, 1H), 7.61 
(m, 2H), 7.21 (d, J = 3.29 Hz, 1H), 7.14 (d, J = 3.29 Hz, 1H), 4.47 (q, J = 7.14 Hz, 2H), 
1.46 (t, J = 7.14 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 179.93, 169.30, 166.80, 134.45, 
134.39, 133.83, 133.17, 132.96, 132.72, 127.94, 127.69, 126.61, 124.03, 118.60, 62.69, 
14.20. 
Butyl 4,9-dihydroxy-1H-cyclopenta[b]naphthalene-3-carboxylate (60) 
OH
OHO O  
 18.3 mg, 24%. 1H NMR (500 MHz, DMSO-d6) δ 9.78 (s, 1H, OH), 8.06 (m, 1H), 
8.00 (m, 1H), 7.48 (m, 2H), 7.39 (s, 1H, OH), 6.90 (t, J = 4.24 Hz, 1H), 4.92 (d, J = 4.27 
Hz, 2H), 4.25 (t, J = 6.57 Hz, 2H), 1.69 (m, 2H), 1.42 (m, 2H), 0.95 (m, 3H). 
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Pentyl 9-hydroxy-4-oxo-4H-cyclopenta[b]naphthalene-3-carboxylate (61) 
OH
OO O  
 1.6 mg, 2%. 1H NMR (500 MHz, CDCl3) δ 8.16 (m, 1H), 8.08 (m, 1H), 7.61 (m, 
2H), 7.21 (d, J = 3.29 Hz, 1H), 7.15 (d, J = 3.29 Hz, 1H), 4.41 (t, J = 6.67 Hz, 2H), 1.83 
(m, 2H), 1.45 (dddd, J = 4.18, 6.85, 12.39, 13.98 Hz, 4H), 0.97 (m, 3H). 
3-methylbutyl 4,9-dihydroxy-1H-cyclopenta[b]naphthalene-3-carboxylate (62) 
OH
OHO O  
 33.9 mg, 46%. 1H NMR (500 MHz, CDCl3) δ 8.14 (m, 2H), 7.58 (s, 1H, OH), 
7.50 (m, 2H), 6.89 (t, J = 4.30 Hz, 1H), 5.55 (s, 1H, OH), 4.95 (d, J = 4.32 Hz, 2H), 4.34 
(t, J = 6.85 Hz, 2H), 1.69 (m, 1H), 1.55 (q, J = 6.90, 6.85 Hz, 2H), 0.92 (d, J = 8.07 Hz, 
6H). 
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5 FINAL THOUGHTS 
The three projects I have participated in over the last three years may seem disparate 
on the surface, but their commonality runs deep. My initial work on the MtFBA project 
was exciting and generally gratifying, and it expanded my knowledge of diversification 
and synthesis exponentially. But one of the most rewarding aspects of this endeavor was 
the chance it gave me to develop my second project, the novel quinoline synthesis 
procedure. This presented my first solo plunge into the depths of organic chemistry, and I 
reveled in the chance to make my own way in this area. The allenoate project was a recent 
addition that merged the process of reaction optimization with the construction of diverse 
polycyclic compounds, requiring skills and knowledge earned from the previous two 
projects. As with the quinoline synthesis, this project was also borne out of circumstances 
related to finding analogs for the MtFBA project, expanding the thread that connects these 
three stories.  
My hopes for the future are that both the MtFBA and allenoate projects continue to 
be fruitful. These ventures have granted me moments of both intense joy and intense 
frustration, and I hope whoever carries them on can find some of the answers that have so 
far been elusive. After all: It is good to have an end to journey toward; but it is the journey 
that matters, in the end. ~Ernest Hemingway
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